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Abstract 
Childhood and adolescent obesity is a global public health issue, with 
increasing prevalence in developing and industrialized nations. Known to track into 
adulthood, it is a contributor to numerous adverse health indices including Type 2 
Diabetes and cardiovascular disease. Increasing evidence suggests that 
environmental factors may be involved with weight dysregulation, including altering 
hormone balance and number, size, and distribution of adipocytes. Exposures or 
stimuli that occur at sensitive periods of development may alter the growth 
trajectory of an individual. Preterm birth and exposures to the environmental 
endocrine-disrupting compounds (EDC) Bisphenol A (BPA) and phthalates are 
suspected of disrupting numerous physiological processes. Preterm birth is 
hypothesized to be an adverse stimulus that puts the individual on accelerated 
growth trajectory. Whereas, exposures to EDCs have been associated with obesity 
and increased waist circumference. 
The objectives of this dissertation were to determine whether preterm birth 
and exposures to BPA and phthalate metabolites in the third trimester of pregnancy 
and during adolescence were associated with adolescent weight status, fat 
distribution, and altered BMI and height trajectories. Using children from the Early 
Life Exposure in Mexico to ENvironmental Toxicants (ELEMENT) cohorts, we found 
that preterm birth was not associated with adolescent obesity, BMI, and waist 
circumference. BPA and phthalate metabolites were non-monotonically associated 
with adolescent BMI z-score, waist circumference, and triceps skinfold and differed 
in direction of association by sex as well as timing of exposure. Significant 
associations of these outcomes were mainly negative and observed in second and 
third quartile exposures with MECPP, MEHHP, MEOHP, MiBP, MEHP in 
pregnancy. In adolescence, second and third tertiles of BPA, MCPP, and MiBP were 
significantly negatively associated with adolescent outcomes. The third tertile of the 
phthalate metabolite MECPP was associated with the highest trajectory of BMI and 
height in females, whereas the first and second tertiles of MiBP, MBzP, MCPP, MEP, 
MEHHP, and MEOHP were associated with the highest BMI and height trajectories 
in males. 
These results suggest that preterm birth is not associated with adolescent 
anthropometry, but that exposures to EDCs during a developmentally sensitive 
period may have consequences in growth and fat distribution in peripuberty. 
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 CHAPTER 1
Introduction 
Theme 
Overweight and obesity continue to be a significant public health issue in 
adults as well as children (Malik et al. 2012). Increasing evidence suggests that 
genetics, diet, and physical activity behaviors may not be the only reasons for 
excess weight. A variety of potential influences may contribute to the increasing 
prevalence of obesity, including preterm birth and its associated rapid catch-up 
growth, as well as exposures to environmental compounds that may alter 
endogenous hormone balance or stimulate metabolic pathways that lead to 
increased adiposity and growth (Euser et al. 2008; Newbold et al. 2009; Uthaya 
et al. 2005). 
Utilizing a series of sequentially-enrolled birth cohorts with repeated 
measures, the objectives of this dissertation were to examine the associations 
between preterm birth and exposures to the endocrine-disrupting compounds 
Bisphenol A (BPA) and phthalate metabolites on adolescent weight status 
andphysical growth. Archived biological specimens from pregnancy allowed for 
delineation of temporal events. We explored how exposures may impact weight 
status and growth trajectories from the perinatal to adolescent period, addressing 
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current gaps longitudinal analyses, particularly the role of exposures occurring 
during a critical period of development such as pregnancy. 
Obesity 
Worldwide, the prevalence of adult obesity has more than tripled from 
1980 to over 900 million in 2008, resulting in over 34% of all adults classified as 
overweight or obese (Keats and Wiggins 2014). In addition,  over 43 million 
children under the age of 5 are overweight or obese, with 92 million at risk for 
becoming overweight (de Onis et al. 2010). Among adults 20 years or older in the 
United States, 71.3% of males and 65.8% of females were classified as overweight 
(BMI≥25) while 33.5% of males and 36.1% of females were obese (BMI≥30) 
(Ogden et al. 2014). Among female adolescents aged 12-19, 34.2% were 
overweight (≥85th BMI-for-age percentile) and 20.4% were obese (≥95th BMI-for-
age percentile), while 35.3% and 17.2% of males were overweight and obese, 
respectively (Skinner and Skelton 2014). Specifically, among Hispanics aged 12-
19, 34.4% of females and 35.3% of males were overweight, and 19.7% of females 
and 21.4% of males were obese. In 2006 in Mexico, 26.2% of school-aged 
children 5-11 years old were overweight and obese, while 30.8% of female and 
29.3% of male adolescents 12-18 years were classified as overweight or obese 
(Rivera et al. 2009).  
Children with high BMI have an increased risk for insulin resistance, 
dyslipidemia, and cardiovascular health risks; of children who are in the ≥95th 
BMI-for-age percentile, over 50% have ≥1 cardiovascular risk (Flegal et al. 2010; 
Freedman and Sherry 2009; Guo et al. 1994; Lee et al. 2010; Ogden et al. 2012; 
de Onis et al. 2013; Sun et al. 2012). In addition to the myriad health 
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consequences that follow from being overweight or obese, there are a number of 
economic consequences. Being an overweight or obese adult in the United States 
increases total annual medical costs by 10% or 36%, respectively, compared to 
normal-weight individuals. As a whole, the annual United States medical cost of 
elevated BMI in childhood is estimated to be approximately $14.3 billion 
(Trasande and Chatterjee 2009). Indirect costs of obesity include productivity 
loss, transportation costs, and decrease in human capital accumulation 
(Hammond and Levine 2010). Productivity loss from obesity-related illness or 
disability results from a combination of absenteeism, presenteeism, increases in 
the number of disabled adults, and premature mortality (Frone 2007; Ricci and 
Chee 2005; Burkhauser and Cawley 2005; Fontaine et al. 2010). Increases in 
transportation costs result from the need to use more fuel and may, in effect, 
result in an increase in greenhouse gas emissions (Dannenberg et al. 2004; 
Jacobson and McLay 2006). Obesity also has been associated with a decrease in 
quantity as well as quality of educational attainment (Gortmaker et al. 1993; 
Sabia 2007). It has been suggested that total annual costs associated with obesity 
in the United States are in the excess of $215 billion; the impact of obesity is not 
strictly limited to the health of individuals (Hammond and Levine 2010). 
Within the Nutrition Transition 
Obesity prevalence differs within and between developed and developing 
countries. While obesity prevalence has seemingly plateaued or grown at a slower 
rate in industrialized countries, developing countries are still experiencing an 
increase in prevalence (Gupta et al. 2013; Moss et al. 2012; de Onis et al. 2010; 
Skinner and Skelton 2014). Our study population is situated in Mexico, which is 
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at an advanced stage of the nutrition transition, a phenomenon that occurs 
simultaneously with, or following, the epidemiological and demographic 
transition. Respectively, the epidemiological and demographic transitions are 
shifts in prevalence of communicable to non-communicable diseases and shifts 
from prevalence of high to low mortality and fertility (Popkin 2006; Shetty 2013).  
The nutrition transition has been associated with a shift in behaviors such 
as increases in screen time, decreases in physical activity, and changes in dietary 
patterns—particularly fat, animal source foods, refined carbohydrates, and 
caloric sweetener consumption (Popkin 2011; Rivera et al. 2004). Trends in 
Mexico show increased fat, carbohydrate, as well as animal protein consumption 
which vary by region and socioeconomic class, with lower-income and rural areas 
consuming more than those in higher socioeconomic class or urban areas 
(Barquera et al. 2009). In addition to dietary changes, physical activity changes 
occur partly due to the shift in types of occupations and conveniences available 
due to urbanization. The high-energy expenditure activities such as farming and 
forestry gave way to service industries which are not as labor-intensive resulting 
in greater amounts of sedentary activity (Popkin and Gordon-Larsen 2004; 
Popkin 1999).  
With these shifts in dietary and physical activity patterns, changes in types 
of disease also occur, with an increasing prevalence of obesity, cardiovascular 
disease, and other non-communicable diseases (Popkin 2006; Stevens et al. 
2008). However, inequalities in income still exist and the pace of adaptation to 
changing lifestyle habits often result in a double burden of disease, with over- and 
under-nutrition existing within the same country or even households (Monteiro 
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et al. 2002; Popkin et al. 2012). This dual-burden of disease may occur as 
different regions within a country experience variation in stage of the nutritional, 
epidemiological, and demographic transitions (Popkin et al. 2012; Stevens et al. 
2012). As a country develops, individuals affected by the transitions differ by 
regions and demographics; initial increase in overweight and obesity among 
those of higher socioeconomic brackets and urban areas shift to those of lower 
socioeconomic classes and rural areas (Kasper et al. 2014; McLaren 2007; 
Monteiro et al. 2002).  
Due to the shifts in nutrition and lifestyle behaviors in countries 
undergoing the nutrition transition, the environment a fetus is conceived in may 
be drastically different from one that they experience as they grow and develop.  
Developmental Origins of Health and Disease 
The Developmental Origins of Health and Disease framework 
hypothesizes that early life influences may have long-term effects on later health 
and disease (Hales et al. 1991; Hanson and Gluckman 2008). Early life influences 
such as birth weight, mode of infant feeding, and exposures to environmental 
chemicals have been associated with later health consequences such as diabetes 
and obesity (Inadera 2013; Ravelli et al. 2000; Ross and Desai 2013; Thompson 
2012). It is hypothesized that permanent structural or functional changes occur 
in the fetus or infant in response to exposures from environmental factors that 
would require the organism to adapt either immediately for short-term survival, 
or alter its physiological function for predictive long-term survival (Gluckman 
and Hanson 2004; Gluckman et al. 2005; Lucas 1991). This plasticity is a 
mechanism by which organisms adjust to variable environmental circumstances 
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in order to optimize its fitness, such as through inducing insulin resistance and 
storing fat if a poor nutritional environment is experienced or predicted, or 
accelerating sexual maturation postnatally if the environment is favorable 
(Cooper et al. 1996; Fall et al. 1995; Ibáñez et al. 2003).  
The adaptations to match fetal environment with the predicted 
environment are maladaptive when the predicted environment is mismatched to 
that experienced. This “match-mismatch” theory is used to help explain the steep 
increase in prevalence of overweight and obesity in countries undergoing rapid 
nutrition transition (Hanson and Gluckman 2008; Popkin et al. 2012).  In these 
settings, if maternal nutritional status indicates an environment of under-
nutrition, the fetus may be set on a trajectory that would maximize their fitness in 
such an environment. However, if the environment is nutritionally-rich postnally, 
their physiology is mismatched and may contribute to the development of obesity 
(Hanson and Gluckman 2008). Matched scenarios are not necessarily protective 
for the fetus because fetal over-nutrition that may occur in children of obese 
mothers or to gestational diabetes is also a risk factor for the development of 
obesity (Paliy et al. 2014; Whitaker and Dietz 1998).  
 Applying this theory of adaptation to understanding obesity trends has 
suggested that the observed trends may be less likely related to genetic changes, 
as reflected from “natural experiments” such as the Dutch famine, and is more 
likely due to the interaction between genotype and environmental exposures 
which result in developmental adaptations that optimize the phenotype. These 
may occur through epigenetic changes, which are heritable changes in gene 
expression without an actual change in the sequence of the DNA (Gluckman and 
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Hanson 2008; Godfrey et al. 2011; Leimar et al. 2006; Painter et al. 2005). For 
example, children born to mothers exposed to restricted caloric intake during the 
first two trimesters of pregnancy during the Dutch Famine of 1944/1945, 
compared to their same-sex sibling, had a decrease in the methylation of insulin-
like-growth factor 2 (IGF2) gene, an important regulator of human growth 
(Heijmans et al. 2008). This group of children also showed an increased 
prevalence of obesity at age 19 (Ravelli et al. 1976). 
Sensitive and Critical Periods for Development 
 The Developmental Origins of Health and Disease framework focuses on 
prenatal and early life, but this period is only one of several critical and sensitive 
periods for development. A body of evidence suggests that there are sensitive 
periods of time for the development of adult chronic diseases, where risks are 
increased during, but decreased outside, these periods (Dietz 1994, 1997; Gillman 
2008; Lawlor and Chaturvedi 2006).  
Early life sensitive periods for obesity development are generally 
considered to include the pre- and perinatal period, the adiposity rebound, and 
adolescence (Dietz 1994, 1997). During these sensitive periods where there is 
rapid growth and development, perturbations of the trajectory of growth may 
positively or negatively affect risk outcomes. Fetal growth in the first and second 
trimesters is important for cellular differentiation and proliferation; with 
restriction of nutrients, the relegation of resources for growth of certain processes 
over others are hypothesized to adversely affect tissue function or formation, 
potentially leading to increased risk of obesity (Cole 2009; Gluckman et al. 
2007).   
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The adiposity rebound, generally occurring between the ages of three and 
seven years, is a time of adipose hyperplasia and hypertrophy (Campbell et al. 
2011; Dietz 1997; Knittle et al. 1979; Rolland-Cachera et al. 1984). An early 
adiposity rebound may lead to accelerated pubertal maturation, increased body 
mass, and increased adiposity in adolescence and adulthood (Cameron and 
Demerath 2002; Rolland-Cachera et al. 1984; Taylor et al. 2005; Williams and 
Dickson 2002; Williams and Goulding 2009).  
Finally, adolescence is another period of rapid development, with 
alterations in insulin sensitivity and deviations in fat patterning by sex (Alberga 
et al. 2012; Dietz 1997; Mueller 1982; Smith et al. 1988). Adolescent overweight 
has been associated with adult overweight and obesity, increased risk of coronary 
heart disease, heart disease, and cancer, dependent and independent of adult 
BMI (Efrat et al. 2013; Must et al. 1992).  
Preterm Birth 
Preterm birth, defined as <37 weeks gestational age, is the second most 
common cause of death in children under 5 years of age; its associated 
complications account for the majority of neonatal deaths and over half of long-
term morbidity (Clark and Fleischman 2011; Goldenberg et al. 2008; Liu et al. 
2012; McCormick 1985). In 2010, 11.1% of all live births worldwide were preterm, 
with more than 60% of preterm births occurring in sub-Saharan Africa and south 
Asia (Blencowe et al. 2012; World Health Organization 2012). However, 
countries with high human development and economic indices are also affected; 
within the top 10 countries with the highest numbers of preterm births, the 
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United States of America ranks 6th worldwide, accounting for 3.5% of the global 
burden, and 12% of all live births within the United States (Blencowe et al. 2012). 
Trends from 1990-2010 show that almost all countries have stable or 
increasing rates of preterm birth, but increases, especially in industrialized 
countries, may result from medical technologies such as surfactants or antenatal 
steroids enhancing the survival of individuals born  at earlier and earlier 
gestational ages, rather than actual rate increases (Blencowe et al. 2012; Saigal 
and Doyle 2008; World Health Organization 2012). Certain countries may also 
be better prepared to manage and target risk factors, screen for and terminate 
congenital developmental anomalies, or do not report immediate neonatal deaths 
as live births, leading to differences in mortality (Mohangoo et al. 2011; World 
Health Organization 2012). Other factors that may influence preterm prevalence 
may be the method used to determine gestational age. Prevalence may differ 
depending on whether ultrasound or date of last menstrual period is used, as 
ultrasound measurements decrease the error that may result from use of recall of 
last menstrual date (Behrman and Butler 2007; Blondel et al. 2002; Kramer et al. 
1988; Wingate et al. 2007).  
The definition of “preterm” birth has been constantly evolving. In the first 
edition of Williams Obstetrics, Williams wrote “We possess no reliable means of 
estimating the exact date (of confinement) but are obliged to content ourselves 
with…the belief that labor occurs two hundred eighty days from the beginning of 
the last menstrual period.” (Williams 1903). There appears to be continuum 
between gestational age and neonatal morbidity and mortality that reaches a 
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nadir at approximately 39 weeks’ gestation (Clark and Fleischman 2011; Smith 
2001).  
While birth weight is intricately linked with gestational age, the two 
measures are not interchangeable since birth weight is a combination of not only 
time, but intrauterine growth (Behrman and Butler 2007; Kramer 1987). 
Therefore, prematurity is a consequence of inadequate gestational duration and 
has the added complexity of being  additionally defined as appropriate-, small-, 
or large-for-gestational age (Kramer 1987). Low birth weight could result from a 
truncation of the 3rd trimester, where the most rapid fetal growth in weight 
occurs, leading to a small-for-gestational infant, or could occur due to 
intrauterine growth restriction, which could occur at any gestational age (Buckler 
1997; Kramer 1987). Analyses linking these early life events need to distinguish 
between the two, as those born preterm may have different risks than those born 
with the same birth weight at term, but are small-for-gestational age.  
Preterm birth can also be categorized as either spontaneous or indicated, 
where caesarean sections or labor inductions are carried out due to maternal or 
fetal indications (Behrman and Butler 2007; Goldenberg et al. 2008). Indicated 
preterm births are generally associated with acute or chronic fetal compromise 
such as intrauterine growth restriction, maternal hemorrhage, or hypertensive 
disorders (Behrman and Butler 2007; Goldenberg et al. 2008). Spontaneous 
preterm births can occur with intact membranes or due to premature rupture of 
the membranes (PPROM), which can arise from intrauterine infection and short 
cervical length, among others (Behrman and Butler 2007; Goldenberg et al. 
2008; Mercer et al. 2000). In addition to dichotomization as indicated or 
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spontaneous preterm births, subdivisions based on length of gestational period 
are also used, separating extremely preterm (<28 weeks; ~5% of all preterm 
births), severely preterm (28-31 weeks; ~15% of all preterm births), moderate 
preterm (32-33 weeks; ~20% of all preterm births), and near term (34-36 weeks; 
~60-70% of all preterm births) (Goldenberg et al. 2008).  
Increases in singleton preterm births are thought to be due to a rise in 
medically indicated reasons from maternal complications like preeclampsia, or 
fetal compromise, such as intrauterine growth restriction (Ananth et al. 2005).  
The rise of in-vitro fertilization and other medically-assisted fertility programs 
are also associated with increased risks of preterm birth (Goldenberg et al. 2008; 
Jackson et al. 2004).  
Risk Factors 
While it is difficult to determine the exact mechanism, such as increased 
inflammation, placental hemorrhage, or stress, that initiates preterm labor, risk 
factors for preterm birth span a wide range of social and demographic 
characteristics  (Behrman and Butler 2007; Goldenberg et al. 2008; Romero et al. 
2006).  
Maternal characteristics that have been associated with preterm birth 
include educational status, low socioeconomic status, low and high maternal 
ages, being a single mother, tobacco use, previous preterm birth, short 
interpregnancy interval, multiple gestations, medical disorders such as thyroid 
disease, diabetes, hypertension, and asthma, nutritional status such as low and 
high maternal BMI, and work-related stresses such as hard labor and long hours 
which may result in decreases in blood flow from the fetoplacental unit to the 
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active muscles (Andres and Day 2000; Behrman and Butler 2007; Cnattingius et 
al. 1998; Conde-Agudelo et al. 2006; Goldenberg et al. 2008; Launer et al. 1990; 
Mercer et al. 1999; Romero et al. 2006; Saurel-Cubizolles 2004; Smith et al. 
2007, 2003; Thompson et al. 2006).   
Low maternal pre-pregnancy BMI has been associated with an increased 
risk of spontaneous preterm birth. Low BMI may indicate nutritional 
malnourishment in total caloric or protein intake or micronutrient deficiencies, 
such as iron, folate, zinc, could increase risk of maternal infections or a decrease 
in blood volume or flow, resulting in reductions in uterine blood flow (Neggers 
and Goldenberg 2003; Ramakrishnan et al. 1999; Scholl 2005).  
However, increasing maternal BMI is associated with an increase in 
indicated preterm birth (Hendler et al. 2005). Obese women are more likely to 
develop complications such as high blood pressure, diabetes, and preeclampsia 
and maternal obesity is associated with an increased pro-inflammatory 
biomarkers and endothelial dysregulation, which could further drive pregnancy 
complications (Cnattingius et al. 1998, 2013; Greer et al. 1994; Neggers and 
Goldenberg 2003; Ramsay et al. 2002).  
The elevated risks of preterm birth in mothers with low socioeconomic 
status may be due to an increase in psychological or social stress (Copper et al. 
1996; Farley 2012; Lobel et al. 1992). These stressors are hypothesized to affect 
preterm birth through increases in inflammatory markers or changes in vascular 
functions, such as hypertensive or cardiovascular disorders (Wadhwa et al. 
2001).  
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Sub-optimal uteroplacental flow may also occur from women smoking 
during pregnancy; nicotine and carbon monoxide are known to be 
vasoconstrictors which could result in decreased blood flow and placental 
damage (Andres and Day 2000; Cnattingius 2004). The use of tobacco products 
is associated with an increase in inflammatory response and could contribute to 
spontaneous preterm birth and, in addition, maternal smoking during pregnancy 
is associated with later childhood overweight and obesity (Bermudez et al. 2002; 
Goldenberg et al. 2008; von Kries 2002). 
Preterm birth is more common in males than in females. Approximately 55% 
of all preterm births occurring in males, who are also more highly associated with 
fetal and neonatal mortality and morbidity and long-term consequences, than 
their female counterparts (Hintz et al. 2006; Kent et al. 2012; Stevenson et al. 
2000; Zeitlin et al. 2002).  
Given that preterm birth typically results in birth weights that are lower 
than those normally observed at term birth, many studies use birth weight as an 
explanatory variable, rather than gestational age. Most studies have focused on 
indicators of intrauterine growth while limited studies exist for those born 
preterm, which is a risk factor for adverse later life events in adolescence (Euser 
et al. 2005; Hofman et al. 2004). 
Consequences of Preterm Birth 
Preterm babies face a host of complications both immediately post-
delivery and long-term, including respiratory, cardiovascular, gastrointestinal, 
metabolic, neurocognitive impairments, and increased need for medical care 
(Behrman and Butler 2007; Bonner-Weir 2000; Boyle et al. 2012; Finken et al. 
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2006; Goldenberg et al. 2008; Hofman et al. 2004; McCormick et al. 2011; 
Mericq 2006; Pilgaard et al. 2010; Rowe et al. 2011; Saigal and Doyle 2008). 
Though all organs are immature with preterm birth, the brain and lungs 
are particularly sensitive to long-term consequences, as they in critical periods 
for development in late pregnancy (Brown et al. 2013; Jobe and Bancalari 2001; 
Kugelman and Colin 2013; Rees and Inder 2005; Saigal and Doyle 2008; Teune 
et al. 2011). Neurological deficiencies include developmental and behavioral 
disabilities such as suboptimal control of motor function, decreased academic 
performance, hyperactivity, anxiety, as well as others (Aylward 2005; Chyi et al. 
2008; Friedrich et al. 2007; Gray et al. 2004; Huddy et al. 2001; Pike et al. 2012; 
Rees and Inder 2005; Teune et al. 2011). Individuals born preterm are likely to 
develop respiratory distress syndrome due to restricted development and 
inability to make surfactant, preventing the lungs from remaining open to allow 
breathing; proper medical treatment with mechanical ventilation and oxygen 
therapy may still result in injury due to oxidant and ventilation-mediated 
stressors, leading to decreased lung function (Jobe and Bancalari 2001; 
Kugelman and Colin 2013; Teune et al. 2011).  
 Preterm birth has been associated with alterations in metabolism and 
growth, such as impaired glucose and insulin sensitivity, unfavorable body 
composition such as increased visceral fat deposition, and increased BMI in 
childhood and adulthood, (Doyle 2004; Euser et al. 2005; Finken et al. 2006; 
Hofman et al. 2004; Johnson et al. 2012; Pilgaard et al. 2010). While preterm 
babies are typically lighter compared to term babies, at 40 weeks past the last 
recalled menstrual period there were no differences in the amount of adipose 
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tissue present, and altered fat deposition, with increases in visceral, and 
decreases in subcutaneous, fat were observed (Euser et al. 2008; Uthaya et al. 
2005). Even at 1 year of age, infants who were born preterm had greater fat mass 
normalized to weight than those born at term (Cooke et al. 1999). And, children 
who were born preterm had reduced insulin sensitivity, which may contribute to 
a future risk of Type 2 Diabetes, and other diseases related to insulin resistance, 
in adulthood (Hofman et al. 2004). 
Growth trajectories differ by category of preterm and birth weight; those 
born very low birth weight (<1500 g; for reference, low-birth weight infants are 
defined as those with a birth weight ≤2,500 g) undergo growth failure during 
infancy and early childhood, notably in height, but sustained accelerated BMI z-
scores from childhood through adulthood, resulting in a higher attained adult 
BMI  z-score (Doyle 2004; Farooqi et al. 2006; Ford et al. 2000; Powls et al. 
1996; Rowe et al. 2011; Saigal et al. 2006). This could place these individuals at 
increased risk for type 2 diabetes and cardiovascular diseases (Barker 1998; 
Pilgaard et al. 2010; Syddall et al. 2005).  
In preterm infants, accelerated postnatal growth is a known phenomenon. 
This catch-up growth (CUG) occurs up to two years of age in infancy and CUG 
has been linked to an increased deposition of adipose tissue, increased waist 
circumference, greater risk of overweight and obesity and insulin resistance in 
adolescence (Belfort et al. 2013; Dulloo et al. 2006; Euser et al. 2005; Giannì et 
al. 2012; Kerkhof et al. 2012; Mericq 2006; Singhal 2010; Singhal et al. 2003; 
Tzoulaki et al. 2010). In infants born preterm, rapid CUG has been linked to 
higher insulin levels at 19 years of age as well as increased BMI, fat mass, 
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percentage body fat, and waist circumference (Euser et al. 2005; Finken et al. 
2006). This compensatory acceleration of growth after shortened gestational 
length may serve as a method of adaptation for survival and the factors that may 
be involved in this growth may adversely program later adverse health effects. 
Being born preterm may be merely the stimulus needed to set the infant on a 
trajectory leading to future health risks.  
We postulated that preterm birth was associated with adolescent obesity. 
Preterm birth was hypothesized to expose the fetus to an adverse environment 
which it is not developmentally prepared to encounter, resulting in such as 
through insulin resistance or increased fat deposition (Gluckman et al. 2007; 
Mericq 2006). One critical period for insulin sensitivity is hypothesized to occur 
during the early third trimester of pregnancy; disruption of this β-cell 
progression can lead to future complications (Bonner-Weir 2000; Hales and 
Barker 1992; Hofman et al. 2004; Tinnion et al. 2013).While structural and 
functional changes may be difficult to assess, it is thought that these adaptations 
take the form of CUG with preterm birth simply being the stimulus. CUG is a 
phase characterized by insulin resistance and growth that is primarily achieved 
thorough increases in body fat rather than lean tissue (Dulloo et al. 2006; Giannì 
et al. 2012). This demonstration of early insulin resistance and relative increase 
in body fat may be a mechanism by which increased risk in adulthood is 
conferred.  
Environmental Endocrine-Disrupting Compounds 
 Environmental exposures have been increasingly scrutinized in recent 
years as possible factors involved in the rapid increase in overweight and obesity 
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that cannot be explained only by genetics or behavior (Baillie-Hamilton 2002). 
Bisphenol A (BPA) and phthalates are multi-functional materials used in 
everyday products; the prolific use of these products has resulted in widespread 
exposure to these compounds and their metabolites in humans of both genders 
and all age groups (Adibi et al. 2003; Calafat et al. 2008; Callan et al. 2012; 
Frederiksen et al. 2011; Pirard et al. 2012; Silva et al. 2004; Taskeen et al. 2012; 
Vandenberg et al. 2010).  
BPA is one of the most highly manufactured chemicals in the world and is 
used in the production of polycarbonate plastics and epoxy resins; it is commonly 
found in food and beverage containers, medical equipment, toys, the linings of 
canned foods, thermal receipt paper, and dental sealants (Mendum et al. 2011; 
Shelby 2008; Vandenberg et al. 2007a).  
Phthalates are also found in many consumer and industrialized products 
and are used in plastics for flexibility and also as a stabilizing and solubilizing 
material (David et al. 2012; Hauser and Calafat 2005; Meeker 2012).  High 
molecular weight phthalates are used in manufacturing flexible vinyl plastics and 
are commonly found in food and beverage containers, medical equipment, and 
vinyl flooring. Low molecular weight phthalates are often found in solvents, paint 
thinners, medications and personal care products such as lotions, creams, and 
nail polish (David et al. 2012; Hernández-Díaz et al. 2009; Lewis et al. 2013).  
Exposures and Metabolism 
Exposure is widespread, with >92% of the U.S. population six years and 
older exhibiting detectable BPA and phthalate metabolites in their urine; 
metabolites have also been identified during pregnancy, with evidence of these 
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metabolites in the amniotic sac and cord blood (Calafat et al. 2008; Callan et al. 
2012; Cantonwine et al. 2010; Chou et al. 2011; Huang et al. 2014; Meeker 2012; 
Silva et al. 2004; Vandenberg et al. 2010). Phthalates are not bound to the 
materials that they are used in, resulting in leaching and leading to human 
exposure via dermal absorption, inhalation, and ingestion (Meeker et al. 2009b). 
BPA exposure is also conducted through these pathways; BPA in the epoxy resin 
of food cans or polycarbonate plastic food and beverage containers can leach into 
the food material under high heat or pressure conditions, and through repeated 
use (Brede et al. 2003; Kang et al. 2003; Vandenberg et al. 2007a). BPA exposure 
also occurs through dermal absorption, such as from handling thermal receipt 
papers or through personal care products, as well as through inhalation through 
cigarette filters or dust particles (Biedermann et al. 2010; Dodson et al. 2012; Fu 
and Kawamura 2010; Rudel et al. 2003; Vandenberg et al. 2013).  
Metabolism of BPA is dependent on mode of exposure and has a rapid 
half-life of approximately 6 hours (Völkel et al. 2002). When exposed orally, BPA 
enters the gastrointestinal tract and is absorbed and transported to the liver 
where “first-pass metabolism” occurs (Vandenberg et al. 2007a, 2013). This 
process rapidly conjugates BPA into BPA glucuronide or BPA sulfate, lowering 
the concentration of active unconjugated BPA from the blood. Alternate routes of 
exposure do not undergo “first-pass metabolism”, leaving BPA to circulate in the 
bloodstream in the unconjugated form.  
Phthalates metabolism is also dependent on mode of exposure and has a 
half-life of fewer than 24 hours (Koch et al. 2005). The parent phthalate diester 
compound is hydrolyzed by esterases and lipases during phase I 
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biotransformation to form a hydrolytic monoester (reviewed in Hauser and 
Calafat 2005). High molecular weight parent diesters are additionally oxidized to 
form a more hydrophilic metabolite. These oxidized metabolites and monoesters 
could be excreted, or additionally undergo phase II biotransformation to produce 
glucuronide conjugates, which increases solubility in water and facilitates 
increased urinary excretion. 
Both BPA and phthalate metabolites are measureable in urine and blood; 
urine is more commonly used due to several advantages: ability to obtain larger 
sample volumes, ease and non-invasive nature of collection, and reduced 
contamination during sample collection by the parent compounds (Koch and 
Calafat 2009). Total BPA (free+conjugated species) is generally measured due to 
the difficulty in identifying and quantifying conjugated forms, and phthalate 
monoester metabolites are generally used as biomarkers because they are largely 
considered the biologically active molecule (Hauser and Calafat 2005; Koch and 
Calafat 2009). 
Epidemiological Studies 
These environmental exposures have been increasingly examined in recent 
years because classic predictors of behaviors with regards to energy intake and 
expenditure, as well as genetics, do not fully explain the incredible rise in obesity 
(Baillie-Hamilton 2002). Endocrine-disrupting compounds such as BPA and 
phthalates mimic or interfere with the normal functioning of the endocrine 
system that regulates bodily functions such as growth, thyroid function, sexual 
development, insulin production and utilization, weight homeostasis, in addition 
to others (Elobeid and Allison 2008; Grün and Blumberg 2009; Hatch et al. 
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2010; Heindel 2003; Heindel and vom Saal 2009; Newbold 2010; Newbold et al. 
2009).  
 Human epidemiological studies of BPA and phthalate exposurse on child 
and adolescent obesity and weight status have been mostly cross-sectional. Of the 
two long-term prospective studies, both center on associations of BPA 
concentrations in utero on child BMI, waist circumference, and overweight/obese 
status (Harley et al. 2013; Valvi et al. 2013).  
 For BPA, studies have found differences in significance and direction of 
association for males compared to females. Table 1.1 shows existing studies that 
span similar ages to our study population. While some studies found increasing 
concentrations of BPA to be associated with increases in outcome measures 
(BMI, obesity, waist circumference, etc.), others found evidence of non-
monotonic associations.  
 Table 1.2, shows there are only cross-sectional studies of phthalate 
exposure with human BMI and metabolic endpoints, though a 1-year prospective 
study was conducted in children aged 6-8 years old but found no significant 
relationships (Teitelbaum et al. 2012). Increasing concentrations of phthalate 
metabolites were found to be associated with various body composition and 
metabolic endpoints including BMI, waist circumference, and insulin resistance, 
and were also marked by gender differences. One consistent finding was the 
association of increasing MEP concentrations with BMI and waist circumference 
in females (Hatch et al. 2010, 2008; Teitelbaum et al. 2012). 
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Animal and Cell Studies 
in vitro studies have shown that BPA binds to both estrogen receptors 
(ER) α and β and can act as an estrogen mimicker, in addition to other 
mechanisms (Gould et al. 1998; Kuiper et al. 1998; Vandenberg et al. 2013). 
Though it was considered a weak estrogen due to its relatively low affinity for 
nuclear ERs compared with endogenous estradiol, it has been found to stimulate 
responses at concentrations well below those expected as necessary for binding to 
the nuclear ERs (Welshons et al. 2006). In addition, studies have shown that BPA 
has effects at levels less than the reference dose of 50µg/kg/day, showing that 
environmentally relevant exposures have human effects (Vandenberg et al. 
2007a). Studies have also indicated that BPA may be anti-androgenic by 
interacting with the androgen receptor and preventing endogenous androgen 
activity (Wetherill et al. 2007).  
The non-monotonic dose-response curves observed in human 
epidemiological studies have also been found in animal and cell studies and 
(Myers et al. 2009; Vandenberg et al. 2012; Watson et al. 2010). Hypothesized 
mechanisms include opposing signaling effects of different types of receptors 
(such as ERα and ERβ), decreased effects at higher doses due to cytotoxicity or 
receptor down-regulation or desensitization, up-regulation of gene expression at 
low doses, and opposing action responses in different sub-populations of cells. In 
addition, BPA has been found to be more potent in stimulating embryonic ERs 
than initially suspected, given its in vitro activity; this has implications for 
exposures that occur during pregnancy (Lemmen et al. 2004). 
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As BPA has been observed to cross the placental barrier, one question 
raised would be whether the fetus is able to metabolize the compound to the 
same degree as an adult. It is known that the human fetal liver does not express 
UDP-glucuronosyltransferase until after birth, leading to higher levels of 
circulating unconjugated BPA and, in primates, it has been shown that pregnancy 
alters BPA pharmacokinetics (Vom Saal et al. 2014). Fetal exposure and 
elimination of BPA in early pregnancy is thought to occur through passive 
diffusion through the placenta while, in late pregnancy, the fetus may dispose of 
BPA through the fetal kidney and via conjugation (Vom Saal et al. 2014). 
Pregnancy does not appear to affect first-pass metabolism of BPA in the liver 
after absorption from the gastrointestinal tract through oral exposures and that, 
at concentrations that humans are routinely exposed to, BPA exposure during 
pregnancy induced abnormal development in the mammary gland, brain, and 
ovaries. These findings are relevant for humans not only because primates are 
more similar compared to other models, but also because this study showed that 
non-oral routes of exposure may play a larger role than previously anticipated 
and fetal exposures to, and elimination of, BPA differ depending on the 
progression of pregnancy. 
Studies from human adipocytes have shown that  BPA inhibits adiponectin 
release (Hugo et al. 2008; Volberg et al. 2013). Adiponectin, secreted from 
adipocytes, is negatively correlated with fasting insulin, triglycerides, and 
glucose; higher concentrations are associated with lower risks of hypertension, 
dyslipidemia, and diabetes by increasing muscle and liver catabolism of fatty 
acids and glucose (Kadowaki and Yamauchi 2005; Kawada 2013). While, lower 
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levels are associated with type 2 diabetes and metabolic syndrome (Cruz et al. 
2004; Shaibi et al. 2007). BPA has also been found to induce differentiation of 
preadipocytes to adipocytes, as well as increase lipid accumulation in these cells 
in both human explant cells from individuals of healthy BMI, as well as mouse 
fibroblast cells (Boucher et al. 2014; Masuno et al. 2002).  
 Using mouse models, perinatal and adult exposures to BPA have been 
observed to increase adipose tissue and body and alter glucose tolerance and 
insulin resistance; some studies observed differences in association by sex 
(Alonso-Magdalena et al. 2005b; Miyawaki et al. 2007; Ropero et al. 2008). in 
vitro studies have found altered glucose transport and increased differentiation 
of adipocytes (Masuno et al. 2002; Sakurai et al. 2004).  
While BPA and phthalates have both been found to mimic or alter 
endogenous hormones, only phthalates are known to be PPAR activators in 
addition to being anti-andrognic and possible thyroid antagonists (Grün and 
Blumberg 2009; Meeker et al. 2007). PPARs are a family of lipid-sensors that are 
involved in energy homeostasis and can redirect metabolism when activated; 
PPAR-γ in particular has been shown to be a “master regulator” for the formation 
of adipocytes through differentiation and survival; forced expression of PPAR-γ 
in non-adipogenic cells can convert them into adipocytes (Evans et al. 2004; 
Feige et al. 2007; Tontonoz et al. 1994). Exposures during sensitive periods of 
development could result in permanent impacts on adipocyte development (Grün 
and Blumberg 2009; Hurst and Waxman 2003). Surprisingly, PPAR-γ is also 
involved in insulin sensitivity; thiazolidinediones, a class of medications used for 
controlling Type 2 diabetes through increasing insulin sensitivity, are PPAR-γ-
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activating drugs (Berger et al. 2005; Lehrke and Lazar 2005). It is hypothesized 
that, as PPAR-γ activation largely affects adipose tissue by redirecting lipids away 
from liver and muscle, which are the tissues necessary for insulin-mediated 
glucose metabolism, PPAR-γ agonists prevent lipotoxicity-induced insulin 
resistance and prevent hyperglycemia (Bays et al. 2004; Mayerson et al. 2002).  
Sex Differences in Findings 
Differences in associations between exposures to BPA and phthalate 
metabolites for males and females are often observed and nimal studies have also 
indicated that the dose-response curves for females and males are different 
(Miyawaki et al. 2007). While the exact mechanism is not known, it is postulated 
to be related to BPA’s estrogenic qualities, the sexually-dimorphic distribution of 
endogenous estrogen receptors, and its hypothesized ability to interfere with 
endogenous estrogen signaling (Alonso-Magdalena et al. 2005a, 2005b; 
Schneider et al. 2014). Males and females also differ in their energy-balancing 
characteristics behaviorally as well as morphologically and physiologically with 
regards to adipocyte differentiation and distribution (Schneider et al. 2014). It is 
hypothesized that males may be more sensitive than females to exposures to 
endocrine-disrupting compounds because the natural, default, evolution is 
towards the female phenotype whereas formation of the male phenotype 
necessitates hormonal influence from both testosterone and estradiol; alterations 
in these hormones may more negatively affect males (De Coster and van 
Larebeke 2012; Schneider et al. 2014). In addition, BPA may more adversely 
affect thyroid function of males rather than females (Chevrier et al. 2013; 
Sriphrapradang et al. 2013). Previous studies have found that low, circulating 
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levels of testosterone are associated with increased visceral and/or abdominal 
obesity in males; the anti-androgenic effects of phthalates may contribute to 
increased waist circumference and obesity in males but studies in females are 
inconclusive (Gapstur et al. 2002; Tchernof and Després 2013). Estrogen effects 
for females differ by menopausal status, with reduced estrogen levels post-
menopause being associated with increased visceral adiposity (Lovejoy et al. 
2008; Tchernof and Després 2013) 
Estrogens are involved in the control of adipose distribution and 
metabolism and are known to be sexually dimorphic in deposition of 
subcutaneous or visceral fat (Cooke and Naaz 2004; Schneider et al. 2014). They 
are able to impact adipose tissue indirectly through other pathways other than 
through decreasing lipogenesis or increasing fatty acid β-oxidation; estrogen 
receptors are found within the brain in the hypothalamus, where energy balance 
is primarily regulated, and could impact appetite and metabolism (Cooke and 
Naaz 2004). The two estrogen receptors, ERα and ERβ, are nuclear receptors 
that are part of the steroid/thyroid hormone superfamily; binding of a ligand to 
the receptors triggers conformational changes that ultimately leads to changes in 
the rates of estrogen-regulated gene transcription (Nilsson et al. 2001). However, 
endocrine disrupting compounds can also act through classical nuclear receptors 
to initiate transcription, as well as through estrogen-related receptors, or through 
interactions with other targets that may activate pathways such as those involved 
in metabolism (De Coster and van Larebeke 2012; Wang et al. 2012b). Therefore, 
exposure to xenoestrogens, natural or man-made estrogens that mimic 
endogenous estrogen by binding to estrogen receptors, would be thought to 
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decrease the adipose stores. However, it has been shown that adipocyte numbers 
can be increased or decreased depending on the concentration of xenoestrogens 
(Cooke and Naaz 2004; Dang et al. 2003). 
Given the observations from cell, animal, and human epidemiological 
studies, we hypothesized that exposures to BPA and phthalates would be 
associated with increased weight status and adiposity. In keeping with the 
Developmental Origins and critical period frameworks, exposures during early 
life, such as pregnancy, were hypothesized to have stronger associations with 
outcomes than those that occur in less sensitive periods of time. Additionally, it 
was hypothesized that associations would differ for males and females. 
Study Population 
 The study population for this dissertation utilizes participants from the 19-
year Early Life Exposure in Mexico to ENvironmental Toxicants (ELEMENT) 
research collaboration with Mexico’s Instituto Nacional de Salud Pública that 
consists of three sequentially-enrolled birth cohorts.  
The recruitments (starting in 1994, 1997, and 2001) occurred at family 
clinics serving low-to-moderate income populations in Mexico City: Mexican 
Social Security Institute, Manuel Gea González Hospital, and National Institute 
of Perinatology. Cohort 1 (N=616) was recruited between 1994-1995 and followed 
until 1997 as a randomized controlled trial on the effect of calcium 
supplementation during lactation on blood lead levels. Cohort 2 was comprised of 
two groups assessing bone lead, resorption, and fetal lead exposure; cohort 2A 
(N=327) was recruited during pre-pregnancy and followed between 1997-2000 
and 2B (N=462) was recruited during pregnancy and followed between 1999-
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2000. Cohort 3 (N=670) was recruited during pregnancy for a randomized 
controlled trial of calcium supplementation during pregnancy and lactation and 
recruited from 2001-2003. Study methods have been described previously 
(Ettinger et al. 2009; Gonzalez-Cossio et al. 1997; Hernandez-Avila et al. 2003; 
Hu et al. 2006; Téllez-Rojo et al. 2002, 2004).  
In 2006, participants from all three cohorts were invited for a prospective 
follow-up after the child was at least 6 years old; 1,100 mother-child pairs were 
followed to assess the influence of fetal lead exposure on neurobehavioral 
outcomes. In 2012, recruitment of mother-child pairs (N=250) from cohorts 2 
and 3 were initiated. Recruitment priority was based on existence of archived 
biological specimens and perinatal lead exposure data. 
Similar exclusion criteria were applied to all three cohorts such as living 
outside of Mexico City, gestational diabetes, preeclampsia, or pregnancy-related 
hypertensive disorder, as well as other criteria described elsewhere (Ettinger et 
al. 2009; Gonzalez-Cossio et al. 1997; Téllez-Rojo et al. 2004). Common 
recruitment methods allow for pooling of the birth cohorts for analysis.  
Thesis Overview 
 Chapter 2 investigated the association between preterm birth (gestational 
age<37 weeks) and BMI, waist circumference, and odds of obesity in youths aged 
6-17 years, controlling for age, sex, and mother’s BMI, smoking, years of 
education, and marital status.  
 Chapter 3 utilized archived maternal urine samples from the third 
trimester of pregnancy, as well as adolescent urine samples, to assess 
longitudinal and cross-sectional associations of BPA and 9 phthalate metabolites 
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with BMI z-score, waist circumference, and triceps skinfold in youths aged 8-14 
years. Continuous and quartiles of metabolites were examined, controlling for 
specific gravity, child’s age, and mother’s years of schooling and BMI at 1 month 
postpartum,  to explore the non-monotonic relationships noted in previous 
studies. 
 Chapter 4 explored a hypothesized relationship between exposures to BPA 
and 9 phthalate metabolites in the third trimester of pregnancy with the growth 
of children. Using repeated measures, this aim examined the predicted BMI and 
height trajectories of tertiles of specific gravity-adjusted metabolites in 
participants from 0.25 to 14 years of age, controlling for mother’s years of 
schooling and BMI at 1 month postpartum. Estimated differences between 
tertiles in predicted trajectories were analyzed to determine ages where 
significant differences between tertiles of occurred.  
 Chapter 5 summarizes the work of this dissertation and offers suggested 
recommendations and future directions. 
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Table 1.1. Human epidemiological studies of exposures to BPA with weight status outcomes. 
 
Authors 
Study 
Design 
Ages 
Data 
Source 
Exposure Analysis Outcome Result 
Wolff et al 207 
Cross-
sectional 
6-80 U.S. 
BPA, 
phthalates 
N/A 
N/A; 
characterizing 
pilot study 
Higher BPA levels in girls <85th%ile compared to those >85%ile. phthalates 
differed by race/ethnicity in distributions 
Eng et al 2013 
Cross-
sectional 
6-18; 
subset 
12-18 
NHANES 
BPA, 
phthalates 
Quartiles 
Adiposity, 
cholesterol, 
insulin, 
glucose 
Higher odds obesity with non-monotonic BPA quartiles (2nd and 4th higher 
than 3rd), higher odds abnormal WC to height ratio 
Wang et al. 
2012 
Cross-
sectional 
8-15 China BPA 
Continuous 
and quartiles 
BMI 
Associated with increasing BMI; after stratification by age or sex, remained 
significant in females and in those age 8-11 after stratification. Also observed 
non-monotonic associations of BMI with quartiles 2,3,4 compared to 1. 
Trasande et al. 
2012 
Cross-
sectional 
6-19 NHANES BPA 
Continuous 
and quartiles 
Obesity, BMI 
z-score 
Increasing quartiles associated with increases in BMI z-score and non-
monotonic odds of obesity;  stronger association in males 
Wells et al. 
2013 
Cross-
sectional 
6-18; 
subset 
12-18 
NHANES BPA Quartiles 
Waist-to-
height ratio 
Increased WHR associated with greater BPA ;when stratified by sex, found 
significant increase in boys but not girls 
Bhandari et al. 
2013 
Cross-
sectional 
6-18; 
subset 
12-18 
NHANES BPA Quartiles Obesity 
Increasing quartiles associated with odds of obesity; predominantly present 
in boys (note: though test for trend significant, 2Q had stronger effect than 
3Q compared to 1Q reference) 
Harley et al. 
2013 
Longitudinal 
and cross-
sectional 
Pregna
ncy-9 
years  
CHAMAC
OS; USA 
BPA Tertiles 
BMI, fat mass, 
WC, 
overweight, 
obese 
Prenatal associated with decreased BMI at 9 in girls but not boys; results 
strongest in pre-pubertal girls. Cross-sectional BPA concentrations at 9 for 
both boys and girls positively associated with BMI, WC, fat mass, and 
overweight/obese 
Li et al. 2013 
Cross-
sectional 
9-12 China BPA 
High vs low; 
trend test 
using <50th, 
50-75, 75-90, 
>90th%ile 
High weight 
percentile, 
WHR, BMI, 
skinfold, WC 
High, and increasing, levels associated with overweight and hip 
circumference  for girls 9-12; not observed in boys 
Lee et al. 2013 
1 year 
longitudinal 
7-8 at 
baselin
e 
Ewha Birth 
and 
Growth 
Cohort; 
Korea 
BPA Tertiles 
Testosterone, 
estradiol, 
insulin, 
HOMA-IR, 
BMI 
Girls in the high BPA exposure group had higher levels of testosterone, 
estradiol at 1 year compared to baseline. Cross-sectionally, relationship 
between BPA and BMI U-shaped, but not significant, increase in estradiol, 
testosterone, HOMA-IR with increasing tertiles 
Valvi et al. 
2013 
Longitudinal 
and cross-
sectional 
Pregna
ncy-4 
years 
INMA, 
Spain 
BPA Continuous BMI, WC 
At 4 years, BPA associated with increased waist circumference, weakly 
associated (non-significant) with BMI 
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Table 1.2. Human epidemiological studies of exposures to phthalates with weight status outcomes. 
 
Authors Study Design Ages Data Source Exposure Analysis Outcome Result 
Stahlhut et al 
2007 
Cross-sectional > 18 
NHANES 
males 
MBP, 
MEP, 
MEHP, 
MBZP, 
MEHHP, 
MEOHP 
Continuous, 
quintiles 
Waist 
circumference, 
insulin 
resistance 
MBZP, MEHHP, MEOHP, MEP associated with increased WC,. MBP, 
MBZP, MEP associated with insulin resistance 
Hatch et al 
2008 
Cross-sectional 6-8 NHANES 
MEP, 
MEHP, 
MBP, 
MBZP, 
MEHHP, 
MEOHP 
Quartiles BMI, WC 
Consistent association in males age 20-59: BMI and WC increased across 
quartiles of MBZP, and positive association also found for MEOHP, 
MEHHP, MEP, MBP. In females, BMI & WC increased with MEP in girls 
while MEHP was inverse associated with BMI in adolescent girls 
Hatch et al 
2010 
Cross-sectional 6-80 NHANES 
MEP, 
MEHP, 
MBP, 
MBZP, 
MEHHP, 
MEOHP 
Quartiles BMI, WC 
Associations marked by gender; MBZP strong positive relationship with 
BMI, WC with adult males 20-59 but no trend for females. MBP; positive 
suggestion trend for males for BMI and WC, but inverse trends for females. 
MEHP inversely related to BMI and WC in adolescent and adult females, but 
no trends for males. MEHHP, MEOHP similar. although MEP and BMI seen 
for adult males and for adolescent and adult females 
Teitelbaum et 
al 2012 
Prospective; 1 
year 
6-8 
Hispanic and 
Black NYC 
children 
MEP, 
MBP, 
MCPP, 
MBZP, 
MIBP, 
MEHP, 
MEOHP, 
MECPP, 
MEHHP, 
DEHP 
Continuous,   
quartiles  
BMI, WC 
No significant  relationships among boys or girls. dose-response seen with 
MEP and a sum of LMP and BMI and WC among overweight children. For 
increasing MEP quartiles among girls, associated with BMI and WC 
Trasande et al 
2013 
Cross-sectional 6-19 NHANES 
low MW, 
high MW, 
DEHP 
Continuous 
Blood 
pressure, lipid 
levels 
DEHP associated with higher BP. no other association with other outcomes 
or other exposures 
Trasande et al. 
2013 
Cross-sectional 12-19 NHANES DEHP Tertiles 
Insulin 
resistance 
(HOMA-IR) 
Each log increase (~3 fold) in DEHP metabolites increases 0.19 in HOMA-
IR; Third tertile had 21.6% prevalence of insulin resistance compared to 
14.5% in 1st 
 
  
 CHAPTER 2
 
Association of preterm birth with weight status and 
waist circumference in Mexico City youth 
 
Abstract 
Background: Preterm birth has been associated with adverse health profiles 
including impaired insulin sensitivity and increased truncal fat patterning in 
adolescence. In developing countries such as Mexico, changing environments 
coupled with preterm birth may deleteriously impact the development of health 
risks. 
Objective: This study examines the association of preterm birth with adolescent 
obesity and markers of weight status and fat distribution among Mexico City 
adolescents. 
Methods: Among 722 youths aged 6-17, we estimated differences in BMI and waist 
circumference by categories of premature birth (gestational age<37 weeks;N= 
41;5.7%) using linear regression. In addition, we estimated odds ratios and 95% 
confidence intervals for obesity during adolescence according to preterm birth using 
logistic regression models adjusted for adolescent age, sex, and mother’s age, 
education, marital status, smoking during pregnancy, and obesity. 
Results: Premature birth was not associated with obesity (OR=1.03; 95%CI:0.43, 
2.39), but sex-stratified models show possible differences by sex, with a suggestive 
increase in odds of obesity for females (OR=1.33; 95%CI:0.33, 5.24) but decrease for 
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males (OR=0.89; 95%CI:0.30, 2.64). There were non-significant negative 
associations between preterm birth with adolescent BMI (β=0.03; 95%CI:-1.09, 1.15) 
and waist circumference (β=-0.43; 95%CI:-3.33, 2.48) in adjusted models. Odds of 
obesity (OR=4.54, 95%CI:2.78, 7.42), BMI (β=2.63; 95%CI:1.85, 3.40), and waist 
circumference (β=5.88; 95%CI:3.87, 7.88), were significantly increased if mothers 
were obese. 
Conclusions: Preterm birth does not indicate an increase in later adolescent BMI, 
waist circumference, or obesity in Mexico City youth, but there are suggestive 
differences by sex. The direction of association for increased BMI and waist 
circumference suggests a need for further research in a larger sample size. Efforts to 
reduce obesity in this context should consider the child’s sex, socioeconomic status, 
and weight status of the mother.  
  
Background 
 Trends in child and adolescent obesity are of immense public health concern 
because early obesity tends to track into adulthood; children with a high body mass 
index (BMI) have similar health hazards as obese adults including insulin resistance, 
dyslipidemia, and other cardiovascular disease risks (Freedman and Sherry 2009; 
Guo et al. 1994; Ogden et al. 2012; Sun et al. 2012). In countries such as Mexico 
undergoing a nutrition transition, shifts in environments and available resources 
may alter dietary and physical activity behaviors that lead to an increased risk of 
obesity (Popkin and Gordon-Larsen 2004; Popkin 2006). However, these social and 
behavioral changes may not fully explain the rapid rise in childhood and adolescent 
obesity seen in the past few decades. 
 Evidence suggests that the events and environments experienced in early life 
are associated with later adverse health outcomes; exposure to an adverse 
intrauterine environment is thought to stimulate the fetus to adapt for survival 
(Gluckman et al. 2007). If the fetus optimizes its predicted future survival based on 
the environment experienced in utero but the experienced environment is 
mismatched, the fetus may be maladapted, leading to future risk.  
 Most studies regarding birth weight or birth size with adult disease have 
focused on indicators of intrauterine growth while limited studies exist for those 
born preterm, which is itself a risk factor for adverse later life events in adolescence 
(Euser et al. 2005; Hofman et al. 2004). Prematurity is associated with catch-up 
growth (CUG) up to two years of age in infancy and CUG has been linked to an 
increased risk of obesity and insulin resistance in adolescence (Dulloo et al. 2006; 
Mericq 2006; Singhal et al. 2003). This compensatory acceleration of growth after 
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truncated prenatal growth may serve as a method of adaptation for survival; being 
born preterm may be merely the stimulus needed to set the infant on a trajectory 
leading to future health risks. Therefore, preterm birth may be a novel stimulus that 
results in future health consequences and warrants further assessment.  
 The purpose of this paper is to determine the association of preterm birth and 
adolescent weight status, waist circumference, and obesity among Mexico City youth 
aged 6-17 years in a developing country where the shifting burden of obesity lends an 
additional complexity in assessing the development of obesity and health effects. 
Methods 
Subjects and Settings 
The study population consists of participants from the 19-year Early Life 
Exposure in Mexico to ENvironmental Toxicants (ELEMENT) research collaboration 
with Mexico’s Instituto Nacional de Salud Pública (INSP) that involves three pre-
birth cohorts. The recruitments (starting in 1994, 1997, and 2000) occurred at family 
clinics serving low-to-moderate income populations in Mexico City: Mexican Social 
Security Institute, Manuel Gea González Hospital, and National Institute of 
Perinatology. Cohort 1 was a randomized trial of the effect of calcium 
supplementation on blood lead levels during lactation, cohort 2 assessed effects of 
maternal lead burden, and cohort 3 mothers were enrolled in a randomized trial of 
calcium supplementation during pregnancy. Similar exclusion criteria were applied 
to all three cohorts such as living outside of Mexico City, gestational diabetes, 
preeclampsia, or pregnancy-related hypertensive disorder, as well as other criteria 
described elsewhere (Ettinger et al. 2009; Gonzalez-Cossio et al. 1997; Téllez-Rojo et 
al. 2004). Common recruitment methods allow for pooling of the birth cohorts for 
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analysis. Follow-up of the three cohorts were maintained and the children now span 
pre-adolescence and adolescence.  
Mothers were given detailed information regarding study procedures and 
signed a letter of informed consent at the time of initial and follow-up recruitment. 
The research protocols were approved by the Ethics and Research Committees of the 
National Institute of Public Health in Mexico, the University of Michigan School of 
Public Health, and other participating institutions.  
Anthropometric Measures 
At one-month postpartum, maternal height was obtained using professional 
scales (BAME Mod 420) read to the nearest 0.1 centimeter (cm) and maternal weight 
was recorded to the nearest 0.1 kilogram (kg). Current adolescent anthropometry at 
ages 6-17 years were taken by study personnel using established research protocols 
(Lohman et al. 1988). Weight (BAME Mod 420) was measured to the nearest 0.1 kg; 
height (BAME Mod 420) was measured to the nearest 0.1 cm; waist circumference 
was measured with a non-stretchable tape (QuickMedical Model QM2000) to the 
nearest 0.1 cm. Duplicate measures were taken of weight and height while triplicate 
measures were taken of waist circumference; the observed values were then 
averaged. An additional measurement was taken if intra-personal variability 
exceeded the measurement tolerance of 0.5 cm. 
Questionnaires 
A questionnaire assessing social and demographic characteristics such as 
education, reproductive history, and marital status was administered by study 
personnel to the mother at the baseline visit. 
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Outcome Measures 
Outcome measures were adolescent weight status, obesity, and waist 
circumference. Weight status is represented as body mass index (BMI), defined as 
weight divided by height squared ( ), and obesity is defined using the World Health 
Organization (WHO) classifications with the child exceeding a standard deviation 
score of +2 (de Onis 2007). BMI and waist circumference were analyzed as 
continuous variables. 
The WHO growth curves were used to classify obese status because these 
references are used as a standard reflecting how children grow under optimal 
feeding (Garza and de Onis 2004). In contrast, the CDC growth charts are a 
reference of how a particular population of children did grow during a specific time 
period in a specific location while the International Obesity Task Force (IOTF) cut-
offs are calculated from six diverse nations, using the adult BMI cut-offs for 
overweight (25 kg/m2) and obese (30 kg/m2) (Cole et al. 2000; de Onis and Yip 
1996). We elected to use the WHO growth charts to categorize the weight status of 
the adolescent, which are in keeping with current and future studies.  
A sensitivity analysis was also conducted for cohort effect, with the cohort 
variable included in the final models. Major findings did not change after adjustment 
(results not shown). 
Predictor and Covariate Measures 
 Preterm birth (<37 weeks gestational age) was the primary exposure variable. 
Gestational age was estimated from the date of last recalled menstrual period by the 
mother. Covariates were chosen a priori based on biological and social relevance in 
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predicting the outcome measures or as potential confounders of the association 
between preterm birth and adolescent outcomes. They included baseline mother’s 
age, years of education, marital status (married/not married), mother’s smoking 
status during pregnancy (yes/no), obese status (BMI ≥ 30) at 1 month postpartum, 
and child’s current age and sex.  
Statistical Analysis 
 Descriptive statistics and distributions were examined and extreme outliers 
were identified and removed using the generalized extreme studentized deviation 
method (Rosner 1983). Differences in characteristics of children who were followed-
up to adolescence versus those not followed-up were examined using the t-test for 
continuous and chi-square test for categorical measures (results not shown). For 
individuals followed-up and included in this study, the characteristics were stratified 
by sex and examined. Bivariate and multivariable analyses using linear and logistic 
regression models were conducted to assess the association between preterm birth 
and covariates with each outcome. Results were further stratified by sex to explore 
differences in associations.  
Results 
 Table 2.1 shows the descriptive statistics for adolescents by sex. There were 41 
preterm births, with slightly more occurring in males. Children were on average 11.3 
years old and 51.8% male. Most (72.3%) had married mothers who were 25.6 years of 
age at baseline, mostly non-obese (86.6%), and averaged 10.5 years of total 
schooling. There were no differences in number of preterm births, child’s age, BMI, 
and mother’s marital status, smoking during pregnancy, age, obesity, and years of 
schooling between males and females. Males had significantly higher waist 
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circumference (69.1 cm) and were more obese (21.2%) compared to females (65.8 
cm; 12.9%).  
Bivariate linear and logistic regression models are shown in Table 2.2. For 
combined sex, marital status was significantly negatively associated with adolescent 
BMI (β=-0.83; 95%CI:-1.50, -0.15) and waist circumference (β=-1.91; 95%CI:-3.68, -
0.13). This was also observed for males for BMI (β=-1.25; 95%CI: -2.23, -0.27) and 
waist circumference (β=-3.06; 95%CI:-5.67, -0.44). Mother’s obesity was 
significantly positively associated with adolescent BMI, waist circumference, and 
obesity for males (respectively, β=2.47; 95%CI:1.22, 3.71, β=5.00; 95%CI:1.63, 8.35, 
β=5.00; 95%CI:2.67, 9.35), females (respectively, β=1.87; 95%CI:0.63, 3.10, β=4.37; 
95%CI:1.22, 7.50, β=3.70; 95%CI:1.78, 7.64), and combined sex (respectively, 
β=2.18; 95%CI: 1.30, 3.05, β=4.68; 95%CI:2.37, 6.99, β=4.27; 95%CI:2.68, 6.80),.  
Multivariable adjusted linear and logistic regression models are shown in 
Table 2.3. Preterm birth was not associated with odds of adolescent obesity 
(OR=1.03; 95%CI:0.43, 2.39) with the fully-adjusted model, but sex-stratified 
models show possible differences by sex, with a suggestive increase in odds of obesity 
for females (OR=1.33; 95%CI:0.33, 5.24) but decrease for males (OR=0.89; 
95%CI:0.30, 2.64). In fully-adjusted models when stratified by sex, males were 
observed to have a decreased association with adolescent waist circumference (β=-
0.79; 95%CI:-4.75, 3.16) and reduced odds of obesity (OR=0.89; 95%CI:0.30, 2.64) 
while females were observed to have an increased association with adolescent waist 
circumference (β=0.37; 95%CI:-4.01, 4.75) and increased odds of obesity (OR=1.33; 
95%CI:0.33, 5.24). 
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 Mother’s obesity was significantly associated with odds of adolescent obesity 
and increases in BMI and waist circumference for all combined and sex-stratified 
models. Mother’s years of schooling was also significantly associated with increases 
with adolescent BMI (β=0.13; 95%CI:0.03, 0.21) and waist circumference (β=0.29; 
95%CI:0.05, 0.52), which was observed in sex-stratified models with only males 
(BMI β=0.15; 95%CI:0.02, 0.27, waist circumference β=0.36; 95%CI:0.03, 0.67). 
Discussion 
 Our results showed no association in Mexico City youth between preterm 
birth and adolescent obesity, BMI, or waist circumference. However, several other 
studies have observed associations between infants born preterm with obesity and 
related complications such as insulin imbalance and metabolic syndrome (Euser et 
al. 2005; Finken et al. 2006; Hofman et al. 2004). Low birth weight, like preterm 
birth, is an early life event that is a risk factor for later adverse health effects; in a 
study of young Mexican-Americans, it was found that birth weight was significantly 
and inversely related to truncal fat deposition and higher fasting insulin levels 
(Barker 1998; Hales and Barker 1992; Valdez et al. 1994). These studies were carried 
out in industrialized countries, so our lack of significance may also be due to the 
nature of the study setting.  
 Our significant findings that associate maternal obesity with later adolescent 
BMI, waist circumference, and obesity is not surprising, as maternal obesity is 
known to be a risk factor for later obesity in children  (Symonds et al. 2013). 
Additionally, maternal obesity is associated with risk of preterm birth, heightening 
the detrimental effects that maternal body fatness may have on not only birth 
outcomes, but later health indices (Cnattingius et al. 2013). 
                   
40 
 
 We posited that preterm birth exposes the fetus to an adverse environment 
which it is not developmentally prepared to encounter. In order to optimize survival 
in the short-term, the fetus undergoes adaptation in structure or function such as 
through insulin resistance or increased fat deposition (Gluckman et al. 2007; Mericq 
2006). While this plasticity is advantageous for immediate survival, metabolic 
programming during critical periods of development may permanently alter the 
physiology of the infant (Finken et al. 2006; Hofman et al. 2004). For instance, one 
critical period for insulin sensitivity is hypothesized to occur during the early third 
trimester of pregnancy; disruption of this β-cell progression can lead to future 
insulin sensitivity (Bonner-Weir 2000; Hales and Barker 1992; Hofman et al. 2004). 
 While structural and functional changes in physiology may be difficult to 
assess, it is hypothesized that these adaptations take the form of CUG with preterm 
birth simply being the stimulus. Evidence suggests that CUG is a phase characterized 
by insulin resistance and that growth is primarily achieved thorough increases in 
body fat rather than lean tissue (Dulloo et al. 2006). This demonstration of early 
insulin resistance and relative increase in body fat may be the mechanism by which 
increased risk in adulthood is conferred. 
Limitations of our study include possible misclassification of gestational age 
due to the reliance on using mother’s recall of last menstrual period, broad range of 
ages for defining adolescence, and small sample size of preterm births. Selection bias 
was a possible concern, but the cohorts were observational in nature and analysis of 
differences between adolescents who were followed-up and analyzed with those who 
were not were not statistically significant. The strengths of our study include the 
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ability to control for multiple confounding factors and the use of multiple endpoints 
that relate to weight status and adiposity.  
Disentangling the complexities surrounding the etiology of obesity would 
benefit public health interventions aimed at reducing the numbers of obese 
individuals. While the causes of preterm birth remain mostly unexplained (Behrman 
and Butler 2007; Kramer 1987), intervention measures can be directed towards 
those that may be more modifiable such as maternal obesity. Given our hypothesis 
that rapid CUG is the physiologic adaptation, interventions could be aimed at 
preventing overfeeding of preterm infants in a misguided attempt to hasten their 
growth. In addition, knowledge that individuals who were born preterm have been 
found to be at increased risk for later obese weight status could enhance targeted 
intervention strategies for these groups. Future work in this area could be enhanced 
with a larger sample size and the use of repeated measures to determine the extent of 
CUG preterm infants experience and their relation with later weight status and 
adiposity.  
 
 
 
  
 
Table 2.1. Distribution of characteristics by sex. 
 
  Male Female   
 
N Mean(SD)/% N Mean(SD)/% p-value* 
Child premature 
    
0.37 
     Yes 24 6.4 17 4.9 
      No 350 93.6 331 95.1 
 
Child's age (yrs) 374 11.4 (2.9) 348 11.3 (2.9) 0.41 
Child's BMI 374 20.4 (4.3) 348 20.2 (4.1) 0.43 
Child's waist circumference 
(cm) 
374 69.1 (11.4) 348 67.0 (10.3) <0.01 
Child obese 
    
<0.01 
     Yes 79 21.2 45 12.9 
      No 295 78.8 303 87.1 
 
Mother married 
    
0.35 
     Yes 276 73.8 246 70.7 
 
     No 98 26.2 102 29.3 
 
Mother smoked during pregnancy 
   
0.16 
     Yes 11 1.5 17 2.4 
 
     No 362 50.5 327 45.6 
 
Mother's age (yrs) 374 25.6 (5.1) 348 25.8 (5.5) 0.60 
Mother's BMIa 
    
0.96 
     ≥30 50 13.4 47 13.5 
      <30 324 86.6 301 86.5 
 
Mother's education (yrs) 373 10.7 (3.0) 347 10.5 (2.8) 0.50 
  *p-value  t-test for continuous, chi-sq for categorical 
         a1 month postpartum 
 
  
Table 2.2. Bivariate linear and logistic regressions estimating associations with 
adolescent BMI, waist circumference, and obesity. 
 
      BMI Waist circumference Obese 
 
Sex N β 95% CI β 95% CI OR 95% CI 
Preterm birth All 722 -0.44 (-1.75, 0.86) -1.58 (-5.02, 1.85) 1.18 (0.53, 2.62) 
 
Male 374 -0.60 (-2.36, 1.16) -2.91 (-7.62, 1.80) 0.98 (0.35, 2.71) 
 
Female 348 -0.27 (-2.25, 1.71) -0.10 (-5.13, 4.92) 0.39 (0.40, 5.34) 
Mother married All 722 -0.83 (-1.50, -0.15) -1.91 (-3.68, -0.13) 0.73 (0.48, 1.11) 
 
Male 374 -1.25 (-2.23, -0.27) -3.06 (-5.67, -0.44) 0.61 (0.35, 1.04) 
 
Female 348 -0.43 (-1.36, 0.51) -0.93 (-3.30, 1.44) 0.91 (0.46, 1.78) 
Mother smoked All 717 -0.01 (-1.58, 1.56) -0.07 (-4.19, 4.06) 0.95 (0.35, 2.54) 
 
Male 373 -1.19 (-3.75, 1.36) -0.96 (-7.79, 5.88) 0.46 (0.13, 1.60) 
 
Female 344 0.71 (-1.27, 2.68) 0.04 (-5.00, 5.07) 2.42 (0.31, 18.72) 
Mother's age  All 722 -0.01 (-0.06, 0.04) 0.01 (-0.14, 0.15) 1.01 (0.97, 1.05) 
 
Male 374 0.02 (-0.06, 0.10) 0.09 (-0.13, 0.32) 1.02 (0.96, 1.06) 
 
Female 348 -0.04 (-0.11, 0.03) -0.06 (-0.25, 0.13) 1.01 (0.95, 1.07) 
Mother's BMI≥30 All 722 2.18 (1.30, 3.05) 4.68 (2.37, 6.99) 4.27 (2.68, 6.80) 
 
Male 374 2.47 (1.22, 3.71) 5.00 (1.63, 8.35) 5.00 (2.67, 9.35) 
 
Female 348 1.87 (0.63, 3.10) 4.37 (1.22, 7.50) 3.70 (1.78, 7.64) 
Mother's education  All 720 0.004 (-0.10, 0.10) -0.02 (-0.29, 0.25) 1.07 (0.99, 1.13) 
 
Male 373 0.06 (-0.08, 0.19) 0.08 (-0.30, 0.46) 1.08 (0.99, 1.17) 
 Female 347 -0.06 (-.21, 0.08) -0.17 (-0.55, 0.21) 1.03 (0.92, 1.15) 
  
Table 2.3. Multivariable linear and logistic regressions estimating adjusted models of adolescent BMI, waist 
circumference, and obesity. 
 
      BMI Waist circumference Obese 
   
Adjusted model 1a Adjusted model 2b* Adjusted model 1a Adjusted model 2b* Adjusted model 1a Adjusted model 2b* 
 
Sex N β 95% CI β 95% CI β 95% CI β 95% CI OR 95% CI OR 95% CI 
Preterm birth All 722 0.001 (-1.15, 1.15) 0.03 (-1.09, 1.15) -0.46 (-3.42, 2.49) -0.43 (-3.33, 2.48) 1.07 (0.47, 2.39) 1.03 (0.43, 2.39) 
 
Male 374 0.02 (-1.54, 1.58) 0.06 (-1.46, 1.58) -1.06 (-5.07, 2.95) -0.79 (-4.75, 3.16) 0.93 (0.33,2.58) 0.89 (0.30, 2.64) 
 
Female 348 -0.02 (-1.74, 1.70) 0.002 (-1.69, 1.69) 0.52 (-3.88, 4.92) 0.37 (-4.01, 4.75) 1.42 (0.38, 5.19) 1.33 (0.33, 5.24) 
Mother married All 722 -0.49 (-1.08, 0.10) -0.50 (-1.09, 0.08) -1.04 (-2.56, 0.49) -1.13 (-2.65, 0.39) 0.67 (0.44, 1.02) 0.66 (0.42, 1.04) 
 
Male 374 -0.63 (-1.50, 0.24) -0.51 (-1.36, 0.35) -1.17 (-3.42, 1.07) -0.95 (-3.18, 1.27) 0.57 (0.32, 0.97) 0.60 (0.33, 1.07) 
 
Female 348 -0.36 (-1.17, 0.45) -0.43 (-1.26, 0.39) -0.76 (-2.84, 1.32) -1.12 (-3.25, 1.02) 0.90 (0.45, 1.77) 0.85 (0.40, 1.78) 
Mother smoked All 717 0.71 (-0.67, 2.09) 0.51 (-0.83, 1.85) 1.74 (-1.81, 5.29) 1.17 (-2.32, 4.66) 0.79 (0.28, 2.14) 0.65 (0.23, 1.83) 
 
Male 373 -0.47 (-2.73, 1.79) -0.63 (-2.84, 1.57) 1.23 (-4.58, 7.05) 0.62 (-5.11, 6.35) 0.42 (0.11, 1.49) 0.35 (0.09, 1.28) 
 
Female 344 1.50 (-0.22, 3.21) 1.26 (-0.44, 2.95) 1.98 (-2.44, 6.40) 1.40 (-2.98, 5.79) 2.08 (0.26, 16.23) 1.91 (0.23, 15.69) 
Mother's age All 722 0.02 (-0.03, 0.06) -0.01 (-0.05, 0.04) 0.09 (-0.04, 0.21) 0.04 (-0.08, 0.17) 1.01 (0.97, 1.05) 1.00 (0.96, 1.04) 
 
Male 374 0.03 (-0.04, 0.10) 0.01 (-0.06, 0.08) 0.12 (-0.06, 0.31) 0.08 (-0.10, 0.27) 1.02 (0.96, 1.06) 1.01 (0.95, 1.06) 
 
Female 348 0.01 (-0.06, 0.07) -0.02 (-0.08, 0.05) 0.05 (-0.12, 0.21) 0.00 (-0.17, 0.17) 1.01 (0.95, 1.06) 1.00 (0.93, 1.05) 
Mother's BMI≥30 All 722 2.62 (1.85, 3.37) 2.63 (1.85, 3.40) 5.90 (3.93, 7.85) 5.88 (3.87, 7.88) 4.24 (2.64, 6.82) 4.54 (2.78, 7.42) 
 
Male 374 2.77 (1.67, 3.85) 2.73 (1.62, 3.84) 5.88 (3.05, 8.70) 5.76 (2.87, 8.64) 4.93 (2.62, 9.23) 5.00 (2.60, 9.60) 
 
Female 348 2.46 (1.40, 3.52) 2.49 (1.39, 3.58) 5.84 (3.11, 8.56) 5.91 (3.07, 8.73) 3.42 (1.63, 7.14) 3.74 (1.74, 7.99) 
Mother's education All 720 0.11 (0.01, 0.20) 0.13 (0.03, 0.21) 0.27 (0.03, 0.50) 0.29 (0.05, 0.52) 1.05 (0.98, 1.12) 1.07 (0.99, 1.14) 
 
Male 373 0.15 (0.02, 0.27) 0.15 (0.02, 0.27) 0.37 (0.04, 0.69) 0.36 (0.03, 0.67) 1.08 (0.98, 1.16) 1.08 (0.99, 1.18) 
 Female 347 0.06 (-0.07, 0.19) 0.09 (-0.04, 0.22) 0.14 (-0.20, 0.48) 0.21 (-0.14, 0.55) 1.01 (0.90, 1.12) 1.03 (0.91, 1.16) 
aAdjusted for chid's age, child's sex 
bAdditionally adjusted for preterm birth, mother's age, smoking status during pregnancy, marital status, obesity, education 
*N=715 for combined sex, N=372 for males, N=343 for females 
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 CHAPTER 3
 
Bisphenol A and Phthalates Urinary Concentrations in 
utero and in Adolescence: Associations with Weight 
Status and Adiposity Differ by Sex 
 
Abstract 
Background: Childhood and adolescent obesity is known to track into adulthood, 
exacerbating future obesity burden. Environmental exposures to endocrine-
disrupting compounds may contribute to dysregulation of weight gain and 
distribution, especially if exposures occur during critical periods of development. 
Objectives: Assess the relationship between in utero and concurrent adolescent 
Bisphenol A (BPA) and phthalate metabolite exposures on adolescent BMI z-score, 
waist circumference, and triceps skinfolds. 
Methods: This study utilizes participants from the Early Life Exposure in Mexico to 
ENvironmental Toxicants (ELEMENT). BPA and phthalate metabolite urinary 
concentrations were assessed using linear regression with continuous measures of 
adolescent BMI z-score, waist circumference, and triceps skinfolds. Quartiles of 
exposures were also examined following observations of non-monotonicity from 
GAM modeling. 
Results: In utero exposures to continuous BPA and MBzP in females were 
significantly negatively associated with adolescent BMI z-score. Second and third 
quartiles of MEOHP, MEHHP, and MIBP in males, and MEHP, MECPP, MEHHP, 
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and MEOHP in females were significantly associated with adolescent outcomes. 
Concurrent second and third quartiles of exposures were significantly negatively 
associated with adolescent measures of BPA in males and for MCPP and MiBP in 
females. Significantly negative associations between concurrent continuous male 
concentrations of MEHP, and female concentrations of MBP, were observed with 
adolescent outcomes. Non-significant positive associations between female urinary 
concentrations of adolescent MEP and BPA and outcomes were observed. 
Discussion: Significant non-monotonic associations of BPA and phthalates 
exposures in in utero and in adolescence with adolescent BMI z-score, waist 
circumference, and triceps skinfold were observed, with differences by sex. Our 
results suggest that fat distribution for males, but not females, is influenced by 
pregnancy exposures. 
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Background 
Bisphenol A (BPA) and phthalates are multi-functional materials used in 
everyday products, resulting in widespread exposure to these compounds and their 
metabolites in humans of both genders and all age groups (Adibi et al. 2003; Calafat 
et al. 2008; Callan et al. 2012; Frederiksen et al. 2011; Pirard et al. 2012; Silva et al. 
2004; Taskeen et al. 2012). Notably, metabolites have been detected during 
pregnancy, with evidence of these metabolites in the amniotic sac and cord blood 
(Calafat et al. 2008; Callan et al. 2012; Cantonwine et al. 2010; Chou et al. 2011; 
Meeker 2012; Silva et al. 2004; Vandenberg et al. 2007a).  
The Developmental Origins of Health and Disease (DOHaD) framework 
considers early life exposures crucial to later health indices. Fat cell mass and 
number increase substantially in late pregnancy and exposures during this critical 
period, during which the organism undergoes rapid growth, could disrupt and alter 
physiological structure and function (Dietz 1994; Gluckman et al. 2008; Heindel and 
vom Saal 2009; Poissonnet et al. 1984). This increases risk of development of 
chronic diseases, including altered weight status, which could start in childhood. 
Accumulating evidence suggest these chemicals play a role in influencing physiology 
from the perinatal period, with animal studies showing environmentally-relevant 
effects on weight gain, adiposity, and alterations in satiety hormones (Angle et al. 
2013; Wei et al. 2011; Xu et al. 2011).  
Therefore, exposures have implications for development of childhood and 
adolescent overweight, which has been shown to track into adulthood. Overweight 
and obese children have many of the same health hazards as overweight and obese 
adults including insulin resistance, dyslipidemia, and cardiovascular health risks 
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(Flegal et al. 2010; Freedman and Sherry 2009; Guo et al. 1994; Lee et al. 2010; 
Ogden et al. 2012; de Onis et al. 2013; Sun et al. 2012). Studies have implicated these 
compounds to obesity, increased waist circumference and fat mass, alterations in 
adipogenesis, lipogenesis, and metabolic imbalance such as impaired glucose and 
insulin response (Alonso-Magdalena et al. 2005a; Carwile and Michels 2011; Hao et 
al. 2012; Harley et al. 2013; Hatch et al. 2008; Hauser and Calafat 2005; Hugo et al. 
2008; Lang et al. 2008; Lind et al. 2012a, 2012b; Masuno et al. 2002; Newbold 
2010; Ropero et al. 2008; Ryan et al. 2010; Sakurai et al. 2004; Shankar and 
Teppala 2011; Stahlhut et al. 2007; Teitelbaum et al. 2012; Trasande et al. 2012; 
Wang et al. 2012a, 2012b, 2012c; Wei et al. 2011). In addition, many cell and animal 
studies show effects at concentrations below calculated safe doses, making 
environmentally relevant levels  a cause for concern (Alonso-Magdalena et al. 2005a; 
Hao et al. 2012; Marmugi et al. 2012; Vandenberg et al. 2007b).   
Few human studies examine the associations between exposures to BPA and 
phthalates with weight status; of these, most are cross-sectional or are unable to 
assess the implications of early life exposure. Adult cross-sectional data suggest a 
positive association between exposures to BPA and phthalates with increasing BMI, 
waist circumference, fat mass, and diabetes (Carwile and Michels 2011; Hatch et al. 
2010, 2008; Shankar and Teppala 2011; Stahlhut et al. 2007; Wang et al. 2012d). Of 
human studies examining prenatal exposures, only BPA has been assessed, and only 
up to 9 years of age: prenatal urinary BPA concentration were found to be associated 
with lower odds of overweight in males and females, as well as decreased BMI z-
score and percent body fat among females at 9 years of age. Another study observed 
that prenatal BPA exposure resulted in marginal increases in BMI and waist 
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circumference in children at 4 years of age (Harley et al. 2013; Valvi et al. 2013). 
Among females 6-8 years old, a one-year prospective study showed increasing MEP 
quartiles were associated with BMI and waist circumference (Teitelbaum et al. 
2012). Other cross-sectional studies in youth show positive associations between 
BPA and phthalates with odds of obesity, insulin resistance, central adiposity, and 
diabetes (Bhandari et al. 2013; Eng et al. 2013; Li et al. 2013; Trasande et al. 2012, 
2013b, 2013c; Wang et al. 2012a; Wells et al. 2013). Studies report some differences 
in association by sex though results have not been conclusive.  
Given the evidence that development of adiposity occurs early in life and can 
be influenced by exposures to endocrine-disrupting compounds, this study seeks to 
assess the impact in children older than previously reported. We examined the 
association of BPA and phthalate metabolite concentrations in maternal third 
trimester and adolescent urine samples with BMI z-score, waist circumference, and 
triceps skinfold in a cohort of Mexican adolescents aged 8-14.  
Materials and Methods 
Subjects and Settings 
The study population involved participants from the 19-year Early Life 
Exposure in Mexico to ENvironmental Toxicants (ELEMENT) research collaboration 
with Mexico’s Instituto Nacional de Salud Pública (INSP) that consists of three birth 
cohorts. Similar exclusion criteria were applied to all cohorts, as described 
elsewhere(Ettinger et al. 2009; Gonzalez-Cossio et al. 1997; Téllez-Rojo et al. 2004). 
Common recruitment methods allow for pooling of the cohorts for analysis and 
follow-up was continuously maintained. 
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Mothers were given detailed information regarding study procedures and 
signed a letter of informed consent at the time of initial recruitment and follow-up. 
The research protocols were approved by the Ethics and Research Committees of the 
National Institute of Public Health in Mexico, Harvard University and the University 
of Michigan Schools of Public Health. 
Anthropometric Measures 
At one-month postpartum, maternal height was obtained using professional 
scales (BAME Mod 420; Catálogo Médico) read to the nearest 0.1 centimeter (cm) 
and maternal weight was recorded to the nearest 0.1 kilogram (kg). Children’s 
anthropometry were taken by study personnel using established research 
protocol(Lohman et al. 1988). Weight (BAME Mod 420; Catálogo Médico) was 
measured to the nearest 0.1 kg; height (BAME Mod 420; Catálogo Médico) was 
measured to the nearest 0.1 cm; waist circumference was measured with a non-
stretchable tape (QM2000; QuickMedical) to the nearest 0.1 cm. Triceps and 
subscapular  skinfold thickness were measured using a Lange skinfold caliper 
(Lange; Beta Technology) to the nearest 0.1 mm. Duplicate measures were taken of 
weight and height and triplicate measures were taken of waist circumference and 
triceps skinfold thickness; the observed values were averaged. An additional 
measurement was taken if intra-personal variability exceeded the measurement 
tolerance of 0.5 cm. BMI was calculated as kg/m2. Age-specific Body Mass Index 
(BMI) z-score was calculated using the 2007 World Health Organization (WHO) 
data.  
                   
51 
 
Questionnaires 
A questionnaire assessing social and demographic characteristics was 
administered by study personnel to the mother at the baseline and follow-up visit 
when the children were 8-14 years old.  
Urinary BPA and Phthalate Metabolites 
A spot (second morning void) urine sample was collected from each woman 
during her third-trimester visit to the project's research center and frozen at − 80 °C; 
these were matched to urines from adolescents at follow-up. Samples were analyzed 
for total (free + glucuronidated) BPA and nine phthalate metabolites by NSF 
International (Ann Arbor, MI, USA) using validated modification of the Centers for 
Disease Control and Prevention (CDC) methods described elsewhere (Calafat et al. 
2008; Lewis et al. 2013; Silva et al. 2007). The nine phthalate metabolites: 
monoethyl phthalate (MEP), metabolite of diethyl phthalate  (DEP); mono-n-butyl 
phthalate (MBP), metabolite of di-n-butyl phthalate (DBP); mono-isobutyl phthalate 
(MiBP), metabolite of di-isobutyl-phthalate (DiBP); mono(3-carboxypropyl) 
phthalate (MCPP), metabolite of DBP and di-n-octyl phthalate (DOP); monobenzyl 
phthalate (MBzP), metabolite of butylbenzyl phthalate (BBzP); and mono(2-
ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), 
mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-ethyl-5-carboxypentyl) 
phthalate (MECPP), metabolites of di(2-ethylhexyl) phthalate (DEHP). Specific 
gravity (SG) of the urine samples was measured using a handheld digital 
refractometer (ATAGO Company Ltd., Tokyo, Japan).  
BPA and phthalate metabolite concentrations below the limit of quantitation 
(LOQ) were assigned a value of LOQ/sqrt(2). Urinary concentrations were 
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statistically adjusted for specific gravity to adjust for variability in urine output 
(Mahalingaiah et al. 2008; Pearson et al. 2009).  
Statistical Analysis 
Data analysis was completed using SAS version 9.3 for Windows (SAS 
Institute, Cary, NC, USA). We used multivariable linear regression to assess the 
association of BPA and individual phthalates metabolites with continuous outcome 
measures (BMI z-score, waist circumference, and triceps skinfold), stratified by sex. 
Sensitivity analyses were also assessed for the outcomes of BMI and a sum score of 
triceps and subscapular skinfold, as it has been suggested that a sum score would be 
a better measure of adiposity in childhood and adolescence (Boeke et al. 2013). 
Results did not significantly differ; therefore, outcomes for BMI z-score and triceps 
skinfold are shown. Tables and Figures pertaining to BMI and triceps and 
subscapular skinfold results are found in the Appendix. Generalized additive models 
(GAMS) were utilized to visualize the relationship between BPA and phthalates 
metabolites with outcome measures; visual inspection and significant Analysis of 
Deviance p-values confirmed departure from linearity for certain metabolites (Figure 
3.1). Therefore, results are shown with continuous and quartile exposure variables, 
with first quartile as reference.  
Distributions of BPA and phthalate metabolite concentrations, uncorrected 
for SG, were analyzed at third trimester of pregnancy and at 8-14 years of age for 
males and females; comparisons were determined using Wilcoxon rank-sum tests. 
Spearman’s partial-rank correlation coefficients and p-values for SG-corrected BPA 
and phthalates metabolites were calculated for males and females between the two 
time periods.  
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Potential confounding factors identified a priori and retained in the final 
adjusted model included maternal BMI at 1 month postpartum and years of 
education. Descriptive statistics and distributions were performed and extreme 
outliers were identified using the generalized extreme studentized deviation method 
(Rosner 1983).  
Results 
 Table 3.1 shows the sample characteristics. Mean age of males and females 
was 10.3 years. Females had significantly higher measure of triceps skinfolds 
(17.3mm compared to 14.4mm; p<0.0001). Mothers had a mean BMI of 27 at 1 
month postpartum and averaged 11 years of total schooling.  
 Tables 3.2 and 3.3 show the distribution of BPA and phthalates metabolite 
concentrations uncorrected for urinary dilution for samples collected from mothers 
during the third trimester of pregnancy, and in adolescence, respectively. The 
majority of all pregnancy samples had detectable concentrations of BPA (26-
36%<LOQ) and phthalate metabolites (0-11%<LOQ). Only BPA showed marginal 
differences between males and females (GM=0.9ng/mL females; 0.7ng/ml males; 
p=0.05). Compared to maternal third trimester urine samples, there were fewer 
adolescent samples below the LOQ for BPA (14-15%<LOQ) and phthalates 
metabolites (0-6%<LOQ). Geometric means were higher in the adolescent samples 
with the exception of MEP (108.9ng/mL in males; 114.5ng/mL in females in 
maternal third trimester; 66ng/mL in males; 97.5ng/ml in females in adolescence), 
and females had significantly (p=0.03) higher concentrations compared to males. 
Spearman’s partial-rank correlation coefficients comparing SG-corrected BPA and 
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phthalates metabolites concentrations between the two time periods did not show 
statistically significant correlations (data not shown).  
 The associations between sex-stratified continuous measures of maternal 
third trimester urinary BPA and phthalate metabolites with adolescent BMI z-score, 
waist circumference, and triceps skinfolds are shown in Table 3.4. Mothers of 
females had adjusted urinary BPA and MBzP concentrations that were significantly 
(p<0.05) negatively associated with adolescent BMI z-score and were suggestively 
negatively associated with adolescent waist circumference. Additionally, the high 
molecular weight phthalate metabolites MEHP, MECPP, MEHHP, and MEOHP 
were non-significantly positively associated with adolescent waist circumference. 
Males exposed in utero to MBP, MiBP, MBzP, MCPP, MEP, and the high molecular 
weight phthalates metabolites MECPP, MEHHP, and MEOHP were non-
significantly associated with increases in adolescent triceps skinfold. 
Figure 3.1 gives evidence for non-monotonic associations between the sex-
stratified quartiles with adolescent outcomes; test for trend is non-significant for all 
metabolites except female BPA. All metabolites exhibited similar patterns across all 
outcome measures except for female BPA, MEP, MCPP and MBzP. Table 3.5 shows 
the associations between each quartile exposure compared to the reference quartile. 
Significant associations were observed for second and third quartile concentrations; 
in males, this occurred with MEHHP (2nd quartile β=3.70; 95%CI: 0.81, 6.59) and 
MEOHP (2nd quartile β=4.87; 95%CI:1.98, 7.76),with triceps skinfold, and MIBP 
with waist circumference (3rd quartile β=-6.07; 95%CI:-11.54, -0.60). Females had 
significant associations between MECPP (2nd quartile β=-1.21; 95%CI:-1.90, -0.51), 
MEHHP (2nd quartile β=-0.77 95%CI:-1.48, -0.06), and MEOHP (2nd quartile β=-
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0.79; 95%CI:-1.49, -0.09) with BMI z-score. MECPP (2nd quartile β=-4.92; 95%CI:-
7.96, -1.88), MEHHP (2nd quartile β=-3.99; 95%CI:-7.05, -0.92), and MEOHP (2nd 
quartile β=-4.22; 95%CI:-7.28, -1.15) were also significantly associated with triceps 
skinfold.  MEHP was negatively associated with triceps skinfold (3rd quartile β=-
3.92; 95%CI: -7.01, -0.83) and MECPP with waist circumference (2nd quartile β=-
7.66; 95%CI:-13.57, -1.76). 
 Table 3.6 shows the associations between continuous measures of adolescent 
urinary BPA and phthalate metabolites stratified by sex with BMI z-score, waist 
circumference, and triceps skinfolds at ages 8-14. Significant negative associations of 
male adolescent urine concentrations were found between adjusted MEHP with 
waist circumference (β=-1.95; 95%CI:-3.74, -0.15) and triceps skinfold (β=-1.17; 
95%CI:-2.21, -0.12). Suggestive adjusted associations (p<0.1) were observed between 
MEHP with BMI z-score, and MCPP, MEOHP, and MEHHP with waist 
circumference. For females, significant negative associations between crude MBP 
with BMI z-score (β=-0.30; 95%CI:-0.54, -0.05) and waist circumference (β=-2.19; 
95%CI:-2.19, -0.11) were observed. Suggestive negative associations were seen with 
MCPP and MiBP with waist circumference and MBP with triceps skinfold.  
 Comparing across the two time points show that the suggestive and 
significant findings in one time period was not found in the other. However, across 
time periods for males, all metabolites but MBP and MEHP were consistently 
negatively associated with BMI z-score and waist circumference. The positive 
suggestive associations seen for male MBzP, MCPP, MEP, MECPP, and MEHHP 
with triceps skinfold in the third trimester urines were reversed in adolescence. 
Female MBP, MCPP, MiBP, were consistently suggestively negatively associated with 
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all outcomes in both time periods; reversal in direction of association from negative 
in third trimester to positive in adolescence was observed for BPA and MEP for all 
outcomes.  
Adolescent sex-stratified urinary quartiles of urinary biomarkers and outcome 
measures are shown in Figure 3.3. Tests for linear trend were non-significant for all 
metabolites and outcome measures. Similar to quartiles of maternal third trimester 
biomarker concentrations, adolescent urine concentrations of metabolites exhibit 
similar non-monotonic patterns across outcome measures with increasing quartiles. 
Table 3.7 shows the associations between quartiles of exposure with adolescent 
outcomes, compared to the reference quartile. Significant adjusted associations for 
males were observed between BPA (2nd quartile β=-0.82; 95%CI:-1.51, -0.13) with 
BMI z-score, waist circumference (2nd quartile β=-6.45; 95%CI:-11.85, -1.04), and 
triceps skinfold (2nd quartile β=-3.26; 95%CI:-6.46, -0.06). For females, significant 
findings were observed for MCPP with BMI z-score (3rd quartile β=-1.17; 95%CI:-
1.82, -0.53), waist circumference (3rd quartile β=-10.15; 95%CI:-15.76, -4.54), and 
triceps skinfold (3rd quartile β=-3.54; 95%CI:-6.63, -0.44), and MiBP with BMI z-
score (2nd quartile β=-0.91; 95%CI:-1.56, -0.24) and waist circumference (2nd 
quartile β=-7.61; 95%CI:-13.15, -2.08; 4th quartile β=-6.44; 95%CI:-12.68, -0.20).   
Discussion 
Principal findings suggest that prenatal and adolescent exposures to BPA and 
phthalates are differentially associated with adolescent BMI z-score, waist 
circumference, and triceps skinfold by sex, which has been observed in other studies 
(Bhandari et al. 2013; Harley et al. 2013; Hatch et al. 2010, 2008; Teitelbaum et al. 
2012; Wang et al. 2012a; Wells et al. 2013). Contrary to our hypothesized positive 
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association between urinary metabolites and outcome measures, significant results 
were mostly negative. Suggestive associations between continuous urinary 
metabolites and outcome measures were different between the two time periods and 
our findings also showed that, while some BPA and phthalate metabolites may be 
linear in their associations, division into quartile measures demonstrated that that is 
not true for all metabolites.  
Quartile analyses revealed significant associations that occurred with second 
or third quartile exposures rather than the highest exposure quartile, compared to 
the lowest quartile.  In the third trimester urinary concentrations, these significant 
findings were observed in both males and females with the high molecular weight 
phthalates MEHHP, MECCP, and MEOHP whereas, in adolescence, significant 
findings were different from those in the third trimester, as well as for males and 
females. In addition, continuous models of males and females were observed to be 
influenced by different metabolites in different time periods; the marginal increases 
in fat mass and distribution for females seen from adolescent urines were not 
observed from pregnancy urines while males only saw increases in triceps skinfold in 
relation to third trimester exposures.  
Our cross-sectional findings of increases in fat mass and distribution from 
continuous measures of BPA and MEP exposures in females are consistent with 
other cross-sectional studies (Bhandari et al. 2013; Carwile and Michels 2011; Eng et 
al. 2013; Harley et al. 2013; Hatch et al. 2010, 2008; Li et al. 2013; Shankar and 
Teppala 2011; Stahlhut et al. 2007; Teitelbaum et al. 2012; Wang et al. 2012a, 
2012d). For males, contrary to findings from Stahlhut et al. (2007) and Hatch et al. 
(2008), cross-sectional associations between increasing quartiles of male MBP, 
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MBzP, MEHHP, MEOHP, and MEP in our population were not shown to increase 
waist circumference and, in fact, increasing quartiles of MBzP were observed to 
decrease BMI z-score, waist circumference, and triceps skinfolds (Hatch et al. 2010, 
2008; Stahlhut et al. 2007). In addition, our results contrast those found by 
Trasande et al. (2012) and Harley et al (2013), the latter of whom utilizes a Mexican-
American birth cohort with participants now at 9 years of age; in males from that 
study, increasing tertiles of prenatal BPA exposure were found to non-significantly 
increase fat mass and distribution measures while we observed a significant decrease 
in outcome measures with the second exposure quartile, with increasing quartiles 
attenuating those negative associations (Harley et al. 2013; Trasande et al. 2012). It 
may be that our results are tempered by study participants entering the pubertal 
transition; associations may change depending on whether participants are pre- or 
post-transition, and may account for some differences in our results from other 
cross-sectional studies. 
Prenatal (GM=0.8ng/mL) and adolescent (GM=1.3ng/mL) distributions of 
BPA in our study population are lower than that reported from the United States 
National Health and Nutrition Examination Survey (NHANES) for females 
(GM=2.9ng/mL) and Mexican-Americans (GM=2.9ng/mL) (Calafat et al. 2008). 
Pregnancy urinary BPA levels are also lower than concentrations found in other 
American and European populations (Braun et al. 2009; Callan et al. 2012; Harley et 
al. 2013; Philippat et al. 2012; Ye et al. 2008). Concentrations of MCPP were also 
lower in our population for the two time periods (GM=1.1ng/mL; 2.2ng/mL, 
respectively) compared to NHANES data (3.02ng/mL for all ages and sex; 
4.54ng/mL for ages 6-11 years; 3.65ng/mL for ages 12-19; 2.31 for Mexican-
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Americans) (CDC 2013). Higher concentrations of MBP (GM=53.8ng/mL prenatal; 
103.5ng/mL adolescent), MEHP (GM=5.1ng/mL prenatal; 6.0ng/mL adolescent), 
MEHHP (GM=19.2ng/mL prenatal; 46.6ng/mL adolescent), and MEOHP 
(GM=11.6ng/mL prenatal; 46.6ng/mL adolescent) were higher than concentrations 
in NHANES for MBP (14.6ng/mL for all ages and sex; 21.7ng/mL for ages 6-11 years; 
18.9ng/mL for ages 12-19; 17.2ng/mL for Mexican-Americans), MEHP (1.59ng/mL 
for all ages and sex; 1.64ng/mL for ages 6-11 years; 1.82ng/mL for ages 12-19; 
2.08ng/mL for Mexican-Americans), MEHHP (12.9ng/mL for all ages and sex; 
15.0ng/mL for ages 6-11 years; 15.3ng/mL for ages 12-19; 15.3ng/mL for Mexican-
Americans), and MEOHP (8.02ng/mL for all ages and sex; 9.78ng/mL for ages 6-11 
years; 15.3ng/mL for ages 12-19; 9.57ng/mL for Mexican-Americans). Compared to 
other study populations, phthalates metabolites in our study sample are lower, with 
the exception of MBP, MCPP, MEP, MEHHP, and MECPP, though these are not 
consistent across comparisons to all populations (Kasper-Sonnenberg et al. 2012; 
Philippat et al. 2012; Ye et al. 2008).  
One limitation of our study is the use of a single spot-urine during pregnancy 
and in childhood. BPA and phthalates also have short metabolite half-lives, with <5-
6 hours for BPA and <24 hours for phthalates (Koch et al. 2005; Völkel et al. 2002). 
Studies with repeated measurements find very low reproducibility (Braun et al. 
2012a; Teitelbaum et al. 2008; Valvi et al. 2013). The distributions of urine 
metabolites in the third trimester of pregnancy and adolescence reported here are 
similar to those reported by our group earlier among a smaller subset of this study 
population (Lewis et al. 2013). The concentrations of metabolites may vary widely 
throughout the day and are influenced by a variety of factors. However, previous 
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studies have shown that a single measure may be a relatively good measure of 
exposure due to the consistency of behaviors (Braun et al. 2012b; Mahalingaiah et al. 
2008; Teitelbaum et al. 2008). Another limitation was our relatively small sample 
size, but this study supplied evidence of significant non-monotonicity of BPA and 
phthalate urinary metabolites with adolescent anthropometric endpoints and 
provided a baseline for future work utilizing a larger sample size. As with all cross-
sectional studies, it is difficult to assess temporality and results should be interpreted 
with caution. Individuals who are overweight may metabolize BPA and phthalates 
different than lean individuals, possibly leading to the observed positive associations 
in many studies. Overweight individuals may also consume more calories, or eat 
more foods packaged in materials utilizing BPA and phthalates, resulting in a higher 
exposure to these chemicals. Therefore, confidence in results from longitudinal 
studies is higher, where the issue of temporality is already established.  
However, our study has several strengths. It is a prospective design  
establishing temporality, and the importance of early life exposures is well-known. 
The third trimester urine samples allowed us to assess the importance of exposure at 
a time of rapid development, and we had extensive follow-up of participants, 
permitting us to estimate associations at time points later than previously reported 
in the literature. Our findings show no correlations between maternal third trimester 
and adolescent urines, which may reflect differential sources of BPA and phthalates 
as well as differences in metabolism. For instance, it has been shown in our 
population that the use of personal care products by males and females in the 
previous 48-hours contributes to urinary phthalate metabolite concentrations (Lewis 
et al. 2013) 
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 In conclusion, we found that there are differences in association with 
adolescent BMI z-score, waist circumference, and triceps skinfold between exposures 
to BPA and phthalates metabolites in the third trimester of pregnancy and cross-
sectionally in adolescence. Increases in fat mass and distribution with continuous 
measures of BPA and MEP concentrations in adolescent female urines were 
consistent with other findings, while these associations were reversed with maternal 
third trimester urines. Many of the metabolites exhibit non-monotonic relationships 
with the outcome measures and suggest caution in interpretation of linear 
associations. Our results suggest that fat distribution for males may be influenced by 
pregnancy exposures. Further work utilizing a larger sample size will allow for more 
in-depth longitudinal analyses. 
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Table 3.1. Characteristics of mothers and adolescents in sample population. 
 
 
Characteristic Combined Sex Males Females 
 
 
N Mean±SD N Mean±SD N Mean±SD p-value 
Youth's age (yr) 249 10.3±1.6 117 10.3±1.5 132 10.3±1.7 0.95 
  weight (kg) 249 38.0±11.0 117 37.2 ±9.7 132 38.7±12.0 0.30 
  height (cm) 249 138.4±10.7 117 138.6±10.5 132 138.33±10.9 0.87 
  waist circumference (cm) 249 70.7±10.6 117 69.5 ±9.7 132 71.7±11.3 0.10 
  triceps skinfold (mm) 249 16.0±5.7 117 14.4±5.3 132 17.3± 5.7 <0.001 
  BMI z-score 249 0.89±1.2 117 0.91±1.1 132 0.88±1.2 0.85 
Mother's BMI 1 month postpartum 240 27.0±3.9 114 26.7±4.2 126 27.2±3.6 0.31 
  years of education 245 11.0±2.8 115 11.3±2.8 130 10.8±2.8 0.25 
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Table 3.2. Distribution of total (free+glucuronidated) BPA and phthalate metabolites 
in third trimester maternal urine (ng/mL uncorrected for dilution). 
 
      Percentiles 
Analyte LOQa Sex N %>LOQ GM (SE)b 10th 25th 50th 75th 90th 95th Maxc p-value 
BPA 0.4 Male 107 64 0.7 (2.0) <LOQ <LOQ 0.6 1.1 1.8 2.7 9.0 0.05a 
  Female 116 74 0.9 (2.1) <LOQ <LOQ 0.7 1.4 2.3 4.1 18.7  
MBP 0.5 Male 107 100 53.3 (3.1) 11.8 25.5 58.0 112.0 204.0 318.0 1000.0 1.00 
  Female 116 100 54.3 (3.5) 12.7 26.4 54.2 119.0 206.0 606.0 1190.0  
MBzP 0.2 Male 107 99 4.3 (2.5) 1.4 2.6 5.2 7.7 13.4 15.9 32.5 0.18 
  Female 116 100 4.1 (2.7) 1.3 2.2 3.7 7.0 12.8 29.6 109.0  
MCPP 0.2 Male 107 94 1.2 (2.5) 0.3 0.6 1.3 2.3 3.4 4.0 12.1 0.36 
  Female 116 94 1.1 (2.7) 0.2 0.5 1.1 1.9 4.0 6.6 11.1  
MEP 1.0 Male 107 100 108.9 (2.4) 23.2 44.6 111.0 222.0 594.0 1130.0 7950.0 0.80 
  Female 116 99 114.5 (2.8) 20.2 40.8 115.5 241.0 762.0 1900.0 9810.0  
MiBP 0.2 Male 107 98 1.8 (2.7) 0.4 0.9 1.7 3.6 6.4 8.4 40.1 0.33 
  Female 116 98 2.0 (2.9) 0.5 1.0 2.0 3.6 8.6 12.6 33.9  
MEHP 1.0 Male 107 89 5.0 (3.5) 1.0 2.5 6.1 10.0 16.6 18.8 62.0 1.00 
  Female 116 91 5.2 (2.6) 1.0 2.5 5.6 9.5 16.8 30.1 54.7  
MECPP 0.2 Male 107 100 31.9 (2.6) 8.6 19.4 33.7 58.3 107.0 125.0 193.0 0.99 
  Female 116 100 30.9 (2.9) 9.7 15.1 35.4 58.1 107.0 138.0 251.0  
MEHHP 0.1 Male 107 100 19.4 (3.6) 4.7 10.6 16.9 42.7 76.4 95.2 167.0 0.83 
  Female 116 100 19.1 (4.7) 4.9 9.1 22.7 37.5 67.8 96.7 161.0  
MEOHP 0.1 Male 107 100 11.6 (2.7) 3.1 6.0 11.2 25.2 46.0 49.9 85.8 0.83 
  Female 116 100 11.6 (2.9) 3.2 5.8 13.3 24.7 42.7 56.1 133.0  
aLOQ: limit of quantification 
bGM: geometric mean(standard error) 
cMax: maximum 
*p-value from Wilcoxon-Mann-Whitney test for differences between males and females
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Table 3.3.  Distribution of total (free+glucuronidated) BPA and phthalate 
metabolites in adolescent urine (ng/mL uncorrected for dilution). 
 
     
Percentiles 
Analyte LOQa Sex N %>LOQ GM (SE)b 10th 25th 50th 75th 90th 95th Maxc p-value* 
BPA 0.4 Male 113 86 1.2 (2.3) <LOQ 0.7 1.2 1.8 3.1 4.9 33.2 0.62 
  
Female 129 85 1.3 (2.4) <LOQ 0.6 1.3 2.6 5.0 5.8 20.1 
 
MBP 0.5 Male 113 100 98.3 (2.3) 31.9 55.2 97.5 163.0 288.0 398.0 1150.0 0.46 
  
Female 129 100 108.3 (2.8) 30.9 59.4 109.0 224.0 373.0 615.0 6690.0 
 
MBzP 0.2 Male 113 100 5.5 (2.2) 1.9 3.0 5.5 10.0 15.3 18.4 28.9 0.62 
  
Female 129 100 5.8 (2.5) 1.7 3.4 5.8 10.8 17.7 23.5 177.0 
 
MCPP 0.2 Male 113 100 2.1 (2.1) 0.8 1.3 2.1 3.1 5.7 8.0 18.5 0.34 
  
Female 129 98 2.3 (2.8) 0.7 1.1 2.5 3.9 6.6 13.7 140.0 
 
MECPP 0.2 Male 113 100 65.6 (2.4) 27.0 39.0 62.5 101.0 166.0 219.0 12900.0 0.73 
  
Female 129 100 61.8 (2.3) 21.0 36.0 67.1 111.0 149.0 213.0 762.0 
 
MEHHP 0.1 Male 113 100 48.0 (2.6) 18.9 27.7 43.6 78.7 121.0 155.0 13700.0 0.77 
  
Female 129 100 45.4 (2.4) 15.7 23.9 46.1 86.6 133.0 189.0 543.0 
 
MEHP 1.0 Male 113 95 6.1 (2.8) 2.2 3.4 5.1 11.1 16.7 24.2 1910.0 0.60 
  
Female 129 94 5.9 (2.3) 1.9 3.6 5.5 11.4 17.4 19.4 77.3 
 
MEOHP 0.1 Male 113 100 21.3 (2.5) 8.4 12.5 20.4 34.4 51.9 74.5 6000.0 0.84 
  
Female 129 100 20.0 (2.4) 6.7 11.6 20.3 39.0 57.1 84.5 186.0 
 
MEP 1.0 Male 113 100 66.0 (3.5) 16.2 25.8 59.1 134.0 319.0 1120.0 2230.0 0.03 
  
Female 129 100 97.5 (4.2) 19.4 32.2 82.9 243.0 855.0 1230.0 4970.0 
 
MIBP 0.2 Male 113 100 9.5 (2.1) 3.4 5.7 10.0 15.6 23.9 36.5 100.0 0.24 
  
Female 129 100 10.9 (2.3) 3.6 5.9 11.7 19.1 34.3 45.0 121.0 
 
aLOQ: limit of quantification 
bGM: geometric mean(standard error) 
cMax: maximum 
*p-value from Wilcoxon-Mann-Whitney test for differences between males and females
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Table 3.4. Association of BPA and phthalates metabolites concentrations in maternal third trimester urines with 
adolescent BMI z-score, waist circumference, and triceps skinfolds at ages 8-14. 
 
    BMI z-score Waist circumference Triceps skinfold 
Analyte Sex Crudea β(95%CI) 
Adjustedb 
β(95%CI) 
Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) 
BPA 
       
 
Male -0.18 (-0.54, 0.18) -0.19 (-0.58, 0.20) -1.15 (-3.95, 1.65) -0.89 (-4.13, 2.35) -0.88 (-2.51, 0.75) -0.57 (-2.47, 1.34) 
 
Female -0.27 (-0.63, 0.09) -0.36 (-0.71, -0.01)* -1.96 (-5.03, 1.11) -2.54 (-5.68, 0.61) -0.05 (-1.65, 1.54) -0.15 (-1.85, 1.55) 
MBP 
       
 
Male 0.03 (-0.20, 0.27) 0.02 (-0.22, 0.25) 0.01 (-1.81, 1.83) -0.31 (-2.28, 1.66) 0.54 (-0.52, 1.60) 0.5 7(-0.58, 1.73) 
 
Female -0.15 (-0.37, 0.07) -0.1 (-0.32, 0.12) -1.22 (-3.11, 0.66) -0.93 (-3.02, 1.15) -0.14 (-1.12, 0.84) -0.25 (-1.37, 0.86) 
MBzP 
       
 
Male -0.10 (-0.36, 0.16) -0.17 (-0.43, 0.10) -0.04 (-2.08, 2.00) -0.64 (-2.82, 1.54) 0.62 (-0.57, 1.81) 0.41 (-0.87, 1.70) 
 
Female -0.28 (-0.54, -0.02)* -0.25 (-0.53, 0.02) -1.84 (-4.01, 0.34) -1.94 (-4.37, 0.50) -0.01 (-1.15, 1.12) -0.05 (-1.37, 1.26) 
MCPP 
       
 
Male -0.02 (-0.30, 0.27) -0.06 (-0.36, 0.23) -0.13 (-2.35, 2.10) -0.54 (-2.99, 1.90) 0.47 (-0.82, 1.77) 0.58 (-0.86, 2.01) 
 
Female -0.19 (-0.48, 0.10) -0.10 (-0.39, 0.19) -1.46 (-3.94, 1.02) -1.16 (-4.07, 1.75) -0.35 (-1.64, 0.94) -0.37 (-1.92, 1.19) 
MEP 
       
 
Male -0.04 (-0.23, 0.14) -0.04 (-0.23, 0.14) -0.42 (-1.86, 1.01) -0.45 (-2.01, 1.12) 0.26 (-0.58, 1.10) 0.39 (-0.53, 1.31) 
 
Female -0.09 (-0.25, 0.07) -0.12 (-0.28, 0.04) -0.45 (-1.85, 0.96) -0.3 (-1.80, 1.21) -0.03 (-0.76, 0.70) -0.18 (-0.98, 0.62) 
MiBP 
       
 
Male -0.09 (-0.34, 0.17) -0.12 (-0.39, 0.15) -1.11 (-3.07, 0.85) -1.32 (-3.52, 0.87) -0.19 (-1.34, 0.96) 0.12 (-1.18, 1.42) 
 
Female -0.08 (-0.34, 0.19) -0.09 (-0.36, 0.17) -0.55 (-2.85, 1.74) -0.7 (-3.02, 1.61) -0.25 (-1.44, 0.93) -0.51 (-1.74, 0.72) 
MEHP 
       
 
Male 0.04 (-0.23, 0.31) 0.03 (-0.24, 0.30) -0.49 (-2.57, 1.58) -0.83 (-3.15, 1.49) -0.2 (-1.41, 1.02) -0.32 (-1.69, 1.04) 
 
Female -0.12 (-0.41, 0.16) -0.08 (-0.36, 0.21) -0.33 (-2.78, 2.12) 0.26 (-2.27, 2.79) -0.8 (-2.06, 0.46) -0.69 (-2.04, 0.65) 
MECPP 
       
 
Male -0.14 (-0.46, 0.18) -0.18 (-0.49, 0.14) -1.17 (-3.65, 1.31) -1.29 (-3.90, 1.31) 0.34 (-1.12, 1.79) 0.41 (-1.12, 1.95) 
 
Female -0.04 (-0.31, 0.24) -0.04 (-0.31, 0.24) 0.36 (-2.00, 2.72) 0.05 (-2.38, 2.48) -0.56 (-1.77, 0.65) -0.9 (-2.18, 0.38) 
MEHHP 
       
 
Male -0.09 (-0.37, 0.18) -0.1 (-0.37, 0.17) -0.85 (-2.97, 1.27) -0.69 (-2.96, 1.58) -0.06 (-1.30, 1.18) 0.12 (-1.22, 1.46) 
 
Female -0.04 (-0.29, 0.22) -0.02 (-0.27, 0.23) 0.34 (-1.84, 2.52) 0.25 (-1.99, 2.49) -0.33 (-1.46, 0.80) -0.58 (-1.77, 0.61) 
MEOHP 
       
 
Male -0.12 (-0.40, 0.16) -0.12 (-0.39, 0.16) -0.97 (-3.15, 1.20) -0.89 (-3.24, 1.45) 0.17 (-1.10, 1.45) 0.35 (-1.03, 1.73) 
  Female -0.04 (-0.30, 0.21) -0.03 (-0.28, 0.23) 0.2 (-2.01, 2.42) 0.04 (-2.26, 2.34) -0.37 (-1.51, 0.77) -0.61 (-1.83, 0.61) 
aN=107 for males; 116 for females. Adjusted for age, sex, specific gravity 
bN=94 for males; 98 for females. Additionally adjusted for mother’s BMI 1 month postpartum, years of education. 
*p<0.05
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Table 3.5. Multivariable linear regression of associations of adolescent BMI z-score, 
waist circumference, and triceps skinfold with quartiles of maternal third trimester 
urine metabolites compared to the reference first quartile. 
 
        BMI z-score Waist circumference Triceps skinfold 
Analyte Model Sex N β 95% CI β 95% CI β 95% CI 
BPA Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.10 -0.56 0.76 1.43 -3.78 6.63 1.63 -1.39 4.65 
 
Quartile 3 
  
0.21 -0.40 0.83 0.85 -3.98 5.68 1.54 -1.26 4.35 
 
Quartile 4 
  
-0.52 -1.24 0.20 -2.42 -8.05 3.22 -1.43 -4.70 1.84 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
0.40 -0.33 1.13 3.91 -2.23 10.04 -0.81 -4.09 2.47 
 
Quartile 3 
  
-0.01 -0.71 0.70 2.09 -3.81 7.99 0.12 -3.03 3.27 
 
Quartile 4 
  
-0.75 -1.52 0.02 -4.26 -10.72 2.19 -2.12 -5.57 1.33 
MBP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.19 -0.49 0.87 1.71 -3.52 6.94 2.66 -0.41 5.73 
 
Quartile 3 
  
-0.15 -0.80 0.50 -2.10 -7.12 2.93 1.67 -1.28 4.62 
 
Quartile 4 
  
0.05 -0.72 0.83 -1.37 -7.37 4.63 1.31 -2.21 4.83 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
0.03 -0.66 0.71 -0.46 -6.16 5.23 -1.43 -4.33 1.48 
 
Quartile 3 
  
-0.35 -1.10 0.41 -2.83 -9.14 3.48 -2.75 -5.97 0.47 
 
Quartile 4 
  
-0.35 -1.12 0.41 -2.59 -8.98 3.80 0.05 -3.21 3.31 
MBzP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.25 -0.95 0.45 -0.53 -6.02 4.96 -1.33 -4.57 1.91 
 
Quartile 3 
  
-0.64 -1.35 0.08 -2.37 -7.95 3.20 -0.63 -3.92 2.66 
 
Quartile 4 
  
-0.44 -1.16 0.28 -2.49 -8.12 3.13 -0.48 -3.80 2.84 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.24 -0.88 0.39 -2.60 -7.88 2.69 0.06 -2.67 2.80 
 
Quartile 3 
  
-0.33 -0.99 0.32 -1.24 -6.68 4.21 -0.27 -3.09 2.55 
 
Quartile 4 
  
-0.39 -1.13 0.34 -1.79 -7.91 4.33 1.88 -1.29 5.04 
MCPP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.03 -0.72 0.67 -0.22 -5.64 5.20 2.14 -1.02 5.31 
 
Quartile 3 
  
-0.18 -0.92 0.55 -1.06 -6.78 4.66 1.50 -1.84 4.84 
 
Quartile 4 
  
-0.03 -0.79 0.73 0.37 -5.52 6.25 1.65 -1.79 5.08 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.11 -0.80 0.59 -2.44 -8.18 3.30 -1.93 -4.89 1.02 
 
Quartile 3 
  
-0.07 -0.78 0.64 0.30 -5.59 6.20 -1.87 -4.90 1.17 
 
Quartile 4 
  
-0.21 -1.06 0.63 -1.61 -8.56 5.34 -0.20 -3.78 3.38 
MECPP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.23 -0.41 0.86 1.29 -3.65 6.22 2.02 -0.94 4.99 
 
Quartile 3 
  
0.31 -0.40 1.03 3.00 -2.51 8.52 2.39 -0.92 5.71 
 
Quartile 4 
  
-0.67 -1.47 0.14 -5.25 -11.48 0.98 -0.76 -4.50 2.98 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-1.19 -1.89 -0.50 -7.66 -13.57 -1.76 -4.92 -7.96 -1.88 
 
Quartile 3 
  
-0.15 -0.83 0.54 -0.45 -6.25 5.35 -1.94 -4.93 1.05 
 
Quartile 4 
  
-0.25 -1.01 0.52 -0.02 -6.51 6.47 -1.31 -4.65 2.04 
MEHHP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.49 -0.16 1.13 3.06 -1.90 8.03 3.70 0.81 6.59 
 
Quartile 3 
  
0.21 -0.51 0.93 2.72 -2.80 8.25 1.85 -1.37 5.06 
 
Quartile 4 
  
-0.32 -1.09 0.44 -3.69 -9.55 2.18 -0.48 -3.89 2.93 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.75 -1.47 -0.03 -5.29 -11.29 0.70 -3.99 -7.05 -0.92 
 
Quartile 3 
  
-0.21 -0.88 0.47 -1.08 -6.74 4.58 -2.27 -5.16 0.63 
 
Quartile 4 
  
-0.06 -0.94 0.81 0.42 -6.91 7.74 -1.02 -4.77 2.72 
MEHP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.01 -0.65 0.67 -1.42 -6.52 3.68 -0.05 -3.03 2.93 
 
Quartile 3 
  
0.29 -0.39 0.96 0.83 -4.37 6.03 1.66 -1.38 4.69 
 
Quartile 4 
  
-0.05 -0.77 0.66 -3.01 -8.52 2.51 -1.34 -4.56 1.88 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.17 -0.85 0.52 -0.13 -5.86 5.60 -1.87 -4.81 1.07 
 
Quartile 3 
  
-0.66 -1.38 0.07 -4.14 -10.16 1.89 -3.92 -7.01 -0.83 
 
Quartile 4 
  
-0.09 -0.88 0.70 0.71 -5.89 7.31 -1.96 -5.35 1.42 
MEOHP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.62 -0.04 1.28 3.65 -1.44 8.74 4.87 1.98 7.76 
 
Quartile 3 
  
0.18 -0.50 0.87 2.08 -3.23 7.40 2.54 -0.47 5.56 
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Quartile 4 
  
-0.29 -1.07 0.49 -3.68 -9.71 2.35 0.00 -3.43 3.42 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.77 -1.48 -0.06 -5.34 -11.32 0.65 -4.22 -7.28 -1.15 
 
Quartile 3 
  
0.02 -0.68 0.72 0.00 -5.85 5.86 -1.49 -4.49 1.51 
 
Quartile 4 
  
-0.39 -1.25 0.46 -1.89 -9.10 5.32 -2.01 -5.70 1.68 
MEP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.20 -0.85 0.46 -0.05 -5.11 5.02 0.61 -2.42 3.63 
 
Quartile 3 
  
-0.50 -1.17 0.17 -3.83 -9.01 1.34 0.39 -2.70 3.48 
 
Quartile 4 
  
-0.44 -1.20 0.31 -3.19 -8.98 2.60 -0.54 -4.00 2.92 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
0.49 -0.19 1.17 3.66 -2.01 9.34 0.47 -2.50 3.45 
 
Quartile 3 
  
0.18 -0.52 0.88 1.81 -4.04 7.66 0.51 -2.55 3.58 
 
Quartile 4 
  
-0.06 -0.75 0.62 1.07 -4.68 6.82 0.58 -2.43 3.59 
MIBP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.01 -0.65 0.66 -0.61 -5.64 4.42 -0.16 -3.18 2.86 
 
Quartile 3 
  
-0.61 -0.65 0.66 -6.07 -11.54 -0.60 -2.09 -5.37 1.19 
 
Quartile 4 
  
-0.26 -1.00 0.49 -2.92 -8.64 2.81 -0.46 -3.90 2.97 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.44 -1.15 0.27 -3.64 -9.51 2.23 -1.68 -4.76 1.39 
 
Quartile 3 
  
-0.09 -0.81 0.63 -0.77 -6.71 5.17 -0.42 -3.53 2.69 
  Quartile 4     -0.51 -1.31 0.30 -4.64 -11.30 2.01 -1.23 -4.72 2.25 
Adjusted for age, specific gravity, mother's BMI 1 month postpartum, years of education 
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Table 3.6. Association of BPA and phthalates metabolites concentrations adolescent urines with adolescent BMI z-score, 
waist circumference, and sum of triceps skinfolds at ages 8-14. 
 
    BMI z-score Waist circumference Triceps skinfold 
Analyte Sex Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) 
BPA 
       
 
Male -0.13 (-0.42, 0.16) -0.15 (-0.44, 0.14) -0.34 (-2.65, 1.96) -0.50 (-2.89, 1.89) -0.45 (-1.79, 0.90) -0.59 (-1.98, 0.81) 
 
Female 0.09 (-0.22, 0.38) 0.12 (-0.17, 0.42) 0.55 (-1.99, 3.10) 1.02 (-1.51, 3.55) 0.40 (-0.98, 1.79) 0.79 (-0.55, 2.14) 
MBP 
       
 
Male 0.04 (-0.25, 0.33) 0.02 (-0.26, 0.31) -0.27 (-2.58, 2.03) -0.21 (-2.51, 2.09) 0.70 (-0.64, 2.03) 0.74 (-0.60, 2.08) 
 
Female -0.30 (-0.54, -0.05)* -0.20 (-0.45, 0.06) -2.19 (-4.27, -0.11)* -1.54 (-3.73, 0.64) -0.95 (-2.09, 0.19) -0.30 (-1.48, 0.88) 
MBzP 
       
 
Male -0.10 (-0.40, 0.20) -0.07 (-0.38, 0.24) -1.62 (-3.99, 0.76) -1.20 (-3.67, 1.29) -0.79 (-2.18, 0.60) -0.53 (-1.99, 0.92) 
 
Female 0.05 (-0.23, 0.34) 0.06 (-0.22, 0.35) -0.17 (-2.62, 2.28) -0.19 (-2.64, 2.26) 0.32 (-1.01, 1.65) 0.36 (-0.95, 1.67) 
MCPP 
       
 
Male -0.18 (-0.50, 0.14) -0.21 (-0.53, 0.12) -2.05 (-4.64, 0.54) -1.95 (-4.56, 0.66) -0.70 (-2.22, 0.82) -0.65 (-2.19, 0.89) 
 
Female -0.25 (-0.51, 0.01) -0.18 (-0.44, 0.09) -1.73 (-3.93, 0.47) -1.27 (-3.56, 1.03) -0.49 (-1.70, 0.71) -0.08 (-1.32, 1.15) 
MEP 
       
 
Male -0.06 (-0.23, 0.12) -0.05 (-0.23, 0.13) -0.65 (-2.08, 0.78) -0.55 (-2.02, 0.93) -0.23 (-1.07, 0.60) -0.19 (-1.06, 0.67) 
 
Female 0.07 (-0.09, 0.23) 0.06 (-0.11, 0.22) 0.40 (-1.00, 1.80) 0.22 (-1.21, 1.66) 0.30 (-0.46, 1.06) 0.34 (-0.43, 1.10) 
MIBP 
       
 
Male -0.01 (-0.32, 0.29) -0.06 (-0.37, 0.24) -0.02 (-2.42, 2.38) -0.24 (-2.67, 2.20) 0.24 (-1.16, 1.64) 0.18 (-1.25, 1.61) 
 
Female -0.17 (-0.48, 0.12) -0.16 (-0.47, 0.14) -2.07 (-4.64, 0.50) -1.94 (-4.56, 0.68) -0.87 (-2.27, 0.53) -0.58 (-1.99, 0.83) 
MEHP 
       
 
Male -0.11 (-0.32, 0.10) -0.21 (-0.43, 0.01) -1.24 (-2.95, 0.47) -1.95 (-3.74, -0.15)* -0.76 (-1.75, 0.24) -1.17 (-2.21, -0.12)* 
 
Female -0.04 (-0.35, 0.27) -0.09 (-0.41, 0.22) -0.80 (-3.48, 1.87) -1.14 (-3.83, 1.54) -0.42 (-1.87, 1.03) -0.56 (-1.99, 0.88) 
MECPP 
       
 
Male -0.06 (-0.31, 0.18) -0.19 (-0.45, 0.06) -0.68 (-2.64, 1.27) -1.48 (-3.54, 0.57) -0.26 (-1.40, 0.88) -0.69 (-1.89, 0.52) 
 
Female 0.09 (-0.24, 0.41) 0.05 (-0.27, 0.37) 0.17 (-2.64, 2.96) -0.003 (-2.81, 2.80) 0.05 (-1.47, 1.57) -0.06 (-1.57, 1.44) 
MEHHP 
       
 
Male -0.05 (-0.28, 0.19) -0.18 (-0.43, 0.06) -0.68 (-2.54, 1.17) -1.45 (-3.41, 0.51) -0.11 (-1.20, 0.97) -0.53 (-1.68, 0.63) 
 
Female 0.10 (-0.21, 0.40) 0.07 (-0.23, 0.37) 0.32 (-2.30, 2.93) 0.24 (-2.37, 2.86) 0.17 (-1.24, 1.59) 0.12 (-1.28, 1.52) 
MEOHP 
       
 
Male -0.07 (-0.31, 0.17) -0.21 (-0.46, 0.03) -0.80 (-2.69, 1.09) -1.63 (-3.62, 0.37) -0.21 (-1.31, 0.90) -0.65 (-1.82, 0.53) 
  Female 0.04 (-0.27, 0.34) 0.03 (-0.28, 0.33) -0.09 (-2.73, 2.55) -0.03 (-2.68, 2.61) 0.08 (-1.36, 1.51) 0.07 (-1.35, 1.48) 
aN=113for males; 129 for females. Adjusted for age, sex, specific gravity 
bN=108 for males; 121 for females. Additionally adjusted for mother’s BMI 1 month postpartum, years of education. 
*p<0.05 
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Table 3.7. Multivariable linear regression of associations of adolescent BMI z-score, 
waist circumference, and triceps skinfold with quartiles of adolescent urine 
metabolites compared to the reference first quartile. 
 
        BMI z-score Waist circumference Tricep skinfold 
Analyte Model Sex N β 95% CI β 95% CI β 95% CI 
BPA Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.82 -1.51 -0.13 -6.45 -11.85 -1.04 -3.26 -6.46 -0.06 
 
Quartile 3 
  
-0.29 -0.95 0.38 -2.15 -7.38 3.08 -1.10 -4.19 2.00 
 
Quartile 4 
  
-0.34 -1.11 0.43 -1.98 -8.04 4.08 -2.01 -5.60 1.57 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
0.05 -0.62 0.72 -0.86 -6.47 4.75 -0.21 -3.21 2.79 
 
Quartile 3 
  
0.14 -0.62 0.72 1.15 -5.13 7.42 1.84 -1.52 5.19 
 
Quartile 4 
  
0.34 -0.40 1.08 3.01 -3.23 9.25 1.59 -1.75 4.92 
MBP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.49 -1.15 0.16 -2.12 -7.34 3.10 -1.05 -4.11 2.01 
 
Quartile 3 
  
-0.16 -0.83 0.52 -1.35 -6.72 4.03 -0.28 -3.43 2.87 
 
Quartile 4 
  
-0.20 -0.89 0.50 -2.56 -8.09 2.98 -0.12 -3.37 3.13 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.50 -1.15 0.15 -2.07 -7.58 3.44 -1.15 -4.11 1.82 
 
Quartile 3 
  
-0.68 -1.39 0.03 -5.16 -11.31 0.99 -1.89 -5.20 1.42 
 
Quartile 4 
  
-0.33 -1.04 0.38 -1.42 -7.46 4.62 -0.02 -3.26 3.23 
MBzP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
0.01 -0.61 0.62 -2.10 -6.99 2.80 -0.24 -3.11 2.64 
 
Quartile 3 
  
-0.31 -0.94 0.33 -3.11 -8.11 1.90 -1.68 -4.61 1.26 
 
Quartile 4 
  
-0.19 -0.89 0.50 -3.52 -8.96 1.93 -1.10 -4.29 2.10 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
0.05 -0.58 0.69 0.37 -5.07 5.81 1.71 -1.19 4.61 
 
Quartile 3 
  
-0.02 -0.72 0.68 -1.39 -7.35 4.56 1.56 -1.61 4.73 
 
Quartile 4 
  
0.20 -0.60 1.00 0.35 -6.41 7.11 2.01 -1.59 5.61 
MCPP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.20 -0.87 0.46 -1.62 -6.86 3.63 -1.23 -4.30 1.84 
 
Quartile 3 
  
-0.39 -1.12 0.34 -2.88 -8.63 2.86 -0.78 -4.15 2.59 
 
Quartile 4 
  
-0.27 -1.02 0.48 -2.95 -8.96 3.06 -1.52 -5.04 2.00 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.35 -1.03 0.33 -3.67 -9.40 2.07 0.10 -3.06 3.26 
 
Quartile 3 
  
-1.17 -1.82 -0.53 -10.15 -15.76 -4.54 -3.54 -6.63 -0.44 
 
Quartile 4 
  
-0.27 -0.96 0.43 -1.85 -7.75 4.05 0.21 -3.04 3.46 
MECPP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.21 -0.87 0.46 -2.97 -8.33 2.39 -0.20 -3.37 2.98 
 
Quartile 3 
  
0.05 -0.67 0.77 -0.15 -5.95 5.64 0.63 -2.80 4.06 
 
Quartile 4 
  
-0.41 -1.12 0.30 -3.70 -9.27 1.87 -0.82 -4.11 2.48 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.19 -0.86 0.48 -3.92 -9.49 1.65 -1.83 -4.84 1.17 
 
Quartile 3 
  
0.20 -0.48 0.87 1.87 -3.77 7.51 0.41 -2.64 3.45 
 
Quartile 4 
  
0.07 -0.65 0.80 -0.93 -7.02 5.16 -0.32 -3.61 2.96 
MEHHP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.57 -1.21 0.07 -4.58 -9.71 0.55 -1.80 -4.81 1.21 
 
Quartile 3 
  
-0.37 -1.07 0.34 -1.87 -7.47 3.72 0.38 -2.90 3.67 
 
Quartile 4 
  
-0.21 -0.90 0.49 -2.68 -8.17 2.80 -1.03 -4.25 2.19 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
0.12 -0.55 0.79 -0.44 -6.10 5.22 -0.38 -3.40 2.65 
 
Quartile 3 
  
0.07 -0.61 0.76 1.18 -4.68 7.05 1.06 -2.07 4.19 
 
Quartile 4 
  
0.35 -0.37 1.07 2.06 -4.10 8.22 1.39 -1.89 4.68 
MEHP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.04 -0.67 0.59 -1.02 -5.99 3.95 -0.13 -3.03 2.76 
 
Quartile 3 
  
-0.32 -0.98 0.34 -2.49 -7.76 2.79 -1.13 -4.20 1.95 
 
Quartile 4 
  
-0.38 -1.04 0.27 -3.80 -9.05 1.45 -2.50 -5.56 0.56 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.29 -0.93 0.34 -2.00 -7.37 3.37 0.31 -2.57 3.18 
 
Quartile 3 
  
-0.38 -1.07 0.31 -3.42 -9.24 2.41 -1.29 -4.41 1.83 
 
Quartile 4 
  
-0.13 -0.87 0.61 -1.74 -8.02 4.54 0.17 -3.19 3.53 
MEOHP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.59 -1.26 0.08 -3.98 -9.34 1.39 -1.26 -4.42 1.90 
 
Quartile 3 
  
-0.45 -1.11 0.22 -2.24 -7.56 3.07 -0.21 -3.34 2.92 
 
Quartile 4 
  
-0.37 -1.08 0.34 -3.29 -8.93 2.34 -1.05 -4.37 2.27 
 
Quartile 1 Female 121 Reference Reference Reference 
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Quartile 2 
  
0.02 -0.64 0.67 -1.54 -7.06 3.97 -0.79 -3.75 2.17 
 
Quartile 3 
  
-0.11 -0.84 0.62 -1.32 -7.50 4.86 0.57 -2.75 3.90 
 
Quartile 4 
  
0.28 -0.46 1.01 2.06 -4.23 8.36 1.06 -2.32 4.44 
MEP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.36 -0.97 0.25 -3.24 -8.05 1.57 -0.78 -3.62 2.06 
 
Quartile 3 
  
-0.04 -0.65 0.56 -0.20 -4.97 4.57 -0.05 -2.87 2.77 
 
Quartile 4 
  
-0.25 -0.93 0.44 -3.14 -8.56 2.29 -1.46 -4.66 1.75 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.23 -0.92 0.46 -3.04 -8.85 2.77 -0.52 -3.64 2.60 
 
Quartile 3 
  
-0.31 -1.00 0.39 -2.57 -8.47 3.33 -0.60 -3.77 2.57 
 
Quartile 4 
  
0.00 -0.68 0.69 -0.69 -6.49 5.10 0.58 -2.54 3.69 
MIBP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.07 -0.75 0.60 -1.20 -6.61 4.20 0.02 -3.14 3.18 
 
Quartile 3 
  
-0.05 -0.75 0.64 -0.91 -6.38 4.56 -0.16 -3.36 3.04 
 
Quartile 4 
  
-0.25 -0.97 0.46 -1.46 -7.12 4.19 -1.05 -4.36 2.26 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.91 -1.56 -0.25 -7.61 -13.15 -2.08 -2.21 -5.24 0.83 
 
Quartile 3 
  
-0.44 -1.14 0.26 -3.60 -9.52 2.31 -0.22 -3.46 3.02 
  Quartile 4     -0.57 -1.30 0.17 -6.44 -12.68 -0.20 -1.47 -4.89 1.95 
Adjusted for age, specific gravity, mother's BMI 1 month postpartum, years of education 
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Figure 3.1. Generalized additive model results for the association of maternal third 
trimester and adolescent urinary concentrations with adolescent outcomes 
measures. 
(A) Maternal third trimester urinary concentrations of MEHHP (ng/mL) in males with adolescent BMI z-score, (B) Maternal 
third trimester MEP (ng/mL) in males with adolescent triceps skinfold, (C) Adolescent male BPA (ng/mL) with adolescent BMI 
z-score, and (D) Adolescent female MCPP and adolescent waist circumference.  
Models are adjusted for specific gravity, child's age, and mother's BMI 1 month postpartum and total years of schooling. 
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Figure 3.2. Sex-stratified associations of maternal third trimester urinary concentrations of quartile BPA and phthalate 
metabolites with adolescent BMI z-score, waist circumference, and triceps skinfold measurements at ages 8-14. 
Point estimates and 95% confidence intervals are adjusted for specific gravity, child’s age, and mother’s 1 month 
postpartum BMI and total years of education. 
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Figure 3.3. Sex-stratified associations of adolescent urinary concentrations of quartile BPA and phthalate metabolites 
with adolescent BMI z-score, waist circumference, and sum of triceps and subscapular skinfold measurements at ages 
8-14. 
Point estimates and 95% confidence intervals are adjusted for specific gravity, child’s age, and mother’s 1 month 
postpartum BMI and total years of education. 
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
 
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q                                                           
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-2
-1.5
-1
-0.5
0
0.5
1
1.5
2
∆
B
M
I
 
z
-
s
c
o
r
e
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-14
-9
-4
1
6
∆
 
W
a
i
s
t
 
c
i
r
c
u
m
f
e
r
e
n
c
e
 
(
c
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
-7
-5
-3
-1
1
3
5
7
∆
 
T
r
i
c
e
p
s
 
s
k
i
n
f
o
l
d
 
(
m
m
)
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
BPA
MALES FEMALES 
MBP
MALES FEMALES 
MBzP
MALES FEMALES 
MCPP
MALES FEMALES 
MECPP
MALES FEMALES 
MEHHP
MALES FEMALES 
1Q       2Q       3Q       4Q                 1Q       2Q       3Q       4Q
MEHP
MALES FEMALES 
MEOHP
MALES FEMALES 
MEP
MALES FEMALES 
MiBP
MALES FEMALES 
MEHP
MALES FEMALES 
MEOHP
MALES FEMALES 
MEP
MALES FEMALES 
MiBP
MALES FEMALES 
BPA
MALES FEMALES 
MBP
MALES FEMALES 
MBzP
MALES FEMALES 
MCPP
MALES FEMALES 
MECPP
MALES FEMALES 
MEHHP
MALES FEMALES 
MEHP
MALES FEMALES 
MEOHP
MALES FEMALES 
MEP
MALES FEMALES 
MiBP
MALES FEMALES 
BPA
MALES FEMALES 
MBP
MALES FEMALES 
MBzP
MALES FEMALES 
MCPP
MALES FEMALES 
MECPP
MALES FEMALES 
MEHHP
MALES FEMALES 
                   
74 
 
Appendix 
                   
75 
 
Figure 3.4. Association of BPA and phthalates metabolites concentrations in maternal third trimester urines with 
adolescent BMI, waist circumference, and sum of triceps and subscapular skinfolds at ages 8-14. 
 
    BMI  Waist circumference Sum skinfold 
Analyte Sex Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) 
BPA 
       
 
Male -0.55 (-1.50, 0.39) -0.37 (-1.45, 0.71) -1.15 (-3.95, 1.65) -0.89 (-4.13, 2.35) -2.18 (-5.50, 1.13) -1.72 (-5.38, 1.95) 
 
Female -0.57 (-1.68, 0.55) -0.80 (-1.95, 0.34) -1.96 (-5.03, 1.11) -2.54 (-5.68, 0.61) -1.96 (-4.45, 2.25) -1.96 (-5.15,1.24) 
MBP 
       
 
Male 0.08 (-0.53, 0.69) 0.01  (-0.65, 0.67) 0.01 (-1.81, 1.83) -0.31 (-2.28, 1.66) 0.25 (-1.91, 2.41) 0.35 (-1.88, 2.58) 
 
Female -0.45 (-1.13, 0.24) -0.35 (-1.11, 0.41) -1.22 (-3.11, 0.66) -0.93 (-3.02, 1.15) -0.72 (-2.78, 1.33) -0.21 (-2.20, 1.79) 
MBzP 
       
 
Male -0.08 (-0.77, 0.60) -0.28 (-1.01, 0.44) -0.04 (-2.08, 2.00) -0.64 (-2.82, 1.54) 0.62 (-1.80, 3.05) 0.21 (-2.30, 2.73) 
 
Female -0.75 (-1.53, 0.04) -0.75 (-1.63, 0.13) -1.84 (-4.01, 0.34) -1.94 (-4.37, 0.50) -0.97 (-3.35, 1.41) -0.31 (-2.79, 2.16) 
MCPP 
       
 
Male 0.01 (-0.74, 0.76) -0.05 (-0.87, 0.76) -0.13 (-2.35, 2.10) -0.54 (-2.99, 1.90) 0.25 (-2.39, 2.90) 0.41 (-2.79, 3.19) 
 
Female -0.56 (-1.45, 0.34) -0.41 (-1.46, 0.65) -1.46 (-3.94, 1.02) -1.16 (-4.07, 1.75) -1.41 (-4.11, 1.29) -0.46 (-3.10, 2.19) 
MEP 
       
 
Male -0.09 (-0.58, 0.39) -0.14 (-0.69, 0.39) -0.42 (-1.86, 1.01) -0.45 (-2.01, 1.12) -0.33 (-3.29, 2.62) -0.53 (-3.51, 2.46) 
 
Female -0.23 (-0.74, 0.28) -0.25 (-0.79, 0.30) -0.45 (-1.85, 0.96) -0.3 (-1.80, 1.21) -0.24 (-2.80, 2.32) -0.34 (-2.83, 2.14) 
MiBP 
       
 
Male -0.32 (-0.98, 0.34) -0.29 (-1.03, 0.44) -1.11 (-3.07, 0.85) -1.32 (-3.52, 0.87) -0.73 (-3.26, 1.79) -0.73 (-3.28, 1.82) 
 
Female -0.13 (-0.96, 0.70) -0.11 (-0.95, 0.73) -0.55 (-2.85, 1.74) -0.7 (-3.02, 1.61) 0.02 (-2.35, 2.39) 0.08 (-2.21, 2.36) 
MEHP 
       
 
Male 0.02 (-0.68, 0.72) -0.11 (-0.88, 0.67) -0.49 (-2.57, 1.58) -0.83 (-3.15, 1.49) -0.83 (-3.30,1 .63) -1.03 (-3.55, 1.49) 
 
Female -0.26 (-1.15, 0.62) -0.10 (-1.02, 0.82) -0.33 (-2.78, 2.12) 0.26 (-2.27, 2.79) -0.89 (-3.55, 1.77) -0.33 (-2.92, 2.26) 
MECPP 
       
 
Male -0.26 (-1.09, 0.58) -0.31 (-1.18, 0.56) -1.17 (-3.65, 1.31) -1.29 (-3.90, 1.31) -0.58 (-3.18, 2.01) -0.53 (-3.16, 2.09) 
 
Female -0.004 (-0.86, 0.85) -0.11 (-0.99, 0.78) 0.36 (-2.00, 2.72) 0.05 (-2.38, 2.48) 0.06 (-2.35, 2.46) 0.12 (-2.22, 2.46) 
MEHHP 
       
 
Male -0.19 (-0.91, 0.52) -0.14 (-0.90, 0.62) -0.85 (-2.97, 1.27) -0.69 (-2.96, 1.58) 0.03 (-1.69, 1.74) 0.42 (-1.35, 2.20) 
 
Female -0.01 (-0.80, 0.78) -0.02 (-0.84, 0.79) 0.34 (-1.84, 2.52) 0.25 (-1.99, 2.49) 0.04 (-1.48, 1.57) -0.22 (-1.70, 1.27) 
MEOHP 
       
 
Male -0.24 (-0.97, 0.50) -0.21 (-0.99, 0.57) -0.97 (-3.15, 1.20) -0.89 (-3.24, 1.45) -1.40 (-3.72, 0.93) -1.14 (-3.69, 1.42) 
  Female -0.02 (-0.82, 0.78) -0.05 (-0.89, 0.78) 0.2 (-2.01, 2.42) 0.04 (-2.26, 2.34) -0.44 (-2.93, 2.06) -0.70 (-3.13, 1.72) 
aN=107 for males; 116 for females. Adjusted for age, sex, specific gravity 
  bN=94 for males; 98 for females. Additionally adjusted for mother’s BMI 1 month postpartum, years of education. 
*p<0.05 
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Figure 3.5. Association of BPA and phthalates metabolites concentrations in adolescent urines with adolescent BMI, waist 
circumference, and sum of triceps and subscapular skinfolds at ages 8-14. 
 
 
  BMI  Waist circumference Sum skinfold 
Analyte Sex Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) Crudea β(95%CI) Adjustedb β(95%CI) 
BPA 
       
 
Male -0.13 (-0.90, 0.64) -0.23 (-1.01, 0.56) -0.34 (-2.65, 1.96) -0.50 (-2.89, 1.89) -0.83 (-3.56, 1.90) -1.11 (-3.94, 1.71) 
 
Female 0.25 (-0.68, 1.18) 0.39 (-0.52, 1.30) 0.55 (-1.99, 3.10) 1.02 (-1.51, 3.55) 1.09 (-1.76, 3.94) 1.64 (-1.12 4.40) 
MBP 
       
 
Male 0.07 (-0.70, 0.83) 0.05 (-0.70, 0.81) -0.27 (-2.58, 2.03) -0.21 (-2.51, 2.09) 0.74 (-1.98, 3.47) 0.83 (-1.89, 3.56) 
 
Female -0.91 (-1.67, -0.16)* -0.62 (-1.40, 0.16) -2.19 (-4.27, -0.11)* -1.54 (-3.73, 0.64) -2.57 (-4.90, -0.23)* -1.40 (-3.80, 0.99) 
MBzP 
       
 
Male -0.30 (-1.09, 0.49) -0.19 (-1.01, 0.62) -1.62 (-3.99, 0.76) -1.20 (-3.67, 1.29) -1.55 (-4.38, 1.27) -0.96 (-3.91, 2.00) 
 
Female -0.04 (-0.93, 0.85) 0.004 (-0.88, 0.89) -0.17 (-2.62, 2.28) -0.19 (-2.64, 2.26) 0.52 (-2.22, 3.26) 0.57 (-2.12, 3.25) 
MCPP 
       
 
Male -0.55 (-1.42, 0.31) -0.58 (-1.42, 0.30) -2.05 (-4.64, 0.54) -1.95 (-4.56, 0.66) -1.87 (-4.95, 1.21) -1.75 (-4.87, 1.37) 
 
Female -0.82 (-1.61, -0.02)* -0.56 (-1.38, 0.26) -1.73 (-3.93, 0.47) -1.27 (-3.56, 1.03) -1.57 (-4.04, 0.90) -0.76 (-3.28, 1.76) 
MEP 
       
 
Male -0.19 (-0.67, 0.29) -0.17 (-0.65, 0.31) -0.65 (-2.08, 0.78) -0.55 (-2.02, 0.93) -0.60 (-2.92, 1.71) -1.46 (-3.91, 0.98) 
 
Female 0.24 (-0.27, 0.75) 0.14 (-0.37, 0.66) 0.40 (-1.00, 1.80) 0.22 (-1.21, 1.66) 0.03 (-3.11, 3.17) -0.19 (-3.26, 2.88) 
MIBP 
       
 
Male -0.003 (-0.80, 0.80) -0.12 (-0.92, 0.68) -0.02 (-2.42, 2.38) -0.24 (-2.67, 2.20) -0.40 (-2.60, 1.81) -1.22 (-3.56, 1.12) 
 
Female -0.61 (-1.55, 0.33) -0.56 (-1.50, 0.39) -2.07 (-4.64, 0.50) -1.94 (-4.56, 0.68) 0.29 (-2.64, 3.22) 0.21 (-2.65, 3.07) 
MEHP 
       
 
Male -0.25 (-0.82, 0.32) -0.56 (-1.15, 0.03) -1.24 (-2.95, 0.47) -1.95 (-3.74, -0.15)* -1.62 (-3.64, 0.40) -2.46 (-4.58, -0.33) 
 
Female -0.22 (-1.19, 0.76) -0.38 (-1.35, 0.58) -0.80 (-3.48, 1.87) -1.14 (-3.83, 1.54) -0.99 (-3.99, 1.99) -1.41 (-4.35, 1.62) 
MECPP 
       
 
Male -0.11 (-0.76, 0.54) -0.44 (-1.11, 0.24) -0.68 (-2.64, 1.27) -1.48 (-3.54, 0.57) -0.57 (-2.82, 1.67) -1.46 (-3.85, 0.92) 
 
Female 0.11 (-0.92, 1.13) 0.04 (-0.97, 1.04) 0.17 (-2.64, 2.96) -0.003 (-2.81, 2.80) -0.14 (-3.10, 2.82) -0.09 (-2.99, 2.80) 
MEHHP 
       
 
Male -0.08 (-0.70, 0.54) -0.41 (-1.06, 0.23) -0.68 (-2.54, 1.17) -1.45 (-3.41, 0.51) -0.87 (-2.57, 0.82) -0.77 (-2.52, 0.98) 
 
Female 0.09 (-0.87, 1.04) 0.06 (-0.88, 0.99) 0.32 (-2.30, 2.93) 0.24 (-2.37, 2.86) 0.40 (-1.17, 1.97) 0.19 (-1.38, 1.76) 
MEOHP 
       
 
Male -0.13 (-0.76, 0.51) -0.47 (-1.13, 0.18) -0.80 (-2.69, 1.09) -1.63 (-3.62, 0.37) 0.13 (-2.71, 2.98) 0.04 (-2.85, 2.94) 
  Female -0.10 (-1.06, 0.87) -0.08 (-1.03, 0.87) -0.09 (-2.73, 2.55) -0.03 (-2.68, 2.61) -2.06 (-4.94, 0.83) -1.56 (-4.44, 1.31) 
aN=113for males; 129 for females. Adjusted for age, sex, specific gravity 
bN=108 for males; 121 for females. Additionally adjusted for mother’s BMI 1 month postpartum, years of education. 
*p<0.05     
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Figure 3.6. Multivariable linear regression of associations of adolescent BMI, waist 
circumference, and triceps skinfold with quartiles of maternal third trimester urine 
metabolites compared to the reference first quartile. 
 
        BMI Waist circumference Sum skinfolda 
Analyte Model Sex N β 95% CI β 95% CI β 95% CI 
BPA Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.55 -1.17 2.26 1.43 -3.78 6.63 3.39 -2.76 9.54 
 
Quartile 3 
  
0.35 -1.24 1.93 0.85 -3.98 5.68 2.26 -3.46 7.97 
 
Quartile 4 
  
-1.24 -3.09 0.62 -2.42 -8.05 3.22 -3.51 -10.17 3.16 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
1.35 -0.83 3.54 3.91 -2.23 10.04 0.06 -6.63 6.74 
 
Quartile 3 
  
0.88 -1.22 2.98 2.09 -3.81 7.99 0.27 -6.16 6.70 
 
Quartile 4 
  
-1.63 -3.92 2.98 -4.26 -10.72 2.19 -5.36 -12.39 1.68 
MBP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.71 -1.03 2.46 1.71 -3.52 6.94 4.16 -2.11 10.44 
 
Quartile 3 
  
-0.34 -2.02 1.34 -2.10 -7.12 2.93 0.35 -5.68 6.37 
 
Quartile 4 
  
0.03 -1.97 2.03 -1.37 -7.37 4.63 0.06 -7.13 7.24 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
0.17 -1.86 2.20 -0.46 -6.16 5.23 -1.01 -7.03 5.01 
 
Quartile 3 
  
-0.61 -2.86 1.64 -2.83 -9.14 3.48 -5.25 -11.92 1.42 
 
Quartile 4 
  
-1.05 -3.33 1.24 -2.59 -8.98 3.80 -0.60 -7.36 6.15 
MBzP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.46 -2.27 1.35 -0.53 -6.02 4.96 -2.51 -9.10 4.09 
 
Quartile 3 
  
-1.42 -3.26 0.42 -2.37 -7.95 3.20 -2.66 -9.35 4.04 
 
Quartile 4 
  
-0.84 -2.70 1.02 -2.49 -8.12 3.13 -1.91 -8.67 4.84 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.72 -2.61 1.17 -2.60 -7.88 2.69 -1.79 -7.42 3.84 
 
Quartile 3 
  
-0.76 -2.70 1.19 -1.24 -6.68 4.21 -1.21 -7.01 4.59 
 
Quartile 4 
  
-1.01 -3.20 1.18 -1.79 -7.91 4.33 2.23 -4.29 8.75 
MCPP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.09 -1.72 1.89 -0.22 -5.64 5.20 2.93 -3.54 9.41 
 
Quartile 3 
  
0.08 -1.82 1.99 -1.06 -6.78 4.66 1.76 -5.08 8.60 
 
Quartile 4 
  
0.02 -1.94 1.98 0.37 -5.52 6.25 1.85 -5.18 8.89 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.23 -2.30 1.83 -2.44 -8.18 3.30 -4.45 -10.55 1.64 
 
Quartile 3 
  
0.04 -2.07 2.16 0.30 -5.59 6.20 -2.74 -8.99 3.52 
 
Quartile 4 
  
-0.45 -2.95 2.05 -1.61 -8.56 5.34 -1.21 -8.59 6.18 
MECPP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
0.84 -0.80 2.48 1.29 -3.65 6.22 3.60 -2.38 9.59 
 
Quartile 3 
  
1.41 -0.43 3.24 3.00 -2.51 8.52 4.35 -2.34 11.04 
 
Quartile 4 
  
-1.24 -3.31 0.83 -5.25 -11.48 0.98 -3.49 -11.04 4.06 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-3.29 -5.37 -1.20 -7.66 -13.57 -1.76 -9.11 -15.41 -2.81 
 
Quartile 3 
  
-0.21 -2.25 1.84 -0.45 -6.25 5.35 -1.60 -7.78 4.58 
 
Quartile 4 
  
-0.55 -2.84 1.73 -0.02 -6.51 6.47 -1.53 -8.45 5.38 
MEHHP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
1.62 -0.02 3.26 3.06 -1.90 8.03 6.51 0.64 12.37 
 
Quartile 3 
  
0.98 -0.85 2.81 2.72 -2.80 8.25 2.94 -3.58 9.46 
 
Quartile 4 
  
-0.72 -2.66 1.23 -3.69 -9.55 2.18 -3.15 -10.07 3.77 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-2.06 -4.20 0.09 -5.29 -11.29 0.70 -7.40 -13.74 -1.05 
 
Quartile 3 
  
-0.54 -2.56 1.48 -1.08 -6.74 4.58 -2.20 -8.19 3.78 
 
Quartile 4 
  
-0.20 -2.82 2.41 0.42 -6.91 7.74 -0.91 -8.66 6.84 
MEHP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.38 -2.08 1.32 -1.42 -6.52 3.68 -0.53 -6.59 5.53 
 
Quartile 3 
  
0.65 -1.08 2.38 0.83 -4.37 6.03 2.56 -3.62 8.74 
 
Quartile 4 
  
-0.44 -2.27 1.40 -3.01 -8.52 2.51 -3.78 -10.34 2.77 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-0.27 -2.32 1.79 -0.13 -5.86 5.60 -2.29 -8.36 3.78 
 
Quartile 3 
  
-1.58 -3.74 0.57 -4.14 -10.16 1.89 -6.78 -13.17 -0.39 
 
Quartile 4 
  
0.00 -2.36 2.37 0.71 -5.89 7.31 -1.51 -8.50 5.48 
MEOHP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
1.86 0.16 3.54 3.65 -1.44 8.74 8.67 2.75 14.58 
 
Quartile 3 
  
0.75 -1.01 2.50 2.08 -3.23 7.40 3.54 -2.63 9.70 
 
Quartile 4 
  
-0.66 -2.65 1.33 -3.68 -9.71 2.35 -2.21 -9.20 4.79 
 
Quartile 1 Female 110 Reference Reference Reference 
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Quartile 2 
  
-1.87 -4.02 0.27 -5.34 -11.32 0.65 -6.78 -13.14 -0.42 
 
Quartile 3 
  
-0.02 -2.12 2.08 0.00 -5.85 5.86 -0.64 -6.85 5.58 
 
Quartile 4 
  
-0.88 -3.46 1.70 -1.89 -9.10 5.32 -2.61 -10.27 5.04 
MEP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.36 -2.05 1.34 -0.05 -5.11 5.02 0.25 -5.90 6.40 
 
Quartile 3 
  
-0.97 -2.70 0.77 -3.83 -9.01 1.34 -0.68 -6.97 5.60 
 
Quartile 4 
  
-1.07 -3.02 0.87 -3.19 -8.98 2.60 -2.79 -9.83 4.25 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
1.41 -0.61 3.43 3.66 -2.01 9.34 2.59 -3.50 8.69 
 
Quartile 3 
  
0.73 -1.35 2.81 1.81 -4.04 7.66 2.23 -4.05 8.51 
 
Quartile 4 
  
-0.19 -2.23 1.86 1.07 -4.68 6.82 1.78 -4.38 7.95 
MIBP Quartile 1 Male 102 Reference Reference Reference 
 
Quartile 2 
  
-0.03 -1.72 1.66 -0.61 -5.64 4.42 -1.44 -7.52 4.65 
 
Quartile 3 
  
-1.53 -3.37 0.30 -6.07 -11.54 -0.60 -6.33 -12.94 0.29 
 
Quartile 4 
  
-0.90 -2.83 1.02 -2.92 -8.64 2.81 -4.26 -11.18 2.67 
 
Quartile 1 Female 110 Reference Reference Reference 
 
Quartile 2 
  
-1.10 -3.20 1.91 -3.64 -9.51 2.23 -2.90 -9.22 3.42 
 
Quartile 3 
  
0.13 -2.00 2.26 -0.77 -6.71 5.17 -0.32 -6.71 6.08 
  Quartile 4     -1.14 -3.53 1.25 -4.64 -11.30 2.01 -3.11 -10.28 4.05 
aSum of triceps and subscapular skinfold measurements 
       Adjusted for age, specific gravity, mother's BMI 1 month postpartum, years of education 
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Figure 3.7. Multivariable linear regression of associations of adolescent BMI, waist 
circumference, and sum of triceps and subscapular skinfold with quartiles of 
adolescent urine metabolites compared to the reference first quartile. 
 
        BMI Waist circumference Sum skinfoldsa 
Analyte Model Sex N β 95% CI β 95% CI β 95% CI 
BPA Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-2.19 -3.95 -0.43 -6.45 -11.85 -1.04 -7.24 -13.69 -0.77 
 
Quartile 3 
  
-0.54 -2.25 1.17 -2.15 -7.38 3.08 -1.91 -8.15 4.33 
 
Quartile 4 
  
-0.68 -2.66 1.30 -1.98 -8.04 4.08 -3.61 -10.84 3.63 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
0.03 -1.99 2.05 -0.86 -6.47 4.75 -0.89 -7.05 5.27 
 
Quartile 3 
  
0.24 -2.02 2.50 1.15 -5.13 7.42 1.23 -5.66 8.11 
 
Quartile 4 
  
1.14 -1.11 3.38 3.01 -3.23 9.25 3.27 -3.58 10.12 
MBP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-1.14 -2.84 0.57 -2.12 -7.34 3.10 -3.44 -9.63 2.75 
 
Quartile 3 
  
-0.47 -2.23 1.28 -1.35 -6.72 4.03 -1.21 -7.59 5.16 
 
Quartile 4 
  
-0.53 -2.33 1.28 -2.56 -8.09 2.98 -1.85 -8.42 4.72 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-1.04 -3.01 0.93 -2.07 -7.58 3.44 -2.99 -9.03 3.04 
 
Quartile 3 
  
-2.28 -4.47 -0.08 -5.16 -11.31 0.99 -5.82 -12.55 0.91 
 
Quartile 4 
  
-0.69 -2.85 1.47 -1.42 -7.46 4.62 -1.45 -8.06 5.16 
MBzP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.07 -1.69 1.54 -2.10 -6.99 2.80 -2.34 -8.18 3.51 
 
Quartile 3 
  
-0.72 -2.37 0.93 -3.11 -8.11 1.90 -3.23 -9.21 2.74 
 
Quartile 4 
  
-0.64 -2.43 1.16 -3.52 -8.96 1.93 -2.93 -9.42 3.57 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
0.19 -1.77 2.15 0.37 -5.07 5.81 1.53 -4.43 7.49 
 
Quartile 3 
  
-0.21 -2.35 1.93 -1.39 -7.35 4.56 1.48 -5.04 8.01 
 
Quartile 4 
  
0.56 -1.87 2.99 0.35 -6.41 7.11 3.27 -4.13 10.67 
MCPP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.81 -2.53 0.91 -1.62 -6.86 3.63 -2.45 -8.69 3.79 
 
Quartile 3 
  
-0.90 -2.79 0.98 -2.88 -8.63 2.86 -2.78 -9.62 4.06 
 
Quartile 4 
  
-0.91 -2.88 1.06 -2.95 -8.96 3.06 -3.29 -10.44 3.86 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.95 -3.00 1.09 -3.67 -9.40 2.07 -1.24 -7.57 5.10 
 
Quartile 3 
  
-3.82 -5.82 -1.82 -10.15 -15.76 -4.54 -9.69 -15.89 -3.49 
 
Quartile 4 
  
-0.71 -2.81 1.40 -1.85 -7.75 4.05 -0.59 -7.10 5.93 
MECPP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.79 -2.57 0.98 -2.97 -8.33 2.39 -0.20 -3.37 2.97 
 
Quartile 3 
  
-0.15 -2.07 1.76 -0.15 -5.95 5.64 0.63 -2.79 4.06 
 
Quartile 4 
  
-0.87 -2.71 0.97 -3.70 -9.27 1.87 -0.82 -4.11 2.48 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-1.02 -3.04 0.99 -3.92 -9.49 1.65 -1.83 -4.84 1.17 
 
Quartile 3 
  
0.74 -1.30 2.78 1.87 -3.77 7.51 0.41 -2.64 3.45 
 
Quartile 4 
  
-0.12 -2.32 2.09 -0.93 -7.02 5.16 -0.32 -3.61 2.96 
MEHHP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-1.47 -3.15 0.21 -4.58 -9.71 0.55 -3.97 -10.10 2.17 
 
Quartile 3 
  
-0.92 -2.75 0.91 -1.87 -7.47 3.72 -0.72 -7.41 5.98 
 
Quartile 4 
  
-0.42 -2.22 1.38 -2.68 -8.17 2.80 -1.69 -8.25 4.87 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.07 -2.11 1.97 -0.44 -6.10 5.22 -2.49 -8.67 3.69 
 
Quartile 3 
  
0.53 -1.58 2.64 1.18 -4.68 7.05 1.11 -5.29 7.51 
 
Quartile 4 
  
0.56 -1.66 2.78 2.06 -4.10 8.22 1.65 -5.08 8.37 
MEHP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.46 -2.09 1.18 -1.02 -5.99 3.95 -0.59 -6.49 5.31 
 
Quartile 3 
  
-0.79 -2.53 0.94 -2.49 -7.76 2.79 -2.54 -8.81 3.72 
 
Quartile 4 
  
-0.90 -2.63 0.83 -3.80 -9.05 1.45 -4.53 -10.77 1.70 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.44 -2.38 1.49 -2.00 -7.37 3.37 -1.23 -7.13 4.66 
 
Quartile 3 
  
-0.91 -3.01 1.19 -3.42 -9.24 2.41 -3.32 -9.72 3.07 
 
Quartile 4 
  
-0.40 -2.66 1.87 -1.74 -8.02 4.54 -1.40 -8.29 5.49 
MEOHP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-1.45 -3.20 0.31 -3.98 -9.34 1.39 -3.41 -9.82 3.00 
 
Quartile 3 
  
-0.93 -2.67 0.81 -2.24 -7.56 3.07 -1.27 -7.63 5.08 
 
Quartile 4 
  
-0.75 -2.60 1.09 -3.29 -8.93 2.34 -2.12 -8.85 4.62 
 
Quartile 1 Female 121 Reference Reference Reference 
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Quartile 2 
  
-0.43 -2.42 1.57 -1.54 -7.06 3.97 -3.13 -9.17 2.91 
 
Quartile 3 
  
-0.07 -2.31 2.17 -1.32 -7.50 4.86 -0.67 -7.44 6.11 
 
Quartile 4 
  
0.45 -1.83 2.72 2.06 -4.23 8.36 1.33 -5.57 8.22 
MEP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.77 -2.35 0.82 -3.24 -8.05 1.57 -2.38 -8.14 3.37 
 
Quartile 3 
  
-0.11 -1.68 1.47 -0.20 -4.97 4.57 -1.63 -7.34 4.08 
 
Quartile 4 
  
-0.83 -2.62 0.96 -3.14 -8.56 2.29 -4.04 -10.53 2.45 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-0.87 -2.95 1.22 -3.04 -8.85 2.77 -2.46 -8.85 3.92 
 
Quartile 3 
  
-1.17 -3.29 0.95 -2.57 -8.47 3.33 -3.22 -9.70 3.26 
 
Quartile 4 
  
0.01 -2.06 2.09 -0.69 -6.49 5.10 -0.88 -7.25 5.48 
MIBP Quartile 1 Male 108 Reference Reference Reference 
 
Quartile 2 
  
-0.49 -2.26 1.28 -1.20 -6.61 4.20 -0.83 -7.24 5.58 
 
Quartile 3 
  
-0.36 -2.15 1.43 -0.91 -6.38 4.56 -1.51 -8.00 4.98 
 
Quartile 4 
  
-0.65 -2.50 1.20 -1.46 -7.12 4.19 -2.67 -9.38 4.04 
 
Quartile 1 Female 121 Reference Reference Reference 
 
Quartile 2 
  
-2.54 -4.55 -0.54 -7.61 -13.15 -2.08 -6.48 -12.65 -0.30 
 
Quartile 3 
  
-1.38 -3.53 0.76 -3.60 -9.52 2.31 -3.18 -9.77 3.42 
  Quartile 4     -1.87 -4.13 0.39 -6.44 -12.68 -0.20 -4.71 -11.67 2.24 
aSum of triceps and subscapular skinfold measurements 
       Adjusted for age, specific gravity, mother's BMI 1 month postpartum, years of education 
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Figure 3.8. Sex-stratified associations of maternal third trimester urinary concentrations of quartile BPA and phthalate 
metabolites with adolescent BMI, waist circumference, and sum of triceps and subscapular skinfold measurements at ages 
8-14.  
Point estimates and 95% confidence intervals are adjusted for specific gravity, child’s age, and mother’s 1 month 
postpartum BMI and total years of education. 
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Figure 3.9. Sex-stratified associations of adolescent urinary concentrations of quartile BPA and phthalate metabolites with 
adolescent BMI, waist circumference, and sum of triceps and subscapular skinfold measurements at ages 8-14. 
Point estimates and 95% confidence intervals are adjusted for specific gravity, child’s age, and mother’s 1 month 
postpartum BMI and total years of education. 
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 CHAPTER 4
 
Differences in BMI and Height Trajectories of Males 
and Females Associated with in utero Urinary 
Concentrations of Bisphenol A and Phthalate 
Metabolites 
 
Abstract 
Background: Exposures to the environmental endocrine-disrupting compounds 
Bisphenol A and phthalates have been linked to a variety of adverse health effects 
including greater weight status and waist circumference. Cross-sectional studies 
have demonstrated non-monotonic relationships between exposure and outcomes, 
as well as sex differences in metabolites of interest and direction of association. 
However, associations from cross-sectional analyses have not been supported by the 
limited number of longitudinal studies. As children and adolescents do not grow 
with constant velocity, assessing outcomes at a single point in time may lead to 
inaccurate estimates of how these exposures may affect growth. 
Objective: To assess the BMI and height trajectories of children from birth to 14 
years of age using tertiles of third trimester maternal urinary concentrations of BPA 
and phthalate metabolites.  
Methods: Fractional age polynomials and mixed effects models were fit separately 
for males and females for BMI and height trajectory models. Likelihood ratio tests 
were used to determine which models were better fit with the inclusion of tertiles of 
each metabolite, covariates, and interaction terms. Models were plotted with 
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covariates centered at average values for each tertile. Ages where salient differences 
between tertiles of predicted BMI and height were determined.  
Results: Highest predicted BMI and height trajectories for females were observed for 
third tertiles of phthalate metabolites, while males with first and second tertiles of 
phthalate metabolites had highest predicted trajectories. The phthalate metabolites 
associated with trajectories for females (MECPP) were different than those for males 
(MiBP, MBzP, MEP, MCPP, MEHP, MEHHP, MEOHP). Findings for Bisphenol A 
and height trajectory were inverted compared to phthalate metabolites, with the 
highest predicted height trajectory occurring with first tertile for females and third 
tertile for males. 
Discussion: Utilizing growth modeling of exposures to environmental endocrine-
disrupting compounds, our results suggest that males and females are associated 
with different phthalate metabolites, suggesting differential sensitivity to exposures. 
Additionally, the BPA tertiles associated with height trajectory for males and females 
were reversed compared to their associations with phthalate metabolites and BMI 
trajectory. 
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Background 
Childhood obesity is a globally persistent disease with multifactorial sources 
and a wide range of complications (Ebbeling et al. 2002). The balance between 
energy intake and expenditure cannot explain the increases in obesity prevalence 
observed in the past few decades; many contributing factors have been suggested, 
including exposures to environmental endocrine-disrupting compounds (Baillie-
Hamilton 2002; Grün and Blumberg 2009; Institute of Medicine 2012; Zinn 2010).  
Two compounds implicated with the rapid increase in childhood obesity are 
Bisphenol A (BPA) and phthalates. These multi-functional materials are used in 
everyday products; their prolific use has resulted in ubiquitous exposure to these 
compounds and their metabolites in humans of both genders and all age groups 
(Adibi et al. 2003; Calafat et al. 2008; Callan et al. 2012; Frederiksen et al. 2011; 
Pirard et al. 2012; Silva et al. 2004; Taskeen et al. 2012). BPA is used in the 
production of polycarbonate plastics and epoxy resins and is commonly found in 
food and beverage containers, medical equipment, toys, the linings of canned foods, 
thermal receipt paper, and dental sealants (Mendum et al. 2011; Shelby 2008; 
Vandenberg et al. 2007a). Phthalates are used as plasticizers in many consumer and 
industrialized products and as a stabilizing and solubilizing material (David et al. 
2012; Hauser and Calafat 2005; Meeker 2012).  High molecular weight phthalates 
are used in manufacturing flexible vinyl plastics and are commonly found in food 
and beverage containers, medical equipment, and vinyl flooring while low molecular 
weight phthalates are often found in solvents, paint thinners, medications and 
personal care products such as lotions, creams, and nail polish (David et al. 2012; 
Hernández-Díaz et al. 2009; Lewis et al. 2013).  
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Exposure is widespread, with >92% of the U.S. population six years and older 
with detectable metabolites in their urine; metabolites have also been detected 
during pregnancy, with evidence of these metabolites in the amniotic sac and cord 
blood (Calafat et al. 2008; Callan et al. 2012; Cantonwine et al. 2010; Chou et al. 
2011; Meeker 2012; Silva et al. 2004; Vandenberg et al. 2007a). Exposures occur 
primarily from ingestion of food and beverages in contact with containers utilizing 
these plasticizers, but are also known to occur through inhalation and dermal contact 
(Adibi et al. 2003; Clark et al. 2011; Rudel et al. 2003; Wilson et al. 2003, 2007; 
Wormuth et al. 2006).  
Exposures to these compounds have been implicated in obesity and increased 
waist circumference and fat mass and may be due to alterations in adipogenesis, 
lipogenesis, and metabolic imbalance such as impaired glucose and insulin response 
(Alonso-Magdalena et al. 2005a; Carwile and Michels 2011; Hao et al. 2012; Harley 
et al. 2013; Hatch et al. 2008; Hauser and Calafat 2005; Hugo et al. 2008; Lang et al. 
2008; Lind et al. 2012a, 2012b; Masuno et al. 2002; Newbold 2010; Ropero et al. 
2008; Ryan et al. 2010; Sakurai et al. 2004; Shankar and Teppala 2011; Stahlhut et 
al. 2007; Teitelbaum et al. 2012; Trasande et al. 2012; Wang et al. 2012a, 2012b, 
2012c; Wei et al. 2011). Other health effects from exposures to BPA and phthalate 
metabolites have been noted: asthma, male reproductive development, timing of 
puberty, neurodevelopment, and shortened gestational length (Braun et al. 2011; 
Cantonwine et al. 2010; Colón et al. 2000; Frederiksen et al. 2012; Hsu et al. 2011; 
Kerkhof et al. 2012; Meeker et al. 2009a; Suzuki et al. 2012; Swan et al. 2005; 
Whyatt et al. 2012). Many cell and animal studies show effects at concentrations 
relevant to those encountered by humans, making current environmental levels a 
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cause for concern (Alonso-Magdalena et al. 2005a; Hao et al. 2012; Marmugi et al. 
2012; Vandenberg et al. 2007b).  
Few human studies examine the associations between exposures to BPA and 
phthalate metabolites with weight status; of these, most are cross-sectional and 
longitudinal studies are limited in age range. Cross-sectional data in youth and adult 
populations suggest a positive association between exposures to BPA and phthalates 
with BMI, waist circumference, fat mass, insulin resistance, and diabetes; many find 
differences in associations by sex as well as evidence of non-monotonic relations 
between exposure and outcomes (Bhandari et al. 2013; Carwile and Michels 2011; 
Eng et al. 2013; Hatch et al. 2010, 2008; Li et al. 2013; Shankar and Teppala 2011; 
Stahlhut et al. 2007; Trasande et al. 2013a, 2012, 2013b; Wang et al. 2012d; Wells et 
al. 2013).  
Of human studies examining associations between prenatal exposures on 
weight status or adiposity, only BPA has been assessed and with inconsistent results. 
Among a primarily Latina community in the United States, a cross-sectional analysis 
at 9 years of age found positive associations with higher BPA concentrations and 
BMI, overweight and obesity, fat mass, and waist circumference (Harley et al. 2013). 
Prenatal urinary BPA concentrations from this population were found to be 
associated with lower odds of overweight and obesity, and lower BMI and percent 
body fat among girls at 9 years of age in the highest tertile of BPA concentrations. In 
contrast, Valvi et al (2013) observed that prenatal BPA exposure was weakly 
associated with waist circumference Z-score and BMI z-score in children at 4 years of 
age, though the latter was non-significant (Valvi et al. 2013).  
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Most epidemiological research on exposures to endocrine-disrupting 
compounds and their associated health effects have focused on assessing the impact 
of exposure on outcomes at one or several static points in time. This approach only 
allows a glimpse into the potential consequences of these exposures, particularly 
when the exposures occur at sensitive or critical periods of development where 
lifelong altered trajectories could be initiated (Inadera 2013; La Merrill and 
Birnbaum 2011). As many studies of BPA and phthalate metabolites find 
contradictory results, these may be due to the use of cross-sectional data as well as 
range of ages where outcomes are assessed.  Therefore, assessing a conclusion at one 
point in time may not be optimal when determining the projected outcomes from 
these exposures, particularly as parameters of growth are influenced by the perinatal 
environment. 
Growth patterns are often assessed by comparing how children grow with a 
standard or reference (de Onis et al. 2007). These patterns indicate the course of 
development for children and adolescents and can be used to assess an individual’s 
growth through time as well as how they compare to peers of their age and sex. These 
trajectories allow estimation of milestones, such as infancy peak or the adiposity 
rebound, and could be used to link childhood growth with adult diseases like obesity 
(Dietz 1997; Rolland-Cachera et al. 1984). Derivation of velocity and acceleration of 
growth can also be used as early measures of later adverse outcomes (van Lenthe et 
al. 1996; Tzoulaki et al. 2010). One trait that growth patterns assess is adiposity; 
although BMI and other measures such as waist circumference and skinfolds are 
commonly used, height is also associated with adiposity in early life (Boeke et al. 
2013; Freedman et al. 2002; Gibson 2005; WHO 1995).  
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Given the advantages of growth trajectories over singular measurements of 
gauges of adiposity, we utilized a birth cohort with children currently aged 8-14 
years. We examined the possibility that exposures to endocrine-disrupting 
compounds in a sensitive period of development such as pregnancy may alter 
subsequent growth trajectories which could have implications for later health. By 
utilizing growth modeling, we fit and assessed the trajectories of BMI and height for 
males and females by tertiles of BPA and phthalate metabolites in a cohort of 
children from 0.25 years to their current ages of 8 to 14 years.  
Methods 
Study Population 
 This investigation utilized data from the Early Life in Mexico to 
ENvironmental Toxicants (ELEMENT) research collaboration with Mexico’s 
Instituto Nacional de Salud Pública (INSP) that consists of three sequentially-
enrolled birth cohorts from Mexico City. The recruitments started in 1994 at family 
clinics serving low-to-moderate income populations. Similar exclusion criteria were 
applied to all three cohorts including living outside of Mexico City, gestational 
diabetes, preeclampsia, or pregnancy-related hypertensive disorder, as well as other 
criteria described elsewhere (Ettinger et al. 2009; Gonzalez-Cossio et al. 1997; 
Téllez-Rojo et al. 2004). Common recruitment methods allow for pooling of the birth 
cohorts for analysis. Follow-up of the three cohorts were continuously maintained, 
with study visits at 3, 6, and 12 months of age and then every six months until 60 
months; these children were then maintained in follow-up with 1-3 additional 
observations after the age of 5 years. Ages of the analytic sample range from 8-14 
years. Trained personnel obtained biological samples, anthropometry, and 
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administered surveys to mothers to gather information on sociodemographic 
characteristics. 
Anthropometric Measures 
At one-month postpartum, maternal height was obtained using professional 
scales (BAME Mod 420; Catálogo Médico) read to the nearest 0.1 centimeter (cm) 
and maternal weight was recorded to the nearest 0.1 kilogram (kg). Children’s 
anthropometry were taken by study personnel using established research protocol 
(Lohman et al. 1988). Weight (BAME Mod 420; Catálogo Médico) was measured to 
the nearest 0.1 kg; height (BAME Mod 420; Catálogo Médico) was measured to the 
nearest 0.1 cm.  Duplicate measures were taken of weight and height; the observed 
values were averaged. An additional measurement was taken if intra-personal 
variability exceeded the measurement tolerance of 0.5 cm. Body Mass Index (BMI) 
was calculated as weight divided by height squared (kg/m2). 
Urinary BPA and Phthalate Metabolites 
A spot (second morning void) urine sample was collected from each woman 
during her third-trimester visit to the project's research center and frozen at − 80 °C; 
these were coordinated with urines from adolescents at follow-up. Samples were 
analyzed for total (free + glucuronidated) BPA and nine phthalate metabolites by 
NSF International (Ann Arbor, MI, USA) using validated modification of the Centers 
for Disease Control and Prevention (CDC) methods described elsewhere (Calafat et 
al. 2008; Lewis et al. 2013; Silva et al. 2007). The nine phthalate metabolites 
included: monoethyl phthalate (MEP), metabolite of diethyl phthalate  (DEP); 
mono-n-butyl phthalate (MBP), metabolite of di-n-butyl phthalate (DBP); mono-
isobutyl phthalate (MiBP), metabolite of di-isobutyl-phthalate (DiBP); mono(3-
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carboxypropyl) phthalate (MCPP), metabolite of DBP and di-n-octyl phthalate 
(DOP); monobenzyl phthalate (MBzP), metabolite of butylbenzyl phthalate (BBzP); 
and mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl) 
phthalate (MEHHP), mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), and mono(2-
ethyl-5-carboxypentyl) phthalate (MECPP), metabolites of di(2-ethylhexyl) phthalate 
(DEHP). Specific gravity (SG) of the urine samples was measured using a handheld 
digital refractometer (ATAGO Company Ltd., Tokyo, Japan).  
BPA and phthalate metabolite concentrations below the limit of quantitation 
(LOQ) were assigned a value of LOQ/sqrt(2). Values were then corrected for SG 
using: 
 =   − 1
 − 1 
where Pc is the SG-corrected BPA or phthalate metabolite concentration (ng/mL), P 
is the measured urinary BPA or phthalate metabolite concentration, SGp is the 
median of the urinary specific gravities for the sample (SGp for mothers = 1.013), and 
SGi is the urinary specific gravity for the individual (Mahalingaiah et al. 2008). 
Specific gravity instead of creatinine was used because creatinine concentrations 
may be confounded by physical activity, time of day, diet, morbidity, and muscularity 
(Boeniger et al. 1993).  
Statistical Analysis 
Data analysis was completed using SAS (version 9.3; SAS Institute, Cary, NC, 
USA) for Windows. Descriptive statistics and distributions for all variables were 
assessed. Each child had 5 to 12 observations for BMI and height.  BMI and height 
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values were checked for biological implausibility by visually assessing their growth 
trajectory. Three participants had one BMI observation that was atypical of their 
individual growth trajectory and three non-overlapping participants had heights that 
did not follow their trajectory; the questionable BMI and height value for each 
participant was removed from statistical analysis while retaining the other values.  
Following an approach similar to published methods, BMI trajectories were 
constructed using a fractional polynomial age approach (Royston and Altman 1994; 
Wen et al. 2012). Whereas Wen et al. (2012) modeled BMI trajectories of individual 
children and used the fitted trajectory to determine the age and BMI at infancy and 
adiposity rebound, we fit sex-stratified models to assess the BMI and height 
trajectories resulting from exposures to tertiles of individual BPA and phthalate 
metabolites from the third trimester of pregnancy. The construction of the expected 
value of BMI was:  
 =  +


 
where m is the model degree and the exponential  is selected from a set of 8 chosen 
values, including -2, -1, -0.5, log, 0.5, 1, 2, and 3. The minimum model degree was set 
at m = 3, since all children had 3 or more observations and the maximum degree was 
set at m = 8. Therefore, 219 candidate models were considered, with 1 model of the 
8th degree, 8 models of the 7th degree, etc., and 56 models of the 3rd degree. The 
optimal number of fractional polynomial age terms from the 219 candidate models to 
include in the final models for males and females was selected based on smallest 
Akaike information criterion (AIC) and Bayesian information criterion (BIC). A 
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smaller AIC signifies a model that is thought be closer to the truth whereas a smaller 
BIC signifies that a model is thought to be more likely to be the truth. BIC more 
heavily penalizes model complexity, so both AIC and BIC are used in the model 
selection. The models were estimated separately by sex for the inclusion terms of 
each degree and assessed by goodness of fit tests. Models for each sex are shown in 
Table 4.1.    
Mixed effects models using proc mixed were used to fit BMI trajectories 
within sex strata, with fixed effects for each fractional polynomial age term, which 
reflects the trend for the population-average, and random effects for intercept and 
linear age for each child, which reflects how each child deviates from the population-
average. For each BPA and phthalate metabolite, tertiles of the metabolites and their 
interaction terms with the age variables were entered as fixed effects along with 
covariates centered at their mean. For example, the unadjusted model for BMI 
trajectory in females with the third tertile as the reference is: 

 =   +  
! +  "
!.$ +  %
.$ +  &
 +  $
% +  '()*+,1

+  -()*+,2
 +  /()*+,1
 × 
! +  1()*+,1
 × 
!.$
+  ()*+,1
 × 
.$ +  ()*+,1
 × 
 +  "()*+,1
 × 
%
+  %()*+,2
 × 
! +  &()*+,2
 × 
!.$ +  $()*+,2

× 
.$ +  '()*+,2
 × 
 +  -()*+,2
 × 
% +  + 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+ 2
 
For each BPA and phthalate metabolite for males and females, the likelihood 
ratio test was conducted with the null model containing the age polynomials 
compared to the partially-adjusted model containing the age polynomials, the SG-
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corrected metabolite, and their interaction terms. Predicted BMI trajectories for each 
tertile of EDC metabolite were plotted for the partially-adjusted models with 
significance at p≤0.1 (results not shown). Likelihood ratio tests were then conducted 
with the null model containing the age polynomials and the a priori identified 
covariates mother’s years of schooling and BMI at 1 month postpartum centered at 
their means, against the fully-adjusted model additionally containing the SG-
corrected metabolites and their interaction terms with the age polynomials. Plots of 
fully-adjusted predicted BMI trajectories for each tertile with covariate values that 
were centered at their means were plotted for models with significance at p≤0.05 
from the likelihood ratio test. Accordingly, these plots demonstrate the estimated 
BMI trajectories for each tertile of the phthalate metabolite or BPA exposure for an 
individual with average characteristics. Estimated differences between tertiles were 
assessed using estimate statements in proc mixed. Results indicating ages at which 
significant differences (p≤0.05) between predicted tertiles occurred were plotted. As 
the likelihood ratio test takes all three tertiles into consideration and tests whether at 
least one group differs from another, the significance detected from the estimated 
differences between tertiles is used as a descriptor of which ages those differences 
occurred. 
BMI velocity was plotted by taking the first derivative of the age polynomials. 
Estimates between tertiles of exposure were conducted using estimate statements in 
proc mixed to assess ages when significant differences (p≤0.05) between tertiles 
occurred (results not shown). 
Height trajectory models were fitted using the same approach with BMI 
trajectory analysis. The optimum age terms were selected for males and females 
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from the 219 candidate models using smallest AIC and BIC. Selected age polynomials 
were different for males and females. The models, inclusion terms for each degree, 
goodness of fit tests, and chosen models for each sex are shown in Table 4.2. 
Likelihood ratio tests were conducted for partially- and fully-adjusted height 
trajectory models with the same approach using the same covariates, mother’s years 
of schooling and BMI at 1 month postpartum centered at their means. Plots of fully-
adjusted estimated height trajectories for each tertile were plotted for models with 
significance at p≤0.05 using covariate values centered at their means. Estimated 
differences between tertiles using the estimate statements in proc mixed were used 
to determine ages where significant differences (p≤0.05) between predicted tertiles 
occurred. Height velocity analysis was conducted using the same approach as for 
BMI velocity (results not shown).  
Results 
 Table 4.3 shows the characteristics of the sample population. Among 249 
children, 47% were male. Current mean age was 10.3 years for males and females, 
current height was 138.cm 6 for males and 138.3 cm for females, current BMI was 
19.1 for males and 19.8 for females. Mothers at 1 month postpartum had an average 
BMI of 26.7 for male children and 27.2 for females, and mothers of male children 
averaged 11.3 years of education and 10.8 years for females. Among 2,162 total visits, 
78% occurred at or under the age of 5 years old.  
 Distributions of BPA and phthalate metabolites in maternal third trimester 
urine are shown in Table 4.4. The majority of all pregnancy samples had detectable 
concentrations of BPA (26-36%<LOQ) and phthalates metabolites (0-11%<LOQ). 
Wilcoxon rank-sum tests comparing differences in concentrations between mothers 
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of males and females showed no significant differences except for BPA 
(GM=0.9ng/mL females; 0.7ng/ml males; p=0.05). 
 The results from the likelihood ratio test for BMI trajectory comparing the 
fully-adjusted model with SG-corrected metabolites, covariates, and age polynomial 
terms and their interactions with metabolites with the null model containing the age 
polynomials and covariates are shown in Table 4.5. Fully-adjusted models for female 
MECPP and male MiBP, MBzP, MCPP, MEHP, MEHHP, and MEOHP were a 
significantly better fit (p≤0.05) than the null models.  
Figures 4.1-7 show the predicted BMI trajectories and the estimated 
differences between tertiles for an individual with average covariate values in each 
tertile of exposure. For female MECPP, the third tertile of exposure has the highest 
predicted BMI trajectory by the children’s current age though, for most of the 
trajectory time period, the third tertile of exposure had the lowest predicted BMI 
trajectory (Figure 4.1).  
For males, the first and second tertiles of exposure had the highest predicted 
BMI trajectory. The first and second tertiles for the low molecular weight phthalate 
metabolites MiBP (Figure 4.2), MBzP (Figure 4.3), and MCPP (Figure 4.4) were 
observed to decline in early childhood before crossing the trajectories of the second 
and third tertiles of exposure and become the highest predicted BMI trajectory.  The 
first and second tertiles for the high molecular weight phthalates MEHP (Figure 4.5), 
MEHHP (Figure 4.6), and MEOHP (Figure 4.7) were consistently high throughout 
childhood. Figure 4.8 graphically shows where the ages and estimated significant 
BMI differences by tertiles of phthalate metabolites were observed. Figure 4.9 shows 
the ages where significant estimated BMI differences between tertiles occurred and 
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the color coding indicates whether those differences are positive (red) or negative 
(blue). For example, significant estimated differences between BMI trajectories were 
observed for female MECPP between tertiles 1 and 3 for the ages of 0.3 to 1.1 years 
and between  tertiles 2 and 3 for ages 0.6 to 2.5 years (Figure 4.8 and 4.9). While 
fully-adjusted MCPP was significant in the likelihood ratio test, there were no 
significantly observed differences between tertiles (Figure 4.8 and 4.9).  
For BMI trajectories, ages of significant differences between tertiles of 
metabolites followed different patterns for high and low molecular weight phthalates 
and between males and females (Figure 4.9). Male low molecular weight phthalate 
metabolites MiBP and MBzP had significant differences in the first few years of life, 
whereas the high molecular weight phthalate metabolites MEHHP and MEOHP were 
found to have significant differences in the mid-childhood years. This was in contrast 
to the female high molecular weight phthalate metabolite MECPP, where ages of 
significant estimated differences between tertiles occurred in early life. 
 Results from the likelihood ratio test for height trajectory comparing the fully-
adjusted model with SG-corrected metabolites, covariates, and age polynomial terms 
and their interactions with the metabolites with the null model containing the age 
polynomials and covariates are shown in Table 4.6. Fully-adjusted models were 
significant (p≤0.05) for female MECPP and male MCPP, MEP, and MEOHP.  
 Figures 4.10-13 show the predicted height trajectories and the estimated 
differences between tertiles for an average individual in each tertile of exposure. For 
female MECPP, the third tertile of exposure had the highest predicted height 
trajectory (Figure 4.10).  
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 For males, the first or second tertiles of exposure for MCPP (Figure 4.11), 
MEP (Figure 4.12), and MEOHP (Figure 4.13) had the highest predicted height 
trajectory. Figure 4.14 graphically shows where the ages and estimated significant 
height differences in growth by tertiles of phthalate metabolites were observed. 
Figure 4.15 shows the ages where significant estimated height differences between 
tertiles occurred and the color coding indicates whether those differences are 
positive or negative. For example, estimates between tertiles of female MECPP 
showed significant differences in height between tertiles 1 and 2 for ages 0.3 to 0.9 
years. While the fully-adjusted model for MEP was significant with the likelihood 
ratio test, there were no significantly observed differences between tertiles of the 
metabolite (Figures 4.14 and 4.15).  
 Significant estimated differences between tertiles of metabolites for height 
trajectories occurred in early life for the high molecular weight phthalate metabolite 
MECPP in females in contrast to the high molecular weight phthalate MEOHP in 
males, where significant differences occurred in the peripubertal years. In males, the 
low molecular weight phthalate metabolite MCPP showed significant differences 
between tertiles for most of the study period. 
Female (Figure 4.16) and male (Figure 4.17) BPA, while non-significant 
(p=0.10; p=0.07, respectively), had opposite findings than those for phthalate 
metabolites. For example, though the third tertile of the phthalate metabolite 
MECPP for females were found to have the highest trajectory, the first tertile of BPA 
had the highest trajectory. 
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Discussion 
 We observed that females with the highest tertile of phthalate metabolites had 
the highest predicted BMI and height trajectories whereas males with the first and 
second tertiles of phthalate metabolites were predicted to have the highest attained 
BMI and height trajectories. Additionally, females and males were influenced by 
different phthalate metabolites, which have been observed previously (Hatch et al. 
2008). Ages of significant estimated differences between tertiles of phthalate 
metabolites differed between males and females, and between low and high 
molecular weight phthalate metabolites in males. Further exploration is needed to 
investigate the pattern behind this finding.  
 Harley et al. (2013) observed that prenatal exposure to the highest tertile of 
BPA was associated with a decrease in BMI z-score in females at 9 years of age, but 
an increase in males. As higher BMI values are correlated with increased height, our 
findings that the highest tertile of BPA is associated with the lowest predicted height 
trajectories for females while, in males, the highest tertile had the highest predicted 
height trajectory, suggestively mirror the observations by Harley et al. (2013). 
Together, these results are compatible within the context of overall growth, where 
height and weight are associated. 
It has been recognized that tall males and females, compared to their shorter 
contemporaries, have a higher prevalence of overweight and obesity (van Dommelen 
et al. 2014). Taller children also tend to have higher skinfold thicknesses and BMI 
levels; additionally, they may experience an earlier adiposity rebound and some 
studies find that they have higher attained BMI as adults, independent of BMI in 
childhood (Freedman et al. 2002). It is hypothesized that excess gain in weight and 
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fat during childhood may be a driver in linear growth and additional energy 
remaining after the promotion of height would be stored as fat (Freedman et al. 
2004; McCarthy 2014). 
Numerous mechanisms for this relationship between height and weight have 
been proposed, including alterations in growth hormone, ghrelin, insulin-like growth 
factor, androgens, and the complex interplay among these hormonal systems 
(Fennoy 2013; Marcovecchio and Chiarelli 2013). Similar biological processes may 
control linear growth and the deposition of adipose, so infants who are heavy for 
their age may grow into tall adolescents, possibly because increased adiposity in 
childhood frequently occurs in before, or in tandem with, height (Garn et al. 1974; 
Johnston and Mack 1980). In addition, sexual maturation and height may be 
biologically linked. Maturation occurs in taller children at a younger age and 
adolescents who mature at younger ages tend to be heavier as adults (van Lenthe et 
al. 1996; Parsons et al. 1999).  
Leptin is hypothesized to be a factor involved in skeletal growth by acting as a 
skeletal growth factor or via other regulatory systems (Maor et al. 2002). Overweight 
and obese children tend to have higher leptin levels and, as fat content and leptin 
levels are correlated and timing of sexual maturation is closely associated with body 
weight and, particularly, fat, leptin may potentially play a role in initiating an earlier 
onset of puberty (Frisch et al. 1973; Shalitin and Phillip 2003). Leptin may also 
influence the activity levels of enzymes necessary for adrenal androgen synthesis; 
obese children have an increase in adrenal androgen levels, which may impact rate of 
growth in the pubertal period (Genazzani et al. 1978; Shalitin and Phillip 2003). In 
addition, central leptin resistance, such as in the hypothalamus, is common among 
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obese individuals, and the differential sensitivity to leptin between these central sites 
and the skeletal growth sites in in the periphery may account for the increase in 
height in overweight and obese children (Shalitin and Phillip 2003). 
Thyroid function is another proposed mechanism which could alter growth; 
thyroid hormone is required for skeletal development and may act through the 
stimulation of insulin-like growth factor 1 (IGF-1), growth hormone, or activation of 
target genes (Bassett and Williams 2003; Yakar and Adamo 2012; Yen 2001). It also 
plays a role in determining function and development of adipose tissue; similar to 
PPARγ, thyroid hormone can induce adipose differentiation and proliferation 
(Flores-Delgado et al. 1987; Tontonoz et al. 1994). Cross-sectional studies have 
found alterations in levels of thyroid stimulating hormone (TSH) and the thyroid 
hormones T3 and T4 associated with BPA and phthalates exposure (Boas et al. 2010; 
Meeker and Ferguson 2011; Meeker et al. 2007; Wu et al. 2013). Variation in thyroid 
hormones may be a mechanism by which these exposures influence waist 
circumference and metabolic imbalance in adults; reductions in thyroid hormones 
have been associated with increases in BMI and in utero concentrations of thyroid 
hormones are known to be involved in programming body weight  (Grün and 
Blumberg 2009; Hatch et al. 2010; Knudsen et al. 2005; Lang et al. 2008; Zoeller 
2007). BPA is known to bind to the thyroid hormone receptor, acting as an 
antagonist and resulting in reduced T3 (Ibhazehiebo and Koibuchi 2011; Moriyama 
et al. 2002; Wetherill et al. 2007; Zoeller 2007). 
Limitations of this study include the relatively small sample size and the 
relatively fewer number of observations of BMI and height measures after the age of 
five, as follow-up was not systematic after that point in time. Extrapolations of 
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estimated values were conducted statistically and may not reflect actual trajectories 
of BMI and/or height. Another limitation is the use of a single spot urine. 
Concentrations of metabolites are known to vary widely throughout the course of a 
day and are influenced by a variety of factors such as diet, physical activity, and use 
of personal care products. However, previous studies have indicated that a single 
measure may be a moderately good measure of exposure due to the consistency of 
behaviors within an individual (Braun et al. 2012b; Mahalingaiah et al. 2008; 
Teitelbaum et al. 2008).  
However, the extensive follow-up within this prospective study design allows 
temporality of events and is a strong component towards establishing causality. The 
use of an exposure sample from pregnancy, when development is occurring rapidly, 
also adds to the strength of this study. The Developmental Origins of Health and 
Disease (DOHaD) framework considers these early life events to be crucial towards 
the possible programming of later health indices (Hanson and Gluckman 2008; 
Heindel and vom Saal 2009). There is accumulating evidence that exposures to these 
chemicals play a role in altered physiology from the perinatal period and animal 
studies have found effects at doses relevant to those encountered by human 
populations on weight gain, adiposity, and numerous metabolic imbalances 
(Marmugi et al. 2012; Wei et al. 2011).  
Some studies find that the association between tallness in overweight and 
obese children disappear after puberty. Pre puberty, obese children have a height 
advantage over their lean peers but they experience a reduced growth spurt in 
comparison, resulting in no difference in attained height (Denzer et al. 2007; He and 
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Karlberg 2001). Future work in disentangling the order of adiposity and linear 
growth as driving forces by modeling weight trajectory would be beneficial. 
In conclusion, this study explored whether exposure to environmental 
endocrine-disrupting compounds differentially alters growth trajectories of BMI and 
height. We found that different metabolites were associated with growth trajectories 
for males and females. MECPP in females was the only metabolite that was 
associated with BMI and height trajectories while MEOHP and MCPP were both 
significantly associated with males in our study population. The third tertile of the 
phthalate metabolite MECPP was associated with the highest trajectory of BMI and 
height in females. For males, the first and second tertiles of the phthalate 
metabolites MiBP, MBzP, MCPP, MEHP, MEHHP, and MEOHP were associated 
with highest attained BMI trajectory and the first and second tertiles of MEP, MCPP, 
and MEOHP were associated with the highest attained height trajectories. The 
tertiles associated with the highest trajectory were reversed with BPA and height 
trajectory, where the highest estimated height trajectory for females was observed 
with the lowest tertile, but the highest tertile in males.  
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Table 4.1. Best fit fractional polynomial function for each model degree for BMI 
trajectory. 
 
Model degree Terms included in best fit model for each degree Goodness of Fita 
 
Age(-2) Age(-1) Age(-0.5) log(Age) Age(0.5) Age Age(2) Age(3) AIC BIC 
Males (N=108) 
          
3rd 
   
X X X 
  
3484.8 3514.3 
4th X 
 
X 
 
X X 
  
3482.5 3525.4 
5th X X 
 
X X X 
  
2920.6 2074.3 
6th 
  
X X X X X X 3478.9 3554.0 
7th X X X X X X X 
 
3478.9 3554.0 
8th X X X X X X X X 3495.9 3592.4 
Females (N=115) 
          
3rd 
   
X X X 
  
3982.6 4012.8 
4th 
    
X X X X 3979.1 4020.3 
5th 
 
X X 
 
X X 
 
X 1411.1 1463.2 
6th X X X X 
  
X X 3973.9 4050.8 
7th X X X X X X X 
 
3981.6 4058.5 
8th X X X X X X X X 3982.5 4081.3 
aFinal model selection based on smallest AIC and BIC are indicated in bold 
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Table 4.2. Best fit fractional polynomial function for each model degree for height 
trajectory. 
 
Model degree Terms included in best fit model for each degree Goodness of Fita 
 
Age(-2) Age(-1) Age(-0.5) log(Age) Age(0.5) Age Age(2) Age(3) AIC BIC 
Males (N=108) 
          
3rd 
   
X 
 
X 
 
X 4513.0 4543.0 
4th 
   
X X X 
 
X 4514.1 4554.3 
5th 
 
XX XX XX 
 
X X XX 4526.5 4582.8 
6th 
 
X X XX XX XX XX XX 4523.4 4598.5 
7th X X X X X X X 
 
4523.4 4598.5 
8th X X X X X X X X 4531.8 4652.5 
Females (N=115) 
          
3rd 
    
X 
 
X X 5073.4 5103.6 
4th XX XX 
  
XX X X 
 
3507.0 3546.0 
5th X X X X X 
   
5073.3 5114.5 
6th X X X X X X 
  
5077.4 5135 
7th X X X X X X X 
 
5080.4 5157.3 
8th X X X X X X X X 5080.4 5157.3 
aFinal model selection based on smallest AIC and BIC are indicated in bold 
  X = model terms selected with equal AIC and BIC values as X; not selected for final model 
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Table 4.3. Characteristics of mothers and children in sample population. 
 
Characteristic Males Females 
 
N Mean±SD/% N Mean±SD/% 
Youth's age (yr) 117 10.3±1.5 132 10.3±1.7 
  height (cm) 117 138.6±10.5 132 138.33±10.9 
  BMI (kg/m2) 117 19.1±3.08 132 19.8±3.98 
Total number of visits 1033 
 
1129 
 
  age ≤1 years old 243 25 263 24 
  age>1 and ≤3 years old 381 36 424 37 
  age>3 and ≤5 years old 182 17 201 18 
  age >5 years old 227 22 241 21 
Mother's BMI 1 month 
postpartum 
114 26.7±4.2 126 27.2±3.6 
  years of education 115 11.3±2.8 130 10.8±2.8 
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Table 4.4. . Distribution of total (free+glucuronidated) BPA and phthalate metabolites in third trimester maternal urine 
(ng/mL uncorrected for dilution). 
 
 
          Percentiles 
Analyte LOQa Sex N %>LOQ GM (SE)b 10th 25th 50th 75th 90th 95th Maxc p-value* 
BPA 0.4 Male 107 64 0.7 (2.0) <LOQ <LOQ 0.6 1.1 1.8 2.7 9.0 0.05 
  
Female 116 74 0.9 (2.1) <LOQ <LOQ 0.7 1.4 2.3 4.1 18.7 
 
MBP 0.5 Male 107 100 53.3 (3.1) 11.8 25.5 58 112 204 318 1000 1.00 
  
Female 116 100 54.3 (3.5) 12.7 26.4 54.2 119 206 606 1190 
 
MBzP 0.2 Male 107 99 4.3 (2.5) 1.4 2.6 5.2 7.7 13.4 15.9 32.5 0.18 
  
Female 116 100 4.1 (2.7) 1.3 2.2 3.7 7.0 12.8 29.6 109 
 
MCPP 0.2 Male 107 94 1.2 (2.5) 0.3 0.6 1.3 2.3 3.4 4.0 12.1 0.36 
  
Female 116 94 1.1 (2.7) 0.2 0.5 1.1 1.9 4.0 6.6 11.1 
 
MEP 1 Male 107 100 108.9 (2.4) 23.2 44.6 111 222 594 1130 7950 0.80 
  
Female 116 99 114.5 (2.8) 20.2 40.8 115.5 241 762 1900 9810 
 
MiBP 0.2 Male 107 98 1.8 (2.7) 0.4 0.9 1.7 3.6 6.4 8.4 40.1 0.33 
  
Female 116 98 2.0 (2.9) 0.5 1.0 2.0 3.6 8.6 12.6 33.9 
 
MEHP 1 Male 107 89 5.0 (3.5) 1.0 2.5 6.1 10 16.6 18.8 62 1.00 
  
Female 116 91 5.2 (2.6) 1.0 2.5 5.6 9.5 16.8 30.1 54.7 
 
MECPP 0.2 Male 107 100 31.9 (2.6) 8.6 19.4 33.7 58.3 107 125 193 0.99 
  
Female 116 100 30.9 (2.9) 9.7 15.1 35.4 58.1 107 138 251 
 
MEHHP 0.1 Male 107 100 19.4 (3.6) 4.7 10.6 16.9 42.7 76.4 95.2 167 0.83 
  
Female 116 100 19.1 (4.7) 4.9 9.1 22.7 37.5 67.8 96.7 161 
 
MEOHP 0.1 Male 107 100 11.6 (2.7) 3.1 6.0 11.2 25.2 46.0 49.9 85.8 0.83 
    Female 116 100 11.6 (2.9) 3.2 5.8 13.3 24.7 42.7 56.1 133   
aLOQ: limit of quantification 
bGM: geometric mean(standard error) 
cMax: maximum 
*p-value from Wilcoxon-Mann-Whitney test for differences between males and females
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Table 4.5. Likelihood ratio test for BMI trajectory with best fit models for females 
and males. 
 
  Female Male 
  -2LL null -2LL full DF p-value -2LL null -2LL full DF p-value 
BPA 3777.8 3767.3 12 0.57 3402.1 3394.8 12 0.84 
MBP 3777.8 3762.6 12 0.23 3402.1 3383.9 12 0.11 
MiBP 3777.8 3763.9 12 0.31 3402.1 3373.3 12 <0.01 
MBzP 3777.8 3764.7 12 0.36 3402.1 3372.6 12 <0.01 
MCPP 3777.8 3768.6 12 0.69 3402.1 3381.3 12 0.05 
MEP 3777.8 3761.0 12 0.16 3402.1 3385.7 12 0.17 
MEHP 3777.8 3766.4 12 0.49 3402.1 3370.5 12 <0.01 
MEHHP 3777.8 3768.5 12 0.68 3402.1 3372.8 12 <0.01 
MEOHP 3777.8 3769.0 12 0.72 3402.1 3381.3 12 0.05 
MECPP 3777.8 3749.6 12 0.01 3402.1 3386.6 12 0.22 
anull model contains age polynomials and covariates 
bfull model contains SG-corrected metabolites, covariates, age polynomials, and their interactions 
cDF=degrees of freedom between null and full models 
*p-value comparing null to full model; significance indicates full model has better fit. 
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Table 4.6. Likelihood ratio test for height trajectory with best fit models for females 
and males. 
 
  Female Male 
  -2LL null -2LL full DF p-value -2LL null -2LL full DF p-value 
BPA 4943.4 4927.3 10 0.10 4460.5 4446.2 8 0.07 
MBP 4943.4 4927.5 10 0.10 4460.5 4451.1 8 0.31 
MiBP 4943.4 4934.8 10 0.57 4460.5 4447.2 8 0.10 
MBzP 4943.4 4935.5 10 0.64 4460.5 4456.6 8 0.87 
MCPP 4943.4 4935.3 10 0.62 4460.5 4420.2 8 <0.01 
MEP 4943.4 4929.9 10 0.20 4460.5 4444.6 8 0.04 
MEHP 4943.4 4926.5 10 0.08 4460.5 4452.8 8 0.46 
MEHHP 4943.4 4936.8 10 0.76 4460.5 4447.2 8 0.10 
MEOHP 4943.4 4936.4 10 0.73 4460.5 4443.9 8 0.03 
MECPP 4943.4 4925.2 10 0.05 4460.5 4446.3 8 0.08 
anull model contains age polynomials and covariates 
bfull model contains SG-corrected metabolites, covariates, age polynomials, and their interactions 
cDF=degrees of freedom between null and full models 
*p-value comparing null to full model; significance indicates full model has better fit
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Figure 4.1. Predicted BMI trajectories and estimated differences between tertiles of 
MECPP for a female with mean covariate values. 
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Figure 4.2. Predicted BMI trajectories and estimated differences between tertiles of 
MiBP for a male with mean covariate values. 
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Figure 4.3. Predicted BMI trajectories and estimated differences between tertiles of 
MBzP for a male with mean covariate values. 
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Figure 4.4. Predicted BMI trajectories and estimated differences between tertiles of 
MCPP for a male with mean covariate values. 
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Figure 4.5. Predicted BMI trajectories and estimated differences between tertiles of 
MEHP for a male with mean covariate values. 
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Figure 4.6. Predicted BMI trajectories and estimated differences between tertiles of 
MEHHP for a male with mean covariate values. 
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Figure 4.7. Predicted BMI trajectories and estimated differences between tertiles of 
MEOHP for a male with mean covariate values. 
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Figure 4.8. Ages and estimates of significant estimated BMI differences between tertiles of phthalate metabolites for males 
and females.  
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Figure 4.9. Ages of significant (p≤0.05) estimated differences between tertiles of 
phthalate metabolites that were significant from the likelihood ratio test for BMI 
trajectory. Red indicates positive estimated differences, blue indicates negative. 
 
 
Sex Metabolite Tertile
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Female MECPP 1 vs 3
1 vs 2
2 vs 3
Male MiBP 1 vs 3
1 vs 2
2 vs 3
Male MBzP 1 vs 3
1 vs 2
2 vs 3
Male MCPP 1 vs 3
1 vs 2
2 vs 3
Male MEHP 1 vs 3
1 vs 2
2 vs 3
Male MEHHP 1 vs 2
2 vs 3
1 vs 3
Male MEOHP 1 vs 2
2 vs 3
1 vs 3
Age
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Figure 4.10. Predicted height trajectories and estimated differences between tertiles 
of MECPP for an average female. 
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Figure 4.11. Predicted height trajectories and estimated differences between tertiles 
of MCPP for an average male. 
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Figure 4.12. Predicted height trajectories and estimated differences between tertiles 
of MEP for an average male. 
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Figure 4.13. Predicted height trajectories and estimated differences between tertiles 
of MEOHP for an average male. 
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Figure 4.14. Ages and estimates of significant estimated height differences between tertiles of phthalate metabolites for 
males and females.  
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Figure 4.15. Ages of significant (p≤0.05) estimated differences between tertiles of 
phthalate metabolites that were significant from the likelihood ratio test for height 
trajectory. Red indicates positive estimated differences, blue indicates negative. 
 
Sex Metabolite Tertile
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14
Female MECPP 1 vs 3
1 vs 2
2 vs 3
Male MCPP 1 vs 3
1 vs 2
2 vs 3
Male MEP 1 vs 3
1 vs 2
2 vs 3
Male MEOHP 1 vs 3
1 vs 2
2 vs 3
Age
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Figure 4.16. Predicted height trajectories and estimated differences between tertiles 
of BPA for an average female. 
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Figure 4.17. Predicted height trajectories and estimated differences between tertiles 
of BPA for an average male. 
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 CHAPTER 5
Conclusions 
 
 This dissertation research sought to investigate potential contributing factors 
in the globally pervasive increases of overweight and obesity. Utilizing the 
frameworks of sensitive and critical periods for development and the Developmental 
Origin of Health and Disease, disruptions during these periods were hypothesized to 
be more detrimental than those occurring outside these periods. This research used a 
study population in Mexico, a country undergoing the nutrition transition, where 
shifting dietary and physical activity behaviors may increase the risks for later 
increased weight status, as fetuses may be exposed to environments that they are not 
physiologically adapted for (Hanson and Gluckman 2008; Popkin et al. 2012). This 
study population was rich resource, having recruited mothers from pregnancy and 
continuously following them and their children, who are now in adolescence. This 
provides an opportunity to temporality establish risk factors and their consequences 
and, given that childhood and adolescent obesity have been shown to track into 
adulthood, to suggest possible reasons for the increase in global obesity burden (Guo 
et al. 1994). 
Chapter 2 focused on preterm birth as a stimulus for adverse catch-up growth 
and the relation with adolescent BMI, waist circumference, and obesity. Chapters 3 
and 4 involved assessment of exposures to the endocrine-disrupting compounds 
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Bisphenol A and phthalate metabolites during pregnancy and adolescence. The 
objectives in chapter 3 were to assess the distributions of urinary metabolites in 
pregnancy and adolescent urines and to examine the continuous and quartile 
exposures in both time periods with adolescent BMI z-score, waist circumference, 
and triceps skinfold. Chapter 4 focused on the novel application of growth trajectory 
methods to examine whether tertiles of exposure to metabolites during pregnancy 
would differentially affect BMI and height trajectories 
In chapter 2, we found no association between preterm birth and later odds of 
obesity or increases in BMI or waist circumference in either males or females. This 
study would greatly benefit from a larger sample size, as well as additional 
information regarding the type of preterm birth that occurred, such as spontaneous 
or medically indicated. However, our findings that maternal obesity was a significant 
risk factor for later child and adolescent obesity mirrored findings from other studies 
(Rooney and Ozanne 2011; Symonds et al. 2013). Possible future work could include 
the use of repeated measures to assess whether catch-up growth occurs for children 
born preterm, as well as whether the velocity of growth. 
Preterm birth research would be greatly enhanced by improved quality and 
systematic reporting of all births in a globally-regulated format. Attaining consensus 
over definition and categories (spontaneous vs. medically-indicated vs. voluntary) of 
preterm birth would help monitor the changes in rates of preterm births reported. 
These practices would be informative to assess differences between low- and high-
income countries particularly with voluntary induction of preterm birth, medical 
technologies, and structure of reporting stillbirths, where the interpretation of 
viability may be prone to misclassification. In developed countries, 5-10% of all 
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preterm births are stillbirths, with antepartum origins but occurring during the 
intrapartum period, which could lead to misclassification (Flenady et al. 2011). 
Availability of advanced early life medical care and technologies could facilitate early 
delivery of fetuses not growing optimally, reducing the number of stillbirths, but 
increasing the number of preterm births.  
Implementation of various intervention strategies such as reducing the number 
of non-indicated caesarean deliveries and induction of labor, decreasing multiple 
embryo transfers during assisted reproductive technologies such as in-vitro 
fertilization, smoking cessation programs, and progesterone supplementation have 
only a projected conservative effect of decreasing the number of preterm birth rates 
by approximately 5% (Chang et al. 2013). However, the risk factors for preterm birth 
are diverse and elusive so it may be that focusing on modifiable behaviors, such as 
maternal over-nutrition, may be a realistic and positive modifier of a child’s risk for 
later adverse weight status. 
In chapter 3, we found that BPA and phthalate metabolites had primarily non-
monotonic associations with adolescent BMI z-score, waist circumference, and 
triceps skinfold, and that direction and magnitude of association differed for males 
and females, similar to other studies (Bhandari et al. 2013; Harley et al. 2013; Hatch 
et al. 2010, 2008; Teitelbaum et al. 2012; Wang et al. 2012a; Wells et al. 2013). 
Additionally, significant findings were observed in lower levels of exposure (e.g. 
second quartile rather than fourth quartile, compared to the first, reference, 
quartile), which was observed in other studies; the non-monotonic relationship 
between these endocrine-disrupting compounds and outcomes may be an exception 
to the oft-quoted notion that, for toxins, “the dose makes the poison” (Marmugi et al. 
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2012; Vandenberg 2014; Welshons et al. 2006). Suggestive associations for 
continuous urinary metabolites and outcome measures were different between the 
two time periods and our adolescent cross-sectional findings of higher fat mass and 
distribution from continuous measures of BPA and MEP exposures in females are 
consistent with other cross-sectional studies (Bhandari et al. 2013; Carwile and 
Michels 2011; Eng et al. 2013; Harley et al. 2013; Hatch et al. 2010, 2008; Li et al. 
2013; Shankar and Teppala 2011; Stahlhut et al. 2007; Teitelbaum et al. 2012; Wang 
et al. 2012a, 2012d).  
Chapter 4 examined BPA and phthalate metabolite tertile exposures in utero and 
the resulting BMI and height trajectories and velocities for each tertile. The objective 
of this chapter was to use growth curve modeling for individuals with the novel 
approach of applying it to tertile levels of exposure during a sensitive period of 
development. Using mixed models and fractional polynomial age terms, models were 
created separately for males and females. The resulting trajectories indicated that 
males and females were influenced by different metabolites and that the highest 
trajectories for females by age 14 were due to the third tertile of exposure, whereas 
the lowest tertile of exposure produced the highest trajectories for males. These 
findings were reversed for males and females with BPA and height trajectories, 
where the lowest tertile in females and highest tertile in males were associated with 
the highest height trajectory.  
Chapters 3 and 4 take advantage of repeated measures available in the study 
cohorts, as well as the archived biological samples from pregnancy, allowing us to 
examine a period of time where rapid development is occurring. The extensive 
follow-up time has also allowed us to examine outcome measures from biomarkers 
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in pregnancy at later ages than those previously reported in the literature. One 
limitation of this study is the use of a single spot urine during pregnancy and in 
adolescence, as BPA and phthalates are known to have short half-lives (Koch et al. 
2005; Völkel et al. 2002). However, other studies have shown that a single measure 
may be a relatively good measure due to the consistency of everyday behaviors 
leading to exposure (Braun et al. 2012b; Mahalingaiah et al. 2008; Teitelbaum et al. 
2008). Additionally, our confidence is stronger in the longitudinal results as reverse 
causality is not an issue. With cross-sectional studies, it is difficulty to establish 
temporality and results may be confounded by reverse causality; overweight 
individuals may consume more calories, or eat more foods packaged in materials 
with BPA and phthalates, resulting in a higher load of these chemicals.  
Future research directions for chapters 3 and 4 would be to assess whether 
associations persist later into adolescence, beyond the pubertal stage, with additional 
follow-up of participants. Additionally, it would be interesting to investigate the 
“double hit” hypothesis, where exposures to EDCs during the perinatal period 
followed by exposures during the peripubertal period are thought to induce 
outcomes that were more severe than if exposures had only occurred at one point in 
time. Furthermore, assessing mixtures of EDCs, rather than individual metabolites, 
would be more representative of how individuals are commonly exposed. 
Eliminating exposures to these compounds is likely impossible, given the 
pervasive nature of their use and multiple routes of exposure. However, several 
preventative strategies could be implemented by individuals to reduce their 
exposures, particularly during vulnerable periods of life such as pregnancy and early 
childhood. Limiting handling of thermal receipt paper, many of which contain BPA, 
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or choosing personal care products that do not contain phthalates could potentially 
reduce dermal exposure (Biedermann et al. 2010; Lewis et al. 2013). And, as oral 
contact is thought to be a major source of exposure, using glass or metal storage 
containers could decrease exposure; a dietary intervention involving the substitution 
of canned and packaged foods for “fresh foods” also found an average decrease of 
66% for BPA and 53-56% for DEHP metabolites, showing a possibility for reduction 
in ingestion exposure (Rudel and Gray 2011; Wormuth et al. 2006).  
Broadly, the results of this dissertation highlight that there may be factors 
outside an individual’s control that may influence weight status and adiposity. 
Finding and understanding these potential factors are beneficial to public health and 
health care practitioners as they may contribute towards the design and 
implementation of more effective prevention or intervention strategies on child 
obesity. 
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